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Abstract 
 
The increasing application of nanoparticles in medicine, particularly in imaging 
and therapy, is heavily reliant on fundamental understanding of their unique 
physicochemical properties. This thesis investigates the interactions that occur 
between nanoparticles and human cells, specifically their toxicity and the 
mechanism of their internalisation. Alkyl-capped silicon quantum dots (SiQDs) 
were chosen for this investigation because their physical properties have been 
well-characterised and they have very bright luminescence. These properties 
facilitate their detection inside cells by fluorescence microscopy and flow 
cytometry.  
Toxicity and uptake mechanisms for SiQDs in human cells were investigated. 
The intestinal cell line CACO-2 was used as a model for ingestion of 
nanoparticles. Uptake and accumulation of SiQS in CACO-2 cells was 
demonstrated by epi-fluorescence microscopy and confocal fluorescence 
microscopy. Cytotoxicity in CACO-2 cells was studied by oxidative stress 
measurement using a intracellular dye method (H2DCFDA) (ROS assay), cell 
viability determination (MTT and ATP assays) and DNA damage measurement 
(Comet assay).  Exposure of CACO-2 to SiQDs resulted in low cytotoxicity with 
regard to cell viability and effects on ATP production. SiQDs did not induce 
intracellular ROS production or DNA strand breaks. Over time periods up to 14 
days,  SiQDs showed no evidence of acute or chronic cytotoxicity.  
Accumulation of SiQDs inside a selection of human cell lines (CACO-2, HeLa, 
HepG2, and Huh7) was studied in detail using flow cytometry. SiQDs were 
internalised by all four cell lines. The highest levels of accumulation were seen 
with HepG2 and HuH7 cells. Some evidence for a role for caveolin 2 in this 
process in HuH7 was obtained using inhibitors and by gene expression 
analysis. The reason why HepG2 cells showed the highest accumulation of 
SiQDs remains unclear as caveolin expression measured by quantitative 
reverse transcriptase-PCR in these cells is very low. Further work on a possible 
role for the protein clathrin in the endocytosis process in these cells is needed 
as the inhibitor used to investigate this was toxic to the cells and firm 
conclusions could not be obtained.  
iii 
 
In summary, SiQDs are a highly promising alternative to heavy-metal based 
quantum dots and as a nanoparticle model to study mechanisms of uptake. 
SiQDs appear non-toxic in CACO-2 cells. However, the internalisation of SiQDs 
is cell-line dependent and further studies on their toxicity in cells such as HuH7 
which show high levels of internalisation and cells relevant to immune 
responses such as macrophages are needed. 
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2 
 
1.1 Nanoparticles 
 
Nanotechnology and nanoscience originate from the idea to make new devices 
and materials by exploiting the ability to change the structure of matter at very 
small (<100 nanometre (nm)) length scales (Leary, 2010, Doak et al., 2012).  In 
particular, small particles of semiconductors show dramatic changes in the 
electronic structure compared to the bulk forms (O'Farrell et al., 2006). These 
changes are a result of the quantum confinement effect (O'Farrell et al., 2006, 
Roduner, 2006) and manifest themselves most notably in the optical spectra of 
the particles. Materials which do not emit luminescence in the bulk or emit only 
at wavelengths outside the visible range (400-700 nm) may become brightly 
fluorescent on the nanoscale, e.g., cadmium selenide (CdSe), silicon (Si) 
(O'Farrell et al., 2006). The rapid growth of knowledge of new material 
properties is paralleled by the exponential growth of applications. However, 
knowledge regarding the interaction of nanomaterials with the environment, 
animals, and humans generally lags behind (O'Farrell et al., 2006).  
 
The nano prefix word has been used worldwide and ‘nano’ originated from the 
Greek meaning ‘dwarf’.  In science it is a prefix whose meaning is one billionth. 
One billionth is equivalent within the international system of units (SI) of 
nanometre (nm) is equal to one-billionth of a metre, 10–9 m (The Royal Society, 
2004, Buzea et al., 2007).   Nanoscience is the part of science in which the 
properties of materials which have at least one small (<100 nm) dimension are 
studied and also include synthesis, characterisation and explanation of the 
novel properties that arise. Nanotechnologies are the technologies to take 
advantages of the unique properties of the small materials to generate novel 
tools or devices. Nanotechnology and nanoscience have great potential benefits 
and to increase the applications of materials in multidisciplinary fields including 
electronics, sensing and healthcare. Nanomaterials at the size range 1-100 nm 
reveal unique properties compared with the original materials (bulk): particularly 
surface area and quantum effects. These effects alter physicochemical 
properties and may lead to increased chemical reactivity as well as changed 
optical, magnetic and electrical properties. This particle size range of 
nanometres (nm) is also found in nature, for example as pollutants and viruses. 
Viruses have diameters or lengths in the range 10-150 nm and they are well-
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known biological nanoparticles which also internalise into human cells by 
endocytosis mechanisms (The Royal Society, 2004, Eash et al., 2004). 
Nanoparticles have been found in nature; either as pollutants produced by 
deliberate manufacture or from natural processes. They have been produced by 
the photochemical activity of plants and algae, volcanic activity, combustion, 
and by human manufacturing, e.g., metal oxides (The Royal Society, 2004). 
 
Nanomaterials or nanoparticles have been categorised into 3 categories: those 
with one ‘nano’ dimension such as thin films, layers, engineered surfaces; two 
‘nano’ dimensions such as tubes and wires and three ‘nano’ dimensions such 
as particles, precipitates, colloids, and quantum dots (The Royal Society, 2004). 
The one and two dimensional nanomaterials are typically found in electronic 
device manufacture, chemistry, and engineering. The three dimensional 
nanomaterials are a huge group of nanoparticles and have been generated 
from various methods and sources. Nanoparticles can also be categorised into 
(at least) five groups: metal nanoparticles, metal-oxide nanoparticles, 
semiconductor nanoparticles, quantum dots (QDs) and fullerenes (Hardman, 
2006, Singh et al., 2009). 
 
In nanoparticles prepared from metals and semiconductors, the bond lengths 
and energies in the small particles are typically different from the bulk owing to 
the large fraction of the atoms that reside on the particle surface and play a 
crucial part in producing the alteration in the properties of nanomaterials 
compared to the bulk (Roduner, 2006). Another effect that occurs in small 
particles of semiconductor is the quantum confinement effect (Roduner, 2006).  
For QDs specifically, gaining knowledge of synthesis, physico-chemical 
properties, biological applications, biological interactions and mechanisms of 
interaction is important.  QDs have an altered electronic structure. The energy 
levels are more widely separated and generate a larger band gap. The band 
gap in QDs determines the luminescence energy and colour (O'Farrell et al., 
2006). From this perspective, the electronic structure of QDs is midway 
between that of bulk material (continuous energy bands with gaps) and 
molecules (discrete energy levels). The luminescence of QDs as of organic 
molecules has characteristics which are a consequence of their electronic 
structure (O'Farrell et al., 2006). Although both QDs and organic dyes generate 
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luminescence, QDs also have advantages over organic dyes with low sensitivity 
to high energy light and the ability to emit multiple colours with one excitation 
wavelength (Bruchez et al., 1998, O'Farrell et al., 2006). QDs are less 
susceptible to degradation under intense laser irradiation in a confocal 
microscope (O'Farrell et al., 2006).  
1.2 Quantum Dots (QDs) 
 
Semiconductor nanomaterials that are confined in all three dimensions are 
known as quantum dots (QDs).  Often QDs are composed of a crystalline core 
and a layer of cap or shell which serves to protect and isolate the core from the 
environment (Hardman, 2006). Typical quantum dots consist of elements in 
groups II and VI (CdSe, CdTe, CdS, ZnS, and ZnSe), groups IV and VI (PbS 
and PbSe, or groups III and V (GaAs, GaN, InP, and InAs) (Erogbogbo et al., 
2010).  QDs in the size range smaller than the Bohr radius of the exciton reveal 
unique physicochemical properties and quantum confinement effects (Hardman, 
2006). Quantum confinement results in an increase in the band gap, the 
threshold at which QDs absorb light is at an energy level higher than in bulk 
particles. In the limited space of a QD the electron-hole pair (exciton) formed by 
absorption of light is confined by the surface of the particle and this is 
responsible for the increase of the gap (Michalet et al., 2005).  The size of the 
QDs is therefore a key factor to produce strong luminescence of controlled 
wavelength (Parak et al., 2005). (Figure 1.1) (O'Farrell et al., 2006).  In general, 
smaller particles produce luminescence at higher energy, i.e., towards the blue 
end of the visible spectrum. 
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Figure1. 1 Schematic showing electron states of bulk and quantum dot. The 
bulk solid has continuous energy bands while the quantum dot has sequence of 
energy levels between two bands.  The diagram was adapted from O’Farrell 
and colleagues, 2006 (O'Farrell et al., 2006).  
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Photo stable QDs with size-tuneable fluorescent emission are now widely 
employed in labelling techniques to investigate cells and cellular processes 
even to the level of tracking individual molecules (Fu et al., 2005, Parak et al., 
2005). Initial investigations of QDs were focused on synthesis, characterisation 
and achieving a monodisperse distribution (narrow size). In the mid-1990s, 
there was a breakthrough in the development of synthetic routes to 
semiconductors comprising elements in groups II –VI; these syntheses provided 
highly crystalline material with good control over the particle size (Murray et al., 
1993, Hines and Guyot-Sionnest, 1996). These syntheses employed 
organometallic reagents at high temperature in a high boiling point coordinating 
solvent (trioctylphosphine oxide). The QDs comprise a luminescent CdSe core 
and are generally capped with a shell of ZnS.  ZnS has a larger energy gap 
than CdSe and therefore does not absorb the emitted light. It is crucial for the 
maintenance of the luminescence in biological media (Hines and Guyot-
Sionnest, 1996, Dabbousi et al., 1997). 
 
Zinc sulphide – capped cadmium selenide (CdSe) QDs have been studied 
further and researchers moved from development of synthetic methods and 
characterisation to in vitro biological investigation in human tumour-derived cell 
lines (e.g., HeLa) (Chan and Nie, 1998). In order to target specific molecules in 
the cell, QDs have been covalently bonded to antibodies  (to target proteins, 
viruses) or oligonucleotides (to target nucleic acid sequences), Mercaptoacetic  
acid ligands or organic polymer coatings are used to make covalent bonds 
between the ZnS shell and the biological molecules; they also help to improve 
the water solubility of the QDs (Chan and Nie, 1998). Nowadays, such QDs are 
commercially available in defined sizes (colours) with a range of bioconjugates 
(antibodies, DNA probes) and are widely used as alternative fluorescent labels 
to organic dyes and/or radioactive tracers. They show high sensitivity and lower 
toxicity or adverse health effects than many of the alternatives. 
 
New ways to prepare QDs with high biocompatibility have also drawn attention 
from many researchers. Hydrophilic QDs with phospholipid block-copolymer 
micelles help to increase applications of CdSe(ZnS) in in vitro and in vivo 
biological fluorescent labelling (Dubertret et al., 2002). Injection of QDs 
conjugated into micelles into Xenopus embryos revealed no adverse effects and 
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stable, long-term fluorescence was observed which allowed their use to trace 
the development of the embryo and determine cell lineage (Dubertret et al., 
2002).  
 
Fluorescent labelling is a powerful technique for exploring cell structure and cell 
function, but it is reliant on suitable fluorescent dyes. Organic dye molecules 
produce fluorescence following absorption of light to promote an electron from 
the highest occupied molecular orbital (HOMO) to the lowest unoccupied 
molecular orbital (LUMO). When the electron falls back into the HOMO, the 
energy difference is emitted as fluorescence. Although organic dyes have the 
capacity to aid microscopic examination of the cell and cell organelles, they are 
unable to maintain high intensity fluorescence for long periods of time because 
of photochemical side reactions that lead to degradation of the dye (O'Farrell et 
al., 2006).Therefore QDs, which are less sensitive to high energy irradiation and 
more stable during observation, are becoming popular as alternative choices for 
fluorescent labelling (Warner et al., 2005). The most studied of these new 
chromophores for biological labelling are CdSe quantum dots. CdSe with a ZnS 
shell emits light in the visible region and shows remarkable size-tuneable 
fluorescent emission (Medintz et al., 2005). Different sizes of CdSe with a ZnS 
shell QDs from left to right emitted different colours (blue to red) excitation with 
a single near –UV lamp (Figure 1.2). 
 
Another advantage of QDs over organic dyes lies in multicolour imaging. This 
has been achieved by embedding CdSe(ZnS) QDs of various sizes inside 
polymeric microbeads. One excitation wavelength in the near UV range 
(Mercury lamp) is sufficient to produce fluorescence from all the various-sized 
QDs in the microbeads and can even be used to encode the beads according to 
the particular combination of QDs embedded  (Han et al., 2001). Figure 1.1 
illustrates in a schematic manner that absorption of a single high energy photon 
can occur over a wide range of energies because of the remnants of the bulk 
band structure; in molecules, only discrete energy levels are present and a 
separate excitation wavelength is often required to excite each dye. 
 
QDs that are highly photo-stable with size tuneable fluorescent emission are  
being  incorporated into new techniques along with powerful traditional 
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fluorescence labelling techniques to investigate cells and cellular process at the 
level of individual molecules (Fu et al., 2005, Parak et al., 2005).  QDs are 
increasingly used as an alternative technique for biomedical applications over 
routine fluorophores in areas including multi cellular imaging, long term studies 
both in vitro and in vivo, high resolution tissue imaging and individual molecule 
trafficking (Fu et al., 2005).     
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Figure 1. 2 The image shows ten luminescent colors of CdSe with ZnS shell 
QDs excited with a near-UV lamp. The colors show the range of particles sizes 
started from small to bigger size left to right (blue to red). The wavelengths 
correspond to fluorescent colors are 443, 473, 481, 500, 518, 543, 565, 587, 
610, and 655 nm, respectively (Chan et al., 2002).  
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Despite the success of ZnS-capped CdSe QDs in biological applications, there 
is still some evidence of leaching of toxic heavy metal ions from the particles 
over long duration observation together with high intensity light which might be 
toxic to the cell. In addition the core-shell structure results in a large overall 
particle diameter of up to 20 nm which makes red-emitting QDs simply too large 
to be used for some intracellular imaging studies.  
1.3 Alkyl- Capped Silicon Quantum Dots (SiQDs) 
 
QDs present several useful points as advanced fluorophores but heavy metal 
issues are slowing down the process to apply QDs in biological and medical 
fields (Derfus et al., 2004, Hardman, 2006, Smith et al., 2008, Borsella et al., 
2013).  Some researchers have shown that the QD shell can restrict the amount 
of heavy metals in contact with living organisms and environment. However, 
there is still some difficulty because under biological environments or high 
intensity energy some studies reveal the release of metal ions from the core 
(Derfus et al., 2004). The adverse effects of QDs on living organisms result from 
release of metal ions (Derfus et al., 2004). However, small nanoparticles have a 
large surface to volume ratio and therefore are also often more reactive than the 
bulk materials from which they derive; they may therefore also induce toxic 
effects via other means such as redox reactions (Buzea et al., 2007). 
 
Red photoluminescence from high porosity  Si under excitation by a green or 
blue laser was observed by Leigh Canham in 1990 at room temperature 
(Canham, 1990); the luminescent image is shown in Figure 1.3. Moreover, Si 
technology is well developed and powerful. Si chips are already incorporated 
into everyday consumer products including some devices implanted within the 
body such as pacemakers (Canham, 2000).    
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Figure 1. 3 The image shows the first observation of Si luminescence: the 
strong red luminescent of monocrystalline Si under irradiation by an argon ion 
laser beam (green light) (Canham, 1990, Canham, 2000).   
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Due to the unique fluorescence as well as protection from heavy metals 
resulting in no inherent toxicity, porous and nanocrystal QDs prepared from 
porous silicon have been increasingly investigated for various biological 
applications (Lie et al., 2002, Park et al., 2009). Many methods have been 
proposed  to synthesise  silicon QDs with visible photoluminescence: porous 
silicon as well as nanocrystalline silicon, including electrochemical etching and 
sonication (Sweryda-Krawiec et al., 1999, Lie et al., 2002), reactive sputtering 
(Furukawa and Miyasato, 1988), sol-gel techniques (Zhang et al., 1998), Si into 
SiO2 implantation (Kovalev et al., 1998), self-assembly (Choi et al., 1998), 
synthesis in inverse micelles (Wilcoxon et al., 1999), laser ablation (Hata et al., 
2001), thermal annealing (Schoenfeld et al., 1996), thermal vaporization (Dinh 
et al., 1996), decomposition of silanes (Littau et al., 1993),  solution synthesis 
(Bley et al., 1996), hybrid techniques (Botti et al., 2001), and plasma processing 
(Mangolini et al., 2005).  However, to achieve useful applications in many fields, 
the synthesis methodology must be capable of providing a narrow and 
controllable size distribution, chemical stability, and strong photoluminescence. 
Si nanoparticles have been widely incorporated in various applications in the 
electronics field; however current synthetic techniques either produce material 
that is not monodisperse or is only available in very small amounts.  
Consequently, Si nanoparticle synthesis is an ongoing field of research. Silicon 
QDs  have high potential as an alternative to II-VI semiconductor QDs and 
organic dyes (O'Farrell et al., 2006).   
1.3.1 Alkyl-Capped Silicon Quantum Dots (SiQDs) Characteristics 
 
Silicon (Si) nanoparticles have been increasingly investigated in 
multidisciplinary fields: studying physicochemical properties, improving the 
synthesis process, increasing yield, making the particles stable in physiological 
conditions, and exploring fabrication methodologies suitable for biological and 
medical applications.   For biological and medical applications high 
specifications are needed such as: strongly fluorescence, less sensitive to 
colour quenching, suitable for multicolour investigations, biodegradable, a small 
particle size suitable for studying at the molecular level as well as low toxicity 
(O'Farrell et al., 2006). 
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SiQDs are one type of semiconductor nanoparticles know as quantum dots. The 
particles sizes are less than 10 nm. SiQDs are composed of a silicon core and 
covered by a C11 alkyl monolayer (C11 = undecyl). The core diameter is about 
2.5 nm and the diameter of the whole particle including the undecyl capping 
layer is about 5 nm (Alsharif et al., 2009).  A schematic model of the whole 
particle is shown in Figure 1.4. Alkyl-capped silicon quantum dots (SiQDs) are 
synthesised from porous silicon under high current densities with hydrofluoric 
(HF) solution (1:1 (HF: ethyl alcohol)) and reacted with undecene by 
hydrosilation reaction (Lie et al., 2002). Similar to hydrosilanes, the highly active 
hydrogen-terminated silicon surface undergoes a hydrosilation reaction with the 
undecene to form an alkyl monolayer in a toluene solution and the layer makes 
the particles hydrophobic as well as highly stable in the ambient environment. 
The stability is a result of the strong, inert Si-C bond which anchors the undecyl 
chain to the Si core.  SiQDs are easy to prepare as colloidal suspensions and 
dry silicon powders using the fabrication method described by Lie et al., 2002. 
In addition, SiQD preparation using an electrochemical technique, etching is 
convenient, cheap, and uses pure silicon (Si wafer) (Kang et al., 2011). 
 
SiQDs can be conveniently dispersed in various organic solvents and may also 
be prepared as non turbid suspensions in physiological solutions with high 
stability (Dickinson et al., 2008). The photo properties of colloidal SiQDs in 
aqueous solutions show stability over the pH range of 5-9. SiQDs suspension 
solutions reveal no turbidity over 6 months (Dickinson et al., 2008).  In addition, 
SiQDs with strong fluorescence, biocompatibility and high stability in 
physiological solutions have been studied in primary and tumour-derived human 
cells as fluorescent probes (Alsharif et al., 2009, Park et al., 2009). The SiQDs 
were found to show no acute toxicity, were successfully used to image tumours 
and then observed to degrade in mouse after 2 hours of exposure. 
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Figure 1. 4 Schematic model of the whole particle of SiQDs. The diameter of the 
whole particle including the crystalline silicon core and surrounding undecyl 
layer is about 5 nm. The core itself is width 2.5 nm (Alsharif et al., 2009).   
  
 
 
 
 
 
 
15 
 
The 11- carbons surrounding the particle core help to stabilise against 
flocculation and protect SiQDs from oxidation under ambient conditions as well 
as make the particle hydrophobic (Lie et al., 2002, Dickinson et al., 2008). The 
Si-C covalently bonding of SiQDs protects the particles from oxidation reactions 
and the particles are also resistant to strongly alkaline solutions (Lie et al., 
2002).  Though SiQDs are water insoluble, they may be dispersed in aqueous 
media after dissolving first in organic solvents in which they are readily soluble. 
Suitable solvents include tetrahydrofuran (THF), dimethyl sulfoxide (DMSO), 
diethyl ether (ether), and dichloromethane (DCM).  
1.3.2 Alkyl-Capped Silicon Quantum Dots (SiQDs) Physicochemical 
Properties 
 
The physicochemical changes in metals and semiconductor nanoparticles when 
the particle size gets smaller are known as quantum confinement effects - the 
size dependent changes of physicochemical properties. In theory, there are two 
main effects at nano size stage: the surface effects and the quantum effects 
(Roduner, 2006). The surface effects changes in reactivity because more atoms 
are on the particle surface and fewer in the bulk. The quantum effects changes 
in electronic structure due to confinement (already discussed). According to the 
quantum effects, the fluorescent characteristics of nanoparticles exhibit a 
discrete energy level spectrum (O'Farrell et al., 2006).  Also the energy gap gets 
bigger and shows high efficacy of the inter-band radiative recombination 
because the electron and hole are confined in close proximity as shown in 
Figure 1.5 (Canham, 1990).   
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Figure 1. 5 Schematic diagram:  A shows electron and hole confinement in 
close proximity in a nanoparticle and B shows electron and hole free to move 
throughout a large space in a bulk sample. In A the chance of electron-hole 
recombination is greater and this increases the quantum yield of fluorescence 
and the brightness. 
 
Therefore, the two characteristics of nanoparticles surface area and electrical 
properties have a huge impact on the physicochemical properties, and in 
addition these properties are very sensitive to diameter change.  There has 
been intense research into the properties and potential applications of Si 
nanomaterials with many studies synthesising particles and trying to find out the 
correlation between particle size and electrical characteristics. In 1988, 
Furukawa and Miyasato fabricated binary nanoparticles: small crystalline silicon 
particles with a hydrogen shell. Determination using reactive sputtering 
technique revealed an optical band gap of 2.4 eV inside the Si:H nanoparticles 
(particle size 20-30 Å). The optical band gap is increased about two-fold in Si:H 
nanoparticles (20-30 Å) when compared with the bulk Si optical band gap (1.1 
eV width) (Shirahata, 2011).  Moreover, the mesoporous Si layers produced 
from high porosity bulk Si wafer using electrochemical and chemical technique 
also showed photoluminescence (excited with green or blue laser) (Canham, 
1990). This implied that the altered diameter, mesoporous Si had higher band 
gap energy than the bulk material.  
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The luminescent Si nanoparticle can also be prepared as a luminescent 
colloidal silicon suspension (Heinrich et al., 1992). To make the luminescent 
silicon suspension, an electrochemical technique was used to break down  the 
porous Si of silicon wafer (n or p type) and disperse it into organic solvents such 
as methylene chloride, acetonitrile, methanol, and toluene (Heinrich et al., 
1992).   Transmission electron microscopy (TEM) revealed that the Si particles 
had high surface area with irregular shapes and strongly polydisperse size 
distribution including both micrometre and  nanometre sizes (Heinrich et al., 
1992).  
 
Si is a well-known and important material in microelectronics and most Si 
comes from flat, crystalline silicon wafers (Buriak, 1999). Immediately when a Si 
wafer is exposed to the air the single crystal Si  is coated with oxygen (O2) and 
turned into Si oxide (Buriak, 1999). Si oxide has proved to be a very useful in 
passivating bulk Si and it is well used in electronic devices (Buriak, 1999). The 
crystalline Si and the Si oxide on the top of Si wafer have been broken down 
into porous Si using ultrasonic dispersion in organic solvents (Bley et al., 1996). 
The particle characterisation of porous Si using high-resolution transmission 
electron microscopy (HRTEM), Fourier transform infrared spectroscopy (FTIR), 
and fluorescence spectroscopy revealed  heterogeneous particles sizes with the 
diameters  in the range of 2 to 50 nm (Bley et al., 1996).  The porous Si also 
containing the oxidised form showed a unique photoluminescence (PL) 
spectrum at 680 nm and between 415 to 446 nm using fluorescence 
spectroscopy.  It was proposed that the red fluorescence at 680 nm was 
attributed to quantum confinement effects and the blue fluorescence between 
145 to 446 was attributed to extremely small crystalline Si   (Bley et al., 1996).   
The surface area and the electrical properties are the key factors in properties 
of nanoparticles.  
 
1.3.3 Alkyl-Capped Silicon Quantum Dots (SiQDs) Preparation 
 
Since Canham, (1990) accidently discovered photoluminescence of 
mesoporous Si this has also advanced nanotechnology. Consequently, because 
of its unique physicochemical properties, porous Si has been fabricated and 
incorporated into the optical and electronic elements of integrated circuits as 
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well as being used for studying fundamental photoluminescence characteristics 
(Buriak, 1999). Moreover, most porous Si is prepared directly from oxidised Si 
crystallites.  Using stable form of porous Si, SiQDs have been prepared using 
electrochemical etching. In this procedure, the oxide surface of crystallite Si is 
replaced with the hydride terminated (Si-H) form. The hydrogen-terminated 
silicon exhibits similarities in behaviour to molecular  hydrosilanes (Lie et al., 
2002).   To make stable SiQDs with less sensitivity to ambient conditions, the 
alkyl termination (Si-C) is inserted by a hydrosilation reaction at hydride 
terminated Si. The Si-C bonds can be formed by direct reaction with the 
undecene and no catalyst. The alkyl termination also allow passivation with 
other chemicals to increase SiQDs applications (Bateman et al., 1998).      
1.4 Biomedical Applications of Alkyl-Capped Silicon Quantum Dots 
(SiQDs) 
 
As they are composed of just a crystalline silicon (Si) core surrounded with alkyl 
monolayers, SiQDs have a very small size and are stable in an aqueous 
environment. Moreover,  SiQDs emit strong fluorescence at the red end of the 
visible region which is low emission in cells as well as cell organelles (O'Farrell 
et al., 2006). In addition, SiQDs reveal outstanding characteristics such as the 
ability to be monitored, high surface areas, and biocompatibility.  It has been 
suggested that the small size of SiQDs which is similar to some cell organelles 
increases the potential of SiQDs to internalise into cells. Their characteristics 
are promising for biomedical applications as fluorescent probes both in vivo and 
in vitro. Consequently, they can be classified as multifunctional nanoparticles 
based on their physicochemical characteristics which make them potentially 
suitable for both diagnosis and treatment of disease at the same time (Park et 
al., 2009).  
 
SiQDs were used as fluorescent labels in in vitro studies by Alsharif and 
colleagues in 2009 in the first study of cytotoxicity. They found SiQDs 
accumulated inside cells and found no adverse effects in malignant and non-
malignant cells. Moreover, the internalisation and accumulation of SiQDs were 
high in malignant cells. In addition, the internalisation process was completely 
blocked by well-known inhibitors of cholesterol-dependent endocytosis. They 
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proposed that in HeLa and SW1353 cells, the internalisation process was 
cholesterol dependent  (Alsharif et al., 2009).  
 
A number of cell imaging studies have used Si quantum dots as probes to study 
cell function and cell organelles.  But not many studies have used simple SiQDs 
directly to study the cells. Almost the entire cell imaging studies used different 
bio-conjugated Si molecules for many purposes particularly for specific cell 
targets as well as to improve the solubility of the particles. Si has been 
conjugated with an oligonucleotide together with a photo inducer and used for 
DNA labelling (Wang et al., 2004). Proving stable and remaining fluorescent in 
aqueous solution as well as a valuable optical probe, Si was coated with 
phospholipid micelles (Erogbogbo et al., 2008). Fujioka and colleagues 
employed the active form of Si nanoparticles, Si oxide for studying oxygen 
radical production in harmful environments and compared this with the use of 
cadmium selenite (CdSe). They found ten times less toxicity of Si oxide than 
CdSe upon exposure to UV (Fujioka et al., 2008). Amino-terminated Si has also 
been studied in HepG2 cells. The cells accumulated Si quantum dots with 
strong fluorescence distributed throughout the cells without cytotoxicity effects  
based on confocal microscopy and assessment of cell viability within 48 hours 
by the MTT assay (Ahire et al., 2012).  Si quantum dots with various biological 
conjugations (lysine, folate, antimesothelin, and transferrin) have also been 
studied using human pancreatic cancer cells (Panc-1) (Erogbogbo et al., 
2011a). Si with different charges conjugated with amine, azide, and carboxylic 
acid have been used as a cell labelling probe to study cytotoxicity effects of 
surface charge and oxidative stress in a macrophage cell line NR8383 
(Bhattacharjee et al., 2010).   This study found that cytotoxic effects and ROS 
production were higher from positively and neutrally charged Si nanoparticles 
than from those with a negative charge.  Positively charged particles are more 
toxic because they can penetrate cells and organelles more easily. In addition, 
they are capable of generating ROS more effectively than neutral or negatively 
charged particles (Bhattacharjee et al., 2010, Froehlich, 2012). To adjust the 
physicochemical properties of Si for biological applications, using biocompatible 
materials is important. Si has been conjugated with poly-acrylic acid (PAAc) to 
improve stability and increase fluorescence and this showed low cytotoxicity in 
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several mammalian cell lines (HHL5, HepG2, and 3T3-L1) within 24 and 48 
hours (Wang et al., 2012).    
 
The toxicity issues relating to traditional quantum dots (cadmium selenite, 
CdSe) remain an important concern for QD applications in biological and 
medical fields (O'Farrell et al., 2006). Many studies have applied functional 
techniques to cover and hide the heavy metals to decrease or get rid of the 
adverse effects. However, under ambient environment and at long exposure 
times (for 2 to 8 hours) with high intensity irradiation during confocal 
microscopy, the biocompatibility might be altered with the heavy metal or the 
core revealed (Derfus et al., 2004). Unlike traditional QDs, SiQDs do not contain 
any heavy metals. Likewise, SiQDs are stable under strong luminescence. The 
optical properties are also less sensitive to high intensity energy during 
prolonged investigation under a fluorescent microscope compared with 
conventional organic fluorophores (Alivisatos, 2005, Michalet et al., 2005, Ipe et 
al., 2005, O'Farrell et al., 2006)  Consequently, SiQDs have been used as 
alternative safety choice of traditional QDs for cell imaging and biological probe 
as well as use as a template for studying the role of surface charge to generate 
cytotoxicity effects (Wang et al., 2005, Erogbogbo et al., 2008, Alsharif et al., 
2009, Park et al., 2009, Bhattacharjee et al., 2010, Shen et al., 2011, Tu et al., 
2011, Erogbogbo et al., 2012, Ohta et al., 2012).  However, silicon dioxide 
(SiO2) can be generated when silicon (Si) nanoparticles (NPs) are exposed to 
an aerobic atmosphere in biological and medical applications (Bhattacharjee et 
al., 2010).  Moreover, Si NP surface groups may vary in their toxicity effects 
depending on the charge of the group (Lie et al., 2002, Ruizendaal et al., 2009). 
Many researchers are interested in making Si NPs stable and safe in a 
biological environment.  
 
1.5 Toxicity studies on Nanoparticles 
1.5.1 General Toxicity of Nanoparticles 
 
Many studies using quantum dots (QDs) as fluorescent labels have shown that 
these QDs are strongly luminescent probes but there remain concerns about 
the use of heavy metals such as Cd. A significant concern is the toxic effects of 
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heavy metal contamination and release to biological materials (O'Farrell et al., 
2006). Furthermore, the size of QDs, which are less than 100 nanometre (nm), 
may result in different pathways of uptake in tissues and cells. QDs have been 
widely used, leading to increase concern about their toxicity and potential 
impact on the environment (Hardman, 2006). The impact of QDs on living 
organisms and the environment do not just originate from their physicochemical 
properties, but also from the composition of the QD. The composition of most 
QDs is metallic or semiconducting and most QDs are hydrophobic and may 
accumulate in membranes. Many researchers are interested in developing 
novel technologies to make QDs even more powerful tools for biology and 
medicine. Furthermore, QDs which absorb energy and emit fluorescence, can 
also generate reactive oxygen species which may cause adverse effects to 
living organisms (Oberdorster et al., 2007). Li et al (2003) studied the effect of 
particle size and composition on cellular uptake and toxicity. They found that 
ultrafine (100 µm) particle (UFPs) with a polycyclic aromatic hydrocarbon (PAH) 
coating had the potential to cause mitochondrial damage in macrophages and 
epithelial cells via oxidative stress (Li et al., 2003). Kirchner et al. (2005) studied 
the cytotoxicity of QDs (CdSe and CdSe/ZnS) with various surface 
modifications, including QDs coated with mercaptopropionic acid, silane, and 
polymer. They studied cytotoxicity of these QDs in various cell lines such as 
fibroblasts and breast cancer cells (Kirchner et al., 2005). They found that many 
parameters were associated with toxicity, including the release of Cd2+ ions from 
the core, the coating material, the stability of the particles, and perturbation of 
ion channels (Kirchner et al., 2005). Localization studies of heavy metals, 
cadmium chloride and QDs containing, CdTe/ZnS/PEG500 found that QDs 
accumulated with time in immunologic cells while cadmium chloride (CdCl2) did 
not accumulate (Yeh et al., 2011). The oxidative stress and cell signalling effects 
on macrophage cells by various surface coated quantum dots (CdTe/CdSe/ZnS) 
were characterized by Clift et al (2010). QDs showed effects on oxidative stress 
parameters on the basis of a decreased glutathione (GSH) concentration and 
impaired ability of the antioxidant Trolox to protect the cells from stress. Calcium 
(Ca2+) and pro-inflammatory cytokine tumour necrosis factor-alpha (TNF-α) 
were measured to determine cell signalling effects. The researchers suggested 
that organic QDs caused oxidative stress and disturbed cellular signalling (Ca2+) 
in macrophages (Clift et al., 2010). Hepatotoxicity effects of QDs 
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(Cd/Se/Te/ZnS/PGE-5000) have been studied in mice (Lin et al., 2011). The 
results showed that QDs 705 altered the balance of antioxidant systems, the 
uptake of essential elements and induced inflammation. However, liver 
morphology was unaffected.    
1.5.2 Cytotoxicity 
 
Cytotoxicity studies are a widely used technique for evaluating potential 
biological effects of nanoparticles in in vitro models. They have been used to 
investigate cellular interactions with nanoparticles. They are useful tools for 
investigation of the mechanism of nanoparticle adverse effects (Fotakis and 
Timbrell, 2006). The common cytotoxicity assays include 3-(4,5-dimethylthiazol-
2yl)-2,5-diphenyltetrazolium bromide (MTT), lactate dehydrogenase leakage 
assay (LDH), neutral red, and protein assay (Fotakis and Timbrell, 2006). 
Specific cytotoxicity designs to investigate the unique cellular responses include 
measurement of adenosine triphosphate (ATP) production, reactive oxygen 
species production (ROS) and cellular inflammatory responses including tumour 
necrosis factor-alpha (TNF-), interleukin6 (IL-6), and nitric oxide (NO) 
production. Various cell lines have been explored as models of specific target 
organs to find out the adverse effects of nanoparticles. Multi-safety evaluations 
are still needed for overall safety evaluation studies of nanoparticles.  
 
Oxygen-passivated Si-QDs have been used for biological labelling in living 
cells. The cytotoxicity effects of these QDs on HeLa cells were investigated 
using LDH release assay, succinate dehydrogenase mitochondrial activity, and 
superoxide anion detection assay (Fujioka et al., 2008).  Low toxicity of Si-QDs 
under UV exposure compared with cadmium selenite QDs (CdSe-QDs) which 
caused cytotoxicity by increasing radical production was shown. The safely of Si 
nanoparticles and microparticles in macrophages (RAW 264.7)  was 
investigated by measuring MTT (mitochondrial dye reduction),  Trypan blue 
assays, and the inflammatory biomarkers TNF-, IL-6, and NO (Choi et al., 
2009). This study found changes induced by both types of particle but low 
concentrations of nanoparticles did not affect cell viability or inflammatory 
markers. The cytotoxicity effects of Si nanoparticle (NPs) with a series of 
different surface charges (positive, neutral, and negative) have been studied in 
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CACO-2 cells using the MTT and 5-bromo-2-deoxyuridine (BrdU) assays to 
assess cell proliferation (Ruizendaal et al., 2009). This study found differences 
between the surface charges with negatively charged NPs less cytotoxic. The 
surface charge of Si QDsc to generate cytotoxicity effects on rat macrophages 
(NR8383) has been investigated using MTT and ROS determination assays 
(Bhattacharjee et al., 2010). This study concluded that surface charge was 
important in determining toxicity. In order to establish safe concentrations of 
nanotechnology materials that can be used without disturbing cellular activities 
and functions, colorimetric MTT and Trypan blue staining assays have been 
used to evaluate the safety of chemical poly-acrylic acid (PAAc) coated on 
silicon (Si) quantum dots (QDs) on human liver cells (HHL5, HepG2) and 
mouse embryonic fibroblasts (3T3-L1)(Wang et al., 2012). That study found that 
the coated QDs did not affect cell morphology, cell proliferation or viability, and 
did not cause DNA damage in the cell lines studied. The cytotoxicity effects of 
amine-terminated Si NPs on HepG2 cells have been investigated using the 
MTT assay but no significant toxicity was detected (Ahire et al., 2012). Recently, 
the mechanisms by which nanoparticles might cause cytotoxicity have been 
suggested to involve effects on parameters such as mitochondria membrane 
potential (∆m), cytoplasmic free Ca
2+ content, and caspase-3 activity. The 
cytotoxicity effects of Si NPs with different charged groups together with 
germanium NPs on CACO-2 cells and rat alveolar macrophage cells (NR8383) 
have been examined using MTT, BrdU, ROS assays, mitochondrial membrane 
potential, ATP content, cytoplasmic free Ca2+ content, TNF-, and caspase-3 
activity (Bhattacharjee et al., 2013).  The results obtained were complex but 
cationic NPs showed the most cytotoxicity with carboxylic acid-coated, dextran-
coated and PEG-coated Si and Ge NPs displaying no toxicity. The cytotoxicity 
with positively charged NPs could be detected by the MTT assay but there were 
other effects including increased levels of ROS, decreased mitochondrial 
membrane potential and increased caspase-3 activity and it was suggested that 
mitochondria played a key role in toxicity.  
 
Though there have been quite a few studies on possible toxicity of other Si NPs 
in mammalian cells as summarised above, information on SiQD interaction with 
mammalian cells is very limited. There is one study from Alsharif et al. (2009) 
which reported SiQD internalization by HeLa with no harmful effects.   
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1.5.3 Oxidative Stress 
 
Oxidative stress is a result of the imbalance of cell activity, with a high 
production of reactive oxygen species (ROS) and decreasing levels of 
antioxidants (Singh et al., 2009). Nanoparticles, size ( 100 nm), large surface 
areas and containing transition metal ions have a strong potential to generate 
cellular oxidative stress. There are two main hypothesises by which QDs could 
generate free radicals: photogenerated and surface oxide generated (Green 
and Howman, 2005). The possible pathways by which NPs might generate 
reactive oxygen species (ROS) and the effects of this including possible DNA 
damage are summarised in Figure 1.6. 
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Figure 1. 6 Possible pathways of internalization and the mechanisms by which 
alkyl-capped silicon quantum dots (SiQDs) generate ROS and cytotoxicity 
(Simko and Mattsson, 2010).   
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Ultrafine (UFPs) ( 0.1 μm) and fine (2.5 μm) have been localised inside 
treated murine macrophage (RAW 246.7) and human bronchial epithelial 
(BEAS-2B) cells using electron microscopy. When these cells were exposed  to 
UFPs (containing organic carbon and polycyclic aromatic hydrocarbon (PAH)) 
they showed high expression of oxidative stress markers: increased haem 
oxygenase-1 (HO-1), decreased intracellular glutathione, and increased free 
radical production (ROS) (Li et al., 2003). 
 
There have been few studies that considered oxidative stress-induced effects of 
Si NPs. However, Sood and colleagues reported that NP accumulation inside 
cells was a possible cause of indirect DNA damage via ROS production (Sood 
et al., 2011). 
 
1.5.4 Genotoxicity 
 
Genotoxicity is the potential of the test substance  to induce DNA damage 
(Singh et al., 2009). Carcinogenesis and fertility abnormality are strongly 
correlated with DNA damage and genotoxicity. QDs might promote DNA 
damage via a free radical pathway or some other effects on DNA possibly by 
direct interaction. (Singh et al., 2009, Sood et al., 2011). There are three 
possible mechanisms involved in genotoxicity. Nanoparticles may generate 
reactive oxygen species (ROS) thereby altering the balance of redox 
homeostasis. Consequently, the highly production of reactive oxygen species 
interact to the cellular macromolecules (DNA). Secondly, oxidative stress 
produces free radicals and leads to an inflammatory response. The cells 
respond to tissue injury or infection by releasing a large variety of soluble 
factors including cytokines and ROS. Finally, when DNA damage occurs, they 
invoke various cellular responses such as cell apoptosis and p53 gene triggers 
apoptosis (extensive DNA damage).  
 
There is no standard safety evaluation in general available to assess 
genotoxicity of nanomaterials at the moment.  The alteration of genetic material 
can cause reactions such as carcinogenesis or have a reproductive impact 
(Doak et al., 2012). According to the Organization for Economic Co-operation 
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and Development (OECD) there are three standard guidelines for genetic 
material toxicity evaluation; bacterial reverse mutation test (OECD 471), in vitro 
micronucleus assay (MNvit OECD 487), and HPRT forward mutation assay 
(OECD 476). The bacterial reverse mutation test or Ames test explores the 
mutation point of Salmonella Typhimurium and Escherichia Coli by using 
essential amino acid requirements. Mnvit is using to evaluate genotoxicity by 
detecting micronuclei in the cytoplasm during the cell’s interphase. The HPRT 
assay investigates the point mutation at the hypoxanthine-guanine 
phosphoribosyl transferase. However, the assays are originally intended to 
assess conventional chemicals and their use for nanoparticles may not be 
appropriate.  
1.6 Endocytosis 
 
Internalization of small and large molecules is one of most important functions 
of the cell. These molecules include essential small molecules such as amino 
acids, sugars and ions as well as macromolecules, albumins, hormones, and 
antigens but also NPs  including SiQDs (Conner and Schmid, 2003, Alsharif et 
al., 2009). The internalization of macromolecules is known as endocytosis.  
Endocytosis functions to control cell survival and response to the environment 
(Conner and Schmid, 2003). The endocytosis process starts at the cell 
membrane (Zimmerberg and Gawrisch, 2006). Endocytosis pathways can be 
classified in several ways but can be divided into phagocytosis and pinocytosis 
(Conner and Schmid, 2003). Pinocytosis pathways include those involving 
clathrin-mediated endocytosis, caveolin-mediated endocytosis involving 
caveolae and macropinocytosis. The phagocytosis and endocytosis processes 
are showed in Figure 1.7. 
 
Caveolae are located in the cell membrane and have an outstanding mini 
invagination structure compared with other vesicle portal of entry. A cholesterol-
/sphingolipid-rich lipid bilayer occupies the main part of the vesicle with the 
shape conferred by a caveolin protein dimer (Conner and Schmid, 2003). 
Cholesterol and caveolin are the key factors in determining caveolae stability 
and function (Silvius, 2003, Tedrick et al., 2004, Alsharif et al., 2009). The 
cholesterol constituent is a target for many pharmacological/chemical inhibitors 
28 
 
of lipid raft/caveolae mediated endocytosis process such as statins, methyl-β-
cyclodextrin (MβCD), filipin, nystatin, and cholesterol oxidase (Ivanov, 2008).    
The protein caveolin is also used as marker to distinguish caveolae  from other 
membrane compartments (Cohen et al., 2004). Moreover, caveolin deficiency 
has been studied in mice and mice with this deficiency are subject to many 
diseases such as diabetes, cancer, cardiovascular, atherosclerosis, pulmonary 
fibrosis, and variety of degenerative muscular dystrophies (Cohen et al., 2004). 
Caveolae are flask-shaped vesicles and are coated with three different proteins: 
caveolin-1, caveolin-2, and caveolin-3 (Cohen et al., 2004). The proteins 
function as structural components and also have a capacity to recruit numerous 
signalling molecules. The vesicle also contains a unique lipid composition, so-
called lipid rafts, which are enriched with cholesterol (Cohen et al., 2004).  
 
Most molecules in the size range smaller than 120 nm are internalised by 
eukaryotic cells using clathrin-mediated endocytosis, caveolin-mediated 
endocytosis, and clathrin- and caveolin-independent endocytosis (Conner and 
Schmid, 2003). QDs including SiQDs have particle sizes smaller than 100 nm 
and are proposed to be internalised by cells using the same mechanisms as 
macromolecules (Canton and Battaglia, 2012). Though roles for clathrin-
mediated endocytosis and clathrin and caveolin-independent endocytosis in 
nanoparticle entry into cells are also possible, several studies point to a more 
important role for caveolin-mediated endocytosis in nanoparticle entry. For 
example, Wang et al. (2009) showed that nanoparticle internalization was more 
efficient for particles smaller than the size of caveolae with the uptake of 20 nm 
and 40 nm nanoparticles 5-10 times greater than 100 nm particles. However, 
they found that caveolae were still able to take up 100 nm nanoparticles though 
with reduced efficiency (Wang et al., 2009). Further evidence that SiQD entry 
into cells involves caveolae comes from studies showing that filippin inhibits 
SiQD entry into HeLa cells (Alsharif et al., 2009). Information on the entry 
process for SiQDs in other cell types is still limited.   
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Figure 1. 7 Endocytosis processes, the dominant endocytosis pathways are 
micropinocytosis, clathrin-mediated endocytosis, caveolin-mediated 
endocytosis, and clathrin- and caveolin- independent endocytosis (Conner and 
Schmid, 2003).    
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1.7 Aims of the studies described in this thesis 
 
The studies described in this thesis have the following aims: 
 
 
(i) To prepare and characterise the physical and optical properties of alkyl-
capped silicon quantum dots (SiQDs)  
 
(ii) To characterise and quantify the optical properties of SiQDs in 
physiological solutions and human cells 
 
(iii) To elucidate the interaction of SiQDs with gastrointestinal cells (CACO-2) 
in short and long term exposure studies 
 
(iv) To explore systematically the uptake of fluorescent SiQDs in various 
human cell lines  
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Chapter 2. General Materials and Methods 
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2. General Materials and Methods 
 
This chapter describes all the materials used in the thesis together with 
methods that are relevant to more than one Chapter. Other methods are 
described in Chapters 3 to 6.  
2.1 Materials 
 
Chemicals and reagents were purchased from Sigma-Aldrich, Fisher Scientific, 
Scientific Laboratory supplies, Vector Labs, Flowgen Bioscience, Culture 
Collection Public Health England, Compart Technology, UK, Life Technologies, 
New England Biolabs, and Qiagen. More details are given below in Table 2.1. 
 
Table 2. 1 Materials and suppliers 
 
Nanoparticles synthesis 
Materials Suppliers 
Silicon wafer, boron-doped p-Si<100> 
oriented wafer (10 Ω cm resistivity) 
Compart Technology, Peterborough, 
UK 
Dichloromethane 99.8% Fisher Scientific 
Ethanol 95% GL Fisher Scientific 
Hydrofluoric acid ≥40% Sigma-Aldrich 
Toluene anhydrous, 99.8% Sigma-Aldrich 
1-Undecene,97% Sigma-Aldrich 
 
Mammalian cell culture 
Materials Suppliers 
IGE Intestinal epithelial 
Asmaa Alharbi (researcher), Saudi 
Arabia 
CACO-2 Human epithelial colorectal 
adenocarcinoma cells 
European Collection of Cell Cultures 
(ECACC) Public Health England, UK 
HeLa Human cervical cancer cells 
Institute of Cellular Medicine, 
Newcastle University   
Huh7 Human liver cancer cells 
Institute of Cellular Medicine, 
Newcastle University   
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Mammalian cell culture 
Materials Suppliers 
HepG2 Human hepatoblastoma 
Institute of Cellular Medicine, 
Newcastle University   
Trypan blue solution 0.4% Sigma-Aldrich 
Dulbecco’s phosphate buffered saline 
modified, without calcium chloride 
and magnesium 
Sigma-Aldrich 
Fetal bovine serum-heat inactivated Sigma-Aldrich 
Dulbecco’s Modified Eagle’s Medium 
- high glucose With 4500 mg/L 
glucose and sodium bicarbonate, 
without L-glutamine, sodium pyruvate, 
and phenol red, liquid, sterile-filtered, 
suitable for cell culture 
Sigma-Aldrich 
L-Glutamine solution 200 mM, 
solution, sterile-filtered, BioXtra, 
suitable for cell culture 
Sigma-Aldrich 
Penicillin/Streptomycin: with 10,000 
units penicillin and 10 mg 
streptomycin per mL in 0.9% NaCl, 
sterile-filtered, BioReagent, suitable 
for cell culture 
Sigma-Aldrich 
MEM Non-essential Amino Acid 
Solution (100×) without L-glutamine, 
liquid, sterile-filtered, BioReagent, 
suitable for cell culture 
Sigma-Aldrich 
Trypsin-EDTA Solution 10X 0.5% 
trypsin, 0.2% EDTA, trypsin gamma 
irradiated by SER-TAIN Process, 
without phenol red, in saline 
Sigma-Aldrich 
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Mammalian cell culture 
Materials Suppliers 
Fetal bovine serum-heat inactivated Sigma-Aldrich 
Dulbecco’s Modified Eagle’s Medium 
- high glucose With 4500 mg L-1 
glucose and sodium bicarbonate, 
without L-glutamine, sodium pyruvate, 
and phenol red, liquid, sterile-filtered, 
suitable for cell culture 
Sigma-Aldrich 
Sodium pyruvate solution 100 mM, 
sterile-filtered, BioReagent, suitable 
for cell culture 
Sigma-Aldrich 
Millex® syringe filter units, 
disposable, mixed esters pore size 
0.22 μm, diam. 33 mm 
Sigma-Aldrich 
Greiner culture flasks (filter cap), 
tissue culture treated surface area 75 
cm2, canted neck 
Sigma-Aldrich 
Centrifuge tube flat top cap sterile 
polypropylene non-pyrogenic 25 
tubes per rack 28 x 115mm 6000 x g 
max 50mL x 5mL Fisherbrand 
Fisher Scientific 
Centrifuge tube flat top cap conical 
bottom sterile / non-pyrogenic 
polypropylene 15mL x 0.5mL 17 x 
119mm 6000 x g max 10 racks of 50 
tubes Fisherbrand 
Fisher Scientific 
Needle 38mm hypodermic syringe 
sterile disposable 21 gauge Terumo 
Fisher Scientific 
Syringe disposable eccentric sterile 
plastic for gases and liquids without 
needles 20mL x 1.0mL Terumo 
Fisher Scientific 
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Mammalian cell culture 
Materials Suppliers 
Pipette serological sterile plastic with 
magnifier stripe individually wrapped 
4 subpacks of 50 pipettes purple 
25mL x 0.2mL Fisherbrand 
Fisher Scientific 
Pipette serological sterile plastic with 
magnifier stripe individually wrapped 
4 subpacks of 50 pipettes orange 
10mL x 0.1mL Fisherbrand 
Fisher Scientific 
 
Cellular internalization 
Materials Suppliers 
Microscope slide ground edges, twin 
frosted glass wrapped in cellophane 
76 mm x 26 mm 0.8 mm to 1.0 mm 
thick 
Fisher Scientific 
Coverslips No 1 24 x24 mm Scientific Laboratory Supplies 
Mowiol 40-88poly(vinyl alcohol) Sigma-Aldrich 
Glycerol BioXtra, ≥99% (GC) Sigma-Aldrich 
VECTASHIELD mounting medium Vector Labs 
 
MTT assay 
Materials Suppliers 
Thiazolyl Blue Tetrazolium Bromide 
powder, BioReagent, suitable for cell 
culture, suitable for insect cell culture, 
≥97.5% (HPLC) 
Sigma-Aldrich 
Microcentrifuge tube Safe-Lock write-
on graduated with lid latch 2.0mL 
colourless Eppendorf 
Fisher Scientific 
Transfer pipette fine tip sterile 
polyethylene 50 subpacks of 20 
pipettes 144mm length 3.5mL 
Fisher Scientific 
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MTT assay 
Materials Suppliers 
Hydrogen peroxide solution 30% 
(w/w) in H2O, containing stabilizer 
Sigma-Aldrich 
Propan-2-ol 99.5+% (GLC) SpeciFied Fisher Scientific 
Tissue culture dish Nunclon flat 
bottom polystyrene radiation sterilised 
128mm x 86mm 12 round well 
Thermo Scientific Nunc 
Fisher Scientific 
Tissue culture dish Nunclon 132mm x 
88mm flat bottom 6 round well 
Fisher Scientific 
Nunclon® MicroWell plates for 
automation 96 well (with lid), flat 
bottom, clear 
Sigma-Aldrich 
 
ATP assay 
Materials Suppliers 
Adenosine 5׳ – triphosphate (ATP) 
bioluminescent somatic cell assay kit 
Sigma-Aldrich 
Microcentrifuge tube Safe-Lock write-
on graduated with lid latch 1.5mL 
amber (light protection) Eppendorf   
Fisher Scientific 
 
ROS assay 
Materials Suppliers 
2,׳7׳ – Dichlorofluorescin diacetate ≥ 
97% 
Sigma-Aldrich 
Corning® 96 well plates, clear bottom 
96 well plate, polystyrene, TC-treated, 
clear flat bottom wells, sterile, w/lid, 
black, 48/cs 
Sigma-Aldrich 
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ROS assay 
Materials Suppliers 
BRAND™ UV cuvettes micro, center 
height 15 mm, chamber volume 70-
550 μL, window W × H 2 mm × 3.5 
mm 
Sigma-Aldrich 
 
Comet assay 
Materials Suppliers 
Greiner culture flasks, tissue culture 
treated T-25 flask, canted neck, 
surface area 25 cm2, capacity 50 mL, 
w/ filter cap (filter cap not pictured) 
Sigma-Aldrich 
Microscope slide superfrost plus 
adhesion glass grounded edges with 
white superfrost marking area 25 mm 
x 75 mm x 1 mm 
Fisher Scientific 
Dimethyl sulfoxide Fisher Scientific 
Macrosive agarose low melt 
seaplaque 25g 
Flowgen Bioscience 
SYBR® Gold nucleic acid gel stain 
(10,000 x concentrate in DMSO) 
Life technologies 
Ethylenediaminetetraacetic acid 
BioUltra, anhydrous ≥ 99% (titration) 
Sigma-Aldrich 
Trizma® base, primary standard and 
buffer ≥ 99.9% (titration), crystalline 
Sigma-Aldrich 
Sodium chloride, BioXtra ≥ 99.5% 
(AT) 
Sigma-Aldrich 
Phosphate buffer saline tablet Sigma-Aldrich 
Sodium hydroxide, BioXtra ≥ 98% 
(acidimetric) pellets (anhydrous) 
Sigma-Aldrich 
Hydrochloric acid ACS reagent, 37% Sigma-Aldrich 
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Gene expression 
Materials Suppliers 
Moloney Murine Leukemia Virus (M-
MuLV) Reverse Transcriptase 
New England Biolabs 
dNTP mix New England Biolabs 
RNase inhibitor New England Biolabs 
TaqMan® Universal Master Mix II, no 
UNG 
Life Technologies 
TaqMan® Gene Expression Assay, 
SM(CAV-1) 
Life Technologies 
TaqMan® Gene Expression Assay, 
SM VIC (GAPDH) 
Life Technologies 
TaqMan® Gene Expression Assay, 
SM(CAV-2) 
Life Technologies 
MicroAmp Fast Optical 48-Well 
Reaction Plate 4375816 
Life Technologies 
MicroAmp Optical Adhesive Film 
4360954 
Life Technologies 
2.2. Confocal Luminescence and Confocal Laser Scanning Microscopy 
 
These methods were used in the studies described in Chapters 3 and 4.   
 
A CRM200 confocal Raman microscope (Witec GmbH, Ulm, Germany) and a 
confocal laser scanning microscope (The Leica TCS SP2 system, with Leica 
DM IRE2 microscope, Argon/Krypton Laser (spectral confocal and multiphoton 
microscope, Leica microsystems Ltd, Milton Keynes, U.K.)) were used to 
visualise luminescence of SiQDs inside the cells and quantify the localisation as 
well as luminescent spectra of SiQDs.  An Argon Ion laser with high power 
intensity 35 mW at wavelength 488 nm is the power source of the confocal 
Raman microscope and was used as excitation source for SiQDs visualisation. 
The acquisition was performed with scan size 50x50 μm and 100x100 pixels. 
The confocal microscope detects structure of SiQDs by collecting light from a 
single focal plane and excludes the light that is out of focus. A fluorescent image 
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is generated by the laser moving rapidly across the SiQDs sample. The 
spectrum image of SiQDs was acquired by Raman spectroscopy.  
 
An Argon/Krypton laser at wavelength 488 nm is the power source for the 
confocal laser scanning microscope. This microscope generates an image in 
three dimensions: plane, horizontal and vertical (X, Y, and Z) by moving the 
sample with movable objective stage (stage scanning) and fixed the position of 
the laser source. Samples were observed using a HCX PLAPOCS 40x1.25 oil 
immersion objective lens.  
2.3 Culture of CACO-2 cells 
 
CACO-2 cells were used in experiments described in Chapters 4, 5 and 6. 
These cells were cultured in 75cm2 flasks containing sterile complete medium 
(syringe filter pore size 0.22 μm, diam. 33 mm) containing 15 mL of Dulbecco’s 
modified Eagle’s medium (D1145) supplemented with 20% (v/v) foetal Bovine 
serum (FBS) (F9665), 1% (v/v) penicillin/streptomycin (P0781), 1% (v/v) MEM 
non-essential amino acid solution (M7145), 1% (v/v) L-glutamine solution 
(G7531), and 1% (v/v) sodium pyruvate solution (S8636). The cells were grown 
at 37 oC, 5% CO2.The cell culture medium was changed every 2-3 days by 
replacing with warmed Dulbecco’s phosphate buffered saline (PBS) (D8537) 
and after washing twice, warmed complete medium was added using sterile 10 
mL pipette. After reaching 70-80 % confluence, cells were sub-cultured using 
trypsin-EDTA solution (5X dilution) (59418C). The culture medium was replaced 
with warmed PBS and washed twice. Then 5 mL of trypsin was added to 
replace the PBS and left on the cells for approximately 5 minutes till the cells 
were rounded up. Ten mL warmed complete medium was added to the flask to 
inhibit the trypsin reaction.  The cell suspension was transferred using 10 mL 
pipette and placed in a 50 mL centrifuge tube. The cell pellet was collected by 
centrifugation at 1000g for 5 minutes and used for new cultures or experiments 
or cell storage. For new cultures or experiments, the cell pellet was re-
suspended in warmed complete medium and divided into portions. For new 
cultures, the cell solution was pipetted into a new flask and made up to 10 mL 
with new warmed medium.  
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To measure cell density, cells were counted using a haemocytometer. The same 
amount of cell solution and Trypan blue solution (T8154) (total volume 20 μL) 
was mixed. The mixed solution (10 μL) was dropped into half cone notch of 
haemocytometer or the edge of the counting area.  Each counting area of 
haemocytometer is divided into nine equal portions of 1 mm by 1 mm. The cell 
counting was counted in 4 areas of the nine portions at the corner (top and 
bottom) using a hand held tally counter. After counting, the cells density was 
calculated as equation below.  
 
Cell density (cells mL-1)  = Counting cells x 2  (dilution factor)
      x 104 (mL-1) / 4 (areas)  
 
From the known cell density (cells mL-1), the required cell density was prepared 
by making serial dilutions using warmed complete medium. 
 
 
Cell stocks were stored in liquid nitrogen for further studies. To freeze down 
cells, the cell pellet was re-suspended in PBS and centrifuged at 1000g for 5 
minutes. The cell pellet was re-suspended in 10% (v/v) (dimethyl sulfoxide 
(DMSO) in FBS and aliquoted (1 mL) into cryo-tubes. The tubes were then 
frozen slowly in a ‘Mr Frosty’ to control the optimal rate of freezing and to 
preserve the cells (-1 oC minute-1) which had been filled with isopropanol and 
put in -80 oC overnight.  After 24 hours all the tubes were transferred into liquid 
nitrogen for longterm storage. 
 
To grow the cells, frozen cells in a cryo-tube were thawed at room temperature. 
After thawing, the cell solution was transferred into a 15 mL centrifuge tube and 
mixed with 4 mL warmed complete medium. The cell pellet was collected by 
centrifugation at 1000g for 5 minutes and re-suspended in 10 mL warmed 
complete medium.  The cell solution was placed in a 75cm2 flask and incubated 
at 37 oC with 5% CO2.          
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Chapter 3. Synthesis and Characterisation of Alkyl-Capped 
Silicon (SiQDs) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
42 
 
3.1 Introduction 
 
The semiconductor from which quantum dots (QDs) have been prepared 
include binary compounds consisting of elements in groups II-VI and III-V of the 
periodic table as well as elemental semiconductors such as Si. A quantum dot 
is a particle of semiconductor whose size is less than the Bohr radius of the bulk 
material (O'Farrell et al., 2006). In this context, the Bohr radius is the radius of 
the 1s orbit of an electron and the hole in the valence band produced by 
absorption of light in the semiconductor; if the particle itself is smaller than this, 
then the energy of the exciton increases and the properties of the particle 
change from that of the bulk material. The size of QDs are generally small as 1-
10 nm (Yu, 2008); QDs show unique optical properties (Alivisatos, 1996).  In 
particular, the photon energy of the light emitted by QDs is greater than that of 
the bulk material of which they are formed (Alivisatos, 1996).  The fluorescence 
characteristics of QDs are also strongly dependent on their size; as they 
become smaller, their electronic structure changes and the wavelength of the 
emitted light shifts towards the blue part of the spectrum. This allows the 
fluorescence of QDs to be tuned to emit at any wavelength simply by adjusting 
their size. QDs have drawn attention from researchers in many fields because 
of their unique photo-physical properties and their potential for diverse 
applications from the life sciences to optoelectronics. The commonly used QDs 
and dominant in biological fluorescence microscopy are comprised of CdSe and 
samples may be prepared which emit from the red to the blue region of the 
spectrum, with narrow line widths that allow multi-colour imaging (Yu, 2008).  
The most technologically important semiconductor, silicon is the second most 
abundant element on earth behind oxygen (Martin, 2013). Silicon in elemental 
form is rarely found in nature and classified as group 4 in the periodic table and 
as a metalloid as well as an inorganic element.  The most common form of 
silicon in nature is silicon dioxide, sand or quartz. Silicon in the form of silicon 
dioxide is widely used in many industries, particularly in biological/medical 
applications such as food and cosmetics as well as in the electronics industry.  
The biological applications have claimed benefits to human health from water 
soluble forms e.g., silicic acid. The dominant form of silicon found in human 
body is orthosilicic acid (Park et al., 2009, Martin, 2013).  
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The metalloid silicon is widely used in electronics in the form of bulk single 
crystal wafers.  Silicon wafer plays an essential role as the substrate on which 
integrated circuits for consumer electronics are formed (Canham, 1990). Porous 
silicon was discovered by A. Uhlir of Bell laboratories in 1956 during the anodic 
etching process as part of standard semiconductor manufacturing techniques, 
but its true nature was not understood until the discovery of room temperature 
luminescence from porous silicon by Canham, 1990. Later on luminescent 
colloidal suspensions of silicon nanoparticles were prepared by electrochemical 
etching of n- or p-type silicon (Heinrich et al., 1992).    
Porous silicon is comprised of pores and thin, nanometre scale pore walls of Si. 
It was originally generated by wet chemical techniques, i.e., anodic etching of 
silicon wafer (Canham, 1990, Buriak et al., 1999). Porous silicon has sufficiently 
fine structures that it displays quantum confinement effects (increase in band 
gap) as well as a substantial surface chemistry (Buriak, 1999). In bulk form, 
silicon has a low band gap energy (1.1 eV corresponding to emission in the 
infrared) and poor photoluminescence because the transition across the 
bandgap is indirect. An indirect gap is one in which the electron must undergo a 
large change in momentum as well as energy in order to cross the gap; light 
cannot supply the momentum and therefore this must be obtained from another 
source, typically the vibrations of the solid lattice and the transition probability is 
reduced (Mangolini et al., 2006, O'Farrell et al., 2006). Absorption of light in bulk 
silicon produces an electron in the conduction band which may either fall back 
into the hole, it left in the valence band with emission of light or it may lose its 
energy in a non-radiative manner by interacting with defects. Because the 
transition has a low probability, the nonradiative process dominates, and the 
energy of the electron is transferred to vibrations of the solid lattice (O'Farrell et 
al., 2006).  However, the optical properties are improved in porous silicon 
(Mangolini et al., 2006). The emission intensity increases because the transition 
is no longer indirect and also the gap between energy levels widens to typical 
values of about 2 eV corresponding to red light (O'Farrell et al., 2006). Bulk 
silicon also has a direct energy gap, but this is at about 3.4 eV and therefore 
corresponds to absorption of blue/near UV light in porous silicon (Lie et al., 
2002). 
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The luminescence properties of porous silicon are determined by the quantum 
confinement and the effects of surface chemical species. In particular silicon 
tends to oxidise and this is known to have a strong effect on the colour of 
luminescence (Wolkin et al., 1999) . Silicon quantum dots (QDs) have been 
synthesised by various methods (Furukawa and Miyasato, 1988, Littau et al., 
1993, Bley et al., 1996, Dinh et al., 1996, Schoenfeld et al., 1996, Choi et al., 
1998, Kovalev et al., 1998, Zhang et al., 1998, Wilcoxon et al., 1999, Botti et al., 
2001, Mangolini et al., 2005, O'Farrell et al., 2006). 
Alkyl-capped silicon quantum dots (SiQDs) are one of many types of quantum 
dots (QDs). Silicon quantum dots (SiQDs) have been synthesised at Newcastle 
University via the intermediate formation of porous silicon. This process starts 
with  Si wafer <100> (p-type, B-doped) (Figure 3.1) (10 Ω cm resistivity, 
Compart Technology, Peterborough, UK) as a silicon source and follows a two-
step procedure of etching and then hydrosilation under reflux (Lie et al., 2002, 
Dickinson et al., 2008, Alsharif et al., 2009).   
 
 
 
 
 
 
Figure 3. 1 The diagram shows A boron-doped (p-type); boron lacks one 
valence electron (compared to silicon) and B phosphorus or arsenic-doped (n-
type); these atoms contain one extra valence electron compared to silicon. 
 
These QDs do not have a heavy metal core and they might provide a solution to 
the problem of developing bright QD fluorescent labels with minimal effect on 
living organisms (Lie et al., 2002). The silicon quantum dots are composed of a 
crystalline silicon core and C11 alkyl monolayer shell (Alsharif et al., 2009). 
These SiQDs are very hydrophobic, but can nevertheless be dispersed in 
aqueous media where they were stable against oxidation and retained strong 
luminescence for several days (Chao et al., 2007, Dickinson et al., 2008). The 
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stability of alkyl-capped SiQDs is a result of the strong, nonpolarised Si-C bond 
at the surface; this covalent linkage also facilitates  functionalization organic 
compounds (Shirahata, 2011).       
SiQDs are a promising alternative to organic fluorescent dyes because they are 
stability under irradiation in various physiological media and do not contain 
heavy metals. SiQDs with strong fluorescence and simple structure have small 
overall particle size of about  5 nanometre (nm) which is an advantage for 
biological and medical applications (Alsharif et al., 2009). SiQDs have been 
used as a fluorescent probe to studies the particle internalisation by human cell 
lines as well as the potential cytotoxicity and the mechanism of internalisation 
by  cells  (Alsharif et al., 2009).  
The characterisation of the photo-physical properties of SiQDs in physiological 
solutions is crucial before applying the SiQDs for biological studies as 
fluorescent probes.  The best way to characterise the relevant properties of 
SiQDs for biological applications is to determine their absorption and emission 
spectra. The typically characteristics of the photo-physical properties include 
three parameters: the emission wavelength, the full width at half maximum 
(FWHM) of the emission spectrum peak, and the quantum yield (Yu, 2008).  
Overall the absorption and emission wavelengths depend on the size of the 
SiQDs via the confinement effect. The FWHM of the emission  reflects the 
particles size distribution and the quantum yield depends on the quality of the 
particle surface (Yu, 2008);  highly defective surfaces result in energy lose by 
non-radiative processes and produce a low fluorescence quantum yield.  
Quantum yield of fluorescence = number of photons emitted as fluorescence / 
number of photons absorbed  
Because the photo-physical properties of SiQDs are strongly dependent on the 
particles size, this should also be studied. Electron microscopy is not so as well-
suited as it is for CdSe QDs because the atomic number of Si is smaller and it is 
a weaker scattered of electrons. However, atomic force microscopy (AFM) was 
found to be ideally suited to directly observe individual particles and to allow the 
measurement of the particle size distribution by collection of many images. 
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This chapter: synthesis and characterisation of SiQDs is part of a complete 
study of SiQDs. The study comprised four parts: synthesis and characterisation 
of SiQDs, cellular internalisation studies of SiQDs, potential cytotoxicity of 
SiQDs, and endocytosis mechanism. The SiQDs core was synthesised from 
bulk crystalline silicon also known as silicon wafer. The bulk silicon or silicon 
wafer was etched to form the structure known as porous silicon; this was then 
broken down into fragments (SiQDs) and simultaneously capped with an 
organic monolayer to increase the stability of the particles. The organic 
monolayer (shell or cap) comprised an 11-carbon alkyl chain anchored to the Si 
core via robust Si-C covalent bonds. In this form SiQDs are stable towards 
oxidation by air or water and had a very hydrophobic.  The final SiQDs were 
characterised for their size and shape using Tapping Mode Atomic Force 
Microscopy (AFM). The SiQDs were characterised by absorption and emission 
spectroscopies. In particular, the emission (luminescence) intensity was found 
to be the simplest method to quantify the SiQDs. Furthermore the spectroscopic 
properties and luminescence of SiQDs in physiologically-relevant media were 
also determined. Finally, confocal microscopy/spectroscopy and luminescence 
microscopy were used to observe the distribution and aggregation of SiQDs in 
various media.         
3.2 Methods 
 
3.2.1 Alkyl-Capped Silicon Quantum Dots (SiQDs) Preparation 
 
SiQDs were prepared according to the procedure developed by Lie et al. (2002) 
with minor modifications as in Dickinson et al. (2008) and Al-sharif et al. (2009). 
Silicon wafer is the silicon source. The wafer Si<100> (P100) (10Ω cm 
resistivity, Compart Technology, Peterborough, UK) was cut into 1.1 x 1.1 = 1.2 
cm2 chips. Each chip was used as a substrate for etching in a 1:1 v/v solution of 
48% aqueous hydrogen fluoride (HF) and ethanol to produce porous silicon. 
The etching was carried out in a cylindrical PTFE electrochemical cell of internal 
diameter 1.5 cm) with a constant current at 400 mA for 5 minutes, supplied by a 
bench top power supply ( Keithley 2601 system source meter).  After 5 minutes 
the porous silicon, a roughly circular brown-yellow area, was formed on the top 
of the silicon chip (Figure 3.2A). Fluorescence of the porous silicon was 
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confirmed by eye with a hand-held UV lamp (365 nm) and the orange 
luminescent indicated successful etches (Figure 3.2B). Next, the porous silicon 
chips (x4) were placed in a Schlenk flask and refluxed under nitrogen (N2) in an 
anhydrous toluene solution  (~20 mL) containing 1 M of the alkene (1-
undecene). During the refluxing process the hydrosilation reaction occurs at the 
Si surface and the stress of bubble formation helps to break-up the porous layer 
into individual SiQDs (Figure 3.2).  
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Figure 3. 2 The porous silicon, a roughly circular brown-yellow area formed on 
the top of the silicon chip (A) and fluorescent image of porous silicon under UV-
lamp 365 nm (B). 
 
The reflux was continued for at least 4 hours till the colourless solution changed 
to a pale yellow colour. The pale yellow solution was decanted into a new flask. 
Solvent from the solution was removed under vacuum on a glass vacuum line - 
the solvent was trapped in a liquid nitrogen-cooled flask till a waxy yellow solid 
remained. The waxy yellow solid was re-dissolved in 200 µL dichloromethane 
(DCM) and excited with a UV lamp (365 nm) to produce orange luminescence 
(Figure 3.3). The DCM solution was divided into small portion in little glass vials 
with 10 µL each and left to allow evaporation of the DCM at room temperature. 
The residual yellow wax of alkyl-capped silicon quantum dots was stored in the 
vial, under which conditions it is known to be stable, Dickinson et al. (2008) and 
used as required in other experiments.  
 
 
 
1.2 cm 1.2 cm 
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Figure 3. 3 Alkyl-capped silicon quantum dots (SiQDs) in DCM which were 
excited by a UV lamp box (365 nm) to produce orange luminescence (A and B). 
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3.2.2 SiQDs Particle Height and Shape Characterisations 
 
Atomic Force Microscopy (AFM) 
The particle size and shape (images) of alkyl-capped silicon quantum (SiQDs) 
dots were characterised using AFM in Tapping ModeTM, a Multimode 
Nanoscope IIIA (Veeco Instruments Inc., Metrology Group, Santa Barbara) 
instrument. Tapping mode is preferred for these measurements over contact 
mode AFM because the SiQDs are weakly-adherent to the substrates and in 
tapping mode there is less tendency for the tip to push the particles around. The 
tip, which is attached to a flexible cantilever, moves across the surface of 
sample as well as executing a tapping motion normal to the surface. Meanwhile 
the laser beam which is focused on the back of the cantilever is deflected 
according to the displacement of the tip as it passes over topographical 
features. The deflected beam is focused on a four-quadrant split photodiode so 
that as the tip moves up/down or twists left/right the amount of light falling on 
each quadrant changes and can be converted electronically into a 
measurement of the tip deflection and therefore the feature height on the 
surface. Finally, the signal from the beam detector is converted into a grayscale 
or false colour image. In tapping mode, not only the height of surface features is 
measured, but the interaction of the tip with the surface changes the phase of 
the tapping motion. The tip deflection may lag the driving force and a phase 
image which provides information on mechanical properties of the surface is 
produced simultaneously with the height image.  
 
Sample preparation: 5 µL of 10% v/v SiQDs in DCM solution was dropped onto 
the top of cleaved mica (using tape) and left overnight. Next day, the mica was 
mounted on the steel chuck. Then the laser beam and the tip were aligned on 
the area of dried SiQDs on the mica. The scanner head was then placed on the 
isolation table (TMC) to prevent noise and vibration. The manufacturer’s 
instrument control software was used to set up the scan size at 10 µm then the 
integral gain and the proportional gain were set at 0.3 and 0.5. Finally, height 
and phase images were investigated.  
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3.2.3 Purification Studies of SiQDs  
 
3.2.3.1 Absorption Spectroscopy 
 
Optical property of alkyl-capped silicon quantum dots (SiQDs) to absorb energy 
was specified using absorption spectroscopy scanning from infrared (IR) to 
ultraviolet (UV), low to high energy (800-200 nm).  The energy (of light) of which 
absorption occurs determines the excitation wavelength in the fluorescence 
spectra (below).  
 
The optical spectroscopic properties of SiQDs were characterised by absorption 
spectra (Cary model 100 spectrometer). A quartz cuvette of 1 cm path length 
was used to measure the absorption spectra. The wavelength range was 800-
200 nm and a baseline correction was set for each absorption measurement. 
The absorption spectra of SiQDs dispersed in an organic solvent, 
dichloromethane (DCM), were measured using UV-Vis absorption spectroscopy 
SiQDs at concentration 1 mg mL-1 in DCM was used as stock solution. The 
serial dilution of SiQDs was prepared by dilution 1 mg mL-1 SiQDs into 1.25 and 
10 μg mL-1  in DCM. The absorption spectrum was scanned from lower energy 
800 nm to high energy 200 nm excitation wavelengths. All experiments were 
repeated at least 3 times. 
3.2.3.2 Emission Spectroscopy 
 
To characterise the optical property of SiQDs to emit fluorescence, emission 
spectroscopy was employed. 
The photoluminescence of SiQDs was characterised by fluorescence emission 
spectra (SpexFluoroMax/GRAMS 32). A quartz cuvette of 1 cm path length was 
used to measure the emission spectra. The excitation wavelength was set at 
330 nm and the range scan 345-850 nm were set for emission measurement. 
The emission slits were set at 5 nm. SiQDs were dispersed in organic solvent, 
dichloromethane (DCM), and their fluorescence was characterised using 
emission spectroscopy (Spex FluoroMax/GRAMS 32). The same samples of 
SiQDs from 3.2.3.1, the concentration of 1.25 and 10 μg mL-1 of SiQDs in DCM 
were measured for fluorescent intensities using emission spectroscopy. All 
experiments were repeated at least 3 times. 
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3.2.4 Quantifying Photochemical Properties and Luminescent Intensity per 
Mass (mg) of SiQDs 
 
3.2.4.1 Absorption Spectroscopy 
 
The optical absorbance of SiQDs as a function of concentration was determined 
in a similar manner to the spectra of section 3.2.3.1 Absorption Spectroscopy. 
Serial dilution of SiQDs was carried out starting from 1 mg mL-1 SiQDs to 
produce concentrations of 0.27, 0.29, 0.31, 0.33, 0.36, 0.40, 0.44, 0.50, 0.57, 
0.67, 0.80, and 1.00 mg mL-1 in DCM. The absorption spectrum of SiQDs in 
various concentrations were scanned from lower energy 800 nm to high energy 
200 nm excitation wavelengths.   
3.2.4.2 Emission Spectroscopy  
 
To study the relationship between concentrations and the corresponding 
photoluminescence intensities of SiQDs, SiQDs dispersed in organic solvent, 
dichloromethane (DCM) and characterised using emission spectroscopy ( Spex 
FluoroMax/GRAMS 32). The same samples of SiQDs as in section 3.2.4.1 were 
prepared at the concentration of 0.27, 0.29, 0.31, 0.33, 0.36, 0.40, 0.44, 0.50, 
0.57, 0.67, 0.80, and 1.00 mg mL-1 in DCM.  
3.2.5 Photochemical Properties Studies of SiQDs in Physiological 
Solutions 
3.2.5.1 Absorption Spectroscopy 
 
The stability of the optical properties of SiQDs in physiological solutions was 
investigated by absorption spectra in various types of physiological solutions. 
Stock solution 1 mg mL-1 of SiQDs in 0.7% (v/v) cremophor was dispersed in 
physiological solutions and the final concentration of SiQDs was 0.2 μg mL-1  
each of phosphate- buffered saline (PBS), Krebs solution, complete RPMI 
medium with phenol red and 10% (v/v) foetal Bovine serum (FBS), and 
complete DMEM medium with phenol red and 20% (v/v) FBS. 
3.2.5.2 Emission Spectroscopy 
 
The stability of the luminescence properties of SiQDs in physiological solutions 
was investigated by emission spectra in various types of physiological solutions. 
Stock solution 1 mg mL-1 of SiQDs in 0.7% (v/v) cremophor was dispersed in 
physiological solutions and the final concentration of SiQDs was 0.2 μg mL-1 
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each of phosphate- buffered saline (PBS), Krebs solution, complete RPMI 
medium with phenol red and 10% (v/v) foetal Bovine serum (FBS), and 
complete DMEM medium with phenol red and 20% (v/v) FBS. 
3.2.6 Luminescent Morphology, Particles Distribution, and Aggregation 
Studies of SiQDs in Physiological Solutions  
 
3.2.6.1 Scanning Confocal Microscope 
 
Morphology and fluorescence  of SiQDs in organic solvent, cremophor and 
dispersed in physiological solution were visualised using a confocal microscope 
(Leica TCS SP2,UK) with the 488 nm line of an Argon ion laser as the excitation 
light. SiQDs in 0.7% v/v cremophor solution (50 μL) were dried on the top of 
cleaned slide and fluorescent images were captured using a confocal 
microscope/spectrograph. All experiments were repeated at least 3 times. 
3.2.6.2 Fluorescent Microscope 
 
Morphology, particles distribution, and aggregation of SiQDs in organic solvent, 
diethyl ether (ether) and dispersed in physiological solution were visualised 
using epi-fluorescence microscope (Leica Laborlux) with excitation provided by 
a mercury arc lamp and a 300-400 nm bandpass filter which selects mainly the 
365 nm line of the mercury lamp.   SiQDs at concentration 1 mg mL-1 in 50 μL 
ether were dispersed in complete medium without phenol red and prepared the 
final concentration at 100 μg mL-1 and 1 mg mL-1 of SiQDs in medium. The 
SiQDs 50 μL from both concentrations were dropped on the top of cleaned slide 
and covered with cleaned coverslid. The slide was then visualised using epi-
fluorescent microscope.  All experiments were repeated at least 3 times. 
3.2.6.3 Studies on cell uptake of SiQDs by Confocal-Raman microscopy 
 
A cell line IGE which is derived from rat intestinal epithelium was used for 
preliminary SiQD uptake studies. We stopped using IGE cells because of 
uncertainty in the original background and stability. The cells were cultured as 
described for CACO2 cells in Section 2.3. Cell internalisation of SiQDs and 
photoluminescent stability of SiQDs inside the cells was examined by confocal 
microscopy. A stock solution at 1 mg mL-1 of SiQDs in 0.7% (v/v) cremophor 
was dispersed in physiological solution to prepare the final concentration of 0.2 
μg mL-1 of SiQDs in complete medium without phenol red. The cells were 
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treated with the SiQDs suspension for 1 hour and the fluorescence of SiQDs 
internalised by the cells was imaged using a confocal microscope/spectrograph 
with an argon ion laser (488 nm) as excitation source (WiTec model CRM 200, 
Ulm, Germany). All experiments were repeated at least 3 times. 
3.3 Results 
3.3.1 SiQDs preparation 
 
The preparation of SiQDs which comprise a silicon core and an organic capping 
layer of C11 alkyl chains used electrochemical etching in hydrofluoric-ethanol 
solution and refluxing in anhydrous toluene with 1-undecene.  During the 
etching, the brown/grey Si wafer is coated with an orange/yellowish layer of 
porous silicon. This porous silicon is then broken-up and dispersed in the 
toluene during the reflux; simultaneously, the hydrogen-terminated surface of 
the porous silicon reacts with the undecene to produce the C11 capping layer.  
After evaporation of the solvent, a yellow wax of SiQDs remains. The SiQDs are 
an intense pale yellow colour at room temperature and revealed strong orange 
luminescence under a hand-held UV lamp at an excitation wavelength of 365 
nm. The SiQDs were water insoluble but when they were dispersed in organic 
solvents, e.g., dichloromethane (DCM) or diethyl ether, colloidal SiQDs showed 
a transparent yellowish solution and revealed strong orange luminescent under 
the handheld UV lamp with excitation wavelength 365 nm. The homogenous 
SiQDs solution in organic solvents was therefore used to make dilutions and to 
measure the concentration via luminescence spectrophotometry for the rest of 
the project.      
3.3.2 Particle Height and Shape Characterisation of SiQDs 
 
Atomic Force Microscopy (AFM) 
AFM is a microscope which employs a very sharp probe scanning on the top of 
the sample to record the sample topography. Probe deflection as it moves over 
protrusions in the sample is recorded by reflecting a small diode laser off the 
back of the probe and using a split photodiode to measure the probe beam 
displacement. The AFM images presented are false-colour images in which the 
heights (deflections) are represented on a colour scale. The images of dried 
SiQDs (1 μg mL-1 SiQDs in DCM) on the top of clean mica showed 
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approximately spherical particles. Such an image of SiQDs is presented in 
Figure 3.4. Line sections across these features were used to determine the 
particle heights and a histogram of particle heights was compiled from 59 
SiQDs . Figure 3.4 presents the size of SiQDs, which was in the range of 2.5 to 
25 nm in the selected area. The size in the range of 5-7.5 nm represented the 
dominant size of SiQDs and included 76% of the SiQDs measured in the 
samples (59 particles). The histogram is shown in Figure 3.5. 
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Figure 3. 4 The particle shape image of SiQDs and the particle size cross 
section of SiQDs measured using TappingMode AFM. The colour scale 
represents height and the inset shows the actual heights of three selected 
particles indicated by the red, green and blue crosses which are all about 6 nm 
in height. The full image width is 10 microns.  
 
. 
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Figure 3. 5 Histogram presents the particles size range of 59 SiQDs. The mean 
diameter was in the range 5 to 7.5 nm. The particle height data were obtained 
using TappingMode AFM.  
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3.3.3 Purification of SiQDs 
3.3.3.1 UV-vis Absorption spectroscopy 
 
UV-Vis absorption spectra of 1.25 and 10 μg mL -1  SiQDs were measured in 
DCM solution.  The absorption spectrum was scanned from lower energy 800-
nm to high energy 200-nm excitation wavelengths.  SiQDs showed increasing 
absorption towards higher energy above about 400-nm excitation wavelength 
and showed maximum absorption at 230-nm excitation wavelength (this is not a 
true maximum in the sample absorption, but rather a limitation arising from 
absorptions in the solvent and cuvettes). The absorption spectra of 1.25 and 10 
μg mL-1 SiQDs in DCM for excitation wavelength range of 200-800 nm are 
shown in Figure 3.6.  
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Figure 3. 6 UV-vis absorption spectra of the alkyl-capped silicon quantum dots 
(SiQDs) in dichloromethane (DCM) with the concentration of 1.25 µg mL -1 and 
10 µg mL -1. The absorbance was measured using a UV-vis spectrometer, Cary 
model 100. 
 
 
 
 
-5.00E-01
0.00E+00
5.00E-01
1.00E+00
1.50E+00
2.00E+00
2.50E+00
3.00E+00
200 300 400 500 600 700 800
A
b
so
rb
an
ce
 
Wavelength (nm) 
DCM
SiQDs in DCM (1.25 µg mL-1)
SiQDs in DCM (10 µg mL-1)
60 
 
 
3.3.3.2 Emission spectroscopy 
 
The fluorescence spectra of 1.25 and 10 μg mL -1 SiQDs were measured in 
DCM using a Spex FluoroMax/GRAMS 32 with 330-nm excitation. 
Fluorescence spectra were recorded between 400 and 850 nm.    SiQDs in 
DCM showed a maximum emission peak at approximately 620 nm with 
excitation wavelength 330 nm. The fluorescence spectra of 1.25 and 10 μg mL-1 
SiQDs in DCM collected between 400 and 850 nm with 330-nm excitation 
wavelength are shown in Figure 3.7.   
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Figure 3. 7 Emission spectra of alkyl-capped silicon quantum dots (SiQDs) 
dispersed in dichloromethane (DCM) with the concentrations of 1.25 µg mL -1 
and 10 µg mL -1. The luminescence intensities were measuring using emission 
spectroscopy, Spex FluoroMax/GRAMS 32 with excitation 330 nm. Note: the 
feature at 660 nm is second order scattering from the excitation wavelength and 
not a property of the sample.  
 
The fluorescence spectra of SiQDs shown in Figure 3.5 is typical; the peak 
absorption is in the red-orange region and the peak wavelength is invariant to 
the wavelength used for excitation (Lie et al., 2002) for any given sample, 
though it may vary between 600 and 670 nm between batches. Previous work 
suggested that fluorescence is superior to absorption for quantitation because 
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of the absence of self-quenching effects in SiQD samples(Dickinson et al., 
2008).  
3.3.4 Quantifying Photochemical Properties and Luminescent Intensity per 
Mass (mg) of SiQDs 
3.3.4.1 UV-vis Absorption spectroscopy 
 
High concentrations of SiQDs were dispersed in organic solvent 
dichloromethane (DCM) and divided into small amounts: 1 mg dried weight per 
vial. Each vial which contained 1 mg of SiQDs was used as SiQDs sample for 
the rest of the project. Serial dilutions of SiQDS were made from SiQDs at 
concentrations of 0.27, 0.29, 0.31, 0.33, 0.36, 0.40, 0.44, 0.50, 0.57, 0.67, 0.80, 
and 1.00 mg mL-1 in DCM.   The absorption spectra of serial dilutions of SiQDs 
in DCM were measured using UV visible absorption spectroscopy.  The 
absorption spectrum was scanned from lower energy 800-nm to high energy 
200-nm excitation wavelengths.  SiQDs showed absorption spectra at high 
energy after 400-nm excitation wavelength and showed maximum absorption 
peak at 240-nm excitation wavelength. The absorption spectra of serial dilutions 
of SiQDs in DCM scanning excitation wavelength 200-800 nm are shown in 
Figure 3.8.  
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Figure 3. 8 UV-vis absorption spectra of the alkyl-capped silicon quantum dots 
(SiQDs) in dichloromethane (DCM) with various concentrations measured using 
a UV-vis spectrometer, Cary model 100.  
 
Although absorption spectroscopy could be used for quantitation, the sensitivity 
is worse than for fluorescence spectroscopy and the absorption varies in a 
complex manner with wavelength and concentration. Complete spectrum shows 
fluorescence more sensitive than absorption. The very high intensity of 
excitation wavelength is the limitation of absorption.   
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3.3.4.2 Emission spectroscopy 
 
The fluorescence of serial dilutions of SiQDs in DCM at concentration 0.27, 
0.29, 0.31, 0.33, 0.36, 0.40, 0.44, 0.50, 0.57, 0.67, 0.80, and 1.00 mg mL-1 were 
measured using a Spex FluoroMax/GRAMS 32 fluorimeter with 365-nm 
excitation. Fluorescence spectra were recorded between 400 and 850 nm.    
SiQDs in DCM showed maximum emission peak approximately 670 nm with 
excitation wavelength 365 nm. High quality with purification and mono size 
distribution in each concentration of SiQDs showed only one peak for entire 
spectrum.  The fluorescence spectra of serial dilutions of SiQDs in DCM 
collected between 400 and 850 nm with 365-nm excitation wavelength are 
shown in Figure 3.9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
65 
 
 
 
 
 
 
 
 
 
Figure 3. 9 Emission spectra of alkyl-capped silicon quantum dots (SiQDs) 
dispersed in dichloromethane (DCM) with various concentrations measured 
using an emission spectrometer, Spex FluoroMax/GRAMS 32 with an excitation 
wavelength of 365 nm. The rest of luminescence intensities after 730 were not 
included because they are the 2nd order of scattering.  
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3.3.4.3 Quantitation study of SiQDs 
 
The fluorescence spectrum for each concentration of SiQDs was integrated to 
obtain spectral intensity for each dilution. The plot of fluorescence intensities 
against concentration of SiQDs showed that the emission intensity is linear with 
the concentration of SiQDs Figure 3.10.   
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Figure 3. 10 Fluorescence intensities against concentrations of SiQDs, the 
fluorescence intensities were calculated from emission spectra of alkyl-capped 
silicon quantum dots (SiQDs) dispersed in dichloromethane (DCM) in various 
concentrations measured using emission spectroscopy, Spex 
FluoroMax/GRAMS 32 with an excitation wavelength of 365 nm. The 
concentration of SiQDs in any sample was calculated by measuring their 
fluorescence and using the calibration curve in this figure.  
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3.3.5 Photochemical Properties Studies of SiQDs in Physiological 
Solutions 
3.3.5.1 UV-vis absorption spectroscopy 
 
The absorption properties of SiQDs were studied in various physiological 
solutions. The SiQDs at a concentration of 0.2 μg mL-1 in 1% (v/v) cremophor 
were dispersed in phosphate- buffered saline (PBS), Krebs solution, complete 
RPMI medium with phenol red and 10% (v/v) foetal Bovine serum (FBS), and 
complete DMEM medium with phenol red and 20% (v/v) FBS. The absorption 
spectra of SiQDs in different physiological solutions were measured using UV 
visible absorption spectroscopy over the wavelength range of 800-200 nm.  The 
SiQDs at concentrations 0.2 μg mL-1 in physiological solutions showed weak 
absorption at wavelengths greater than 400 nm. Physiological solutions 
containing phenol red dye and protein (FBS) also showed second and third 
peaks of absorption spectra at 560 nm for the phenol red dye and at about 260 
nm for the proteins present. The absorption spectra of SiQDs in physiological 
solution are shown in Figure 3.11.  
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Figure 3. 11 UV-vis absorption spectra of alkyl-capped silicon quantum dots 
(SiQDs) measured using UV-vis spectroscopy, Cary model 100. The 0.2 µg 
SiQDs in 1% volume: volume (v:v) cremophor was dispersed in various 
physiological solutions.  
 
An important conclusion from Figure 3.11 is that phenol red may interfere 
substantially with the absorption of light by SiQDs and therefore SiQD 
internalisation experiments carried out in later chapters use phenol red-free 
media whenever appropriate.  
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3.3.5.2 Emission spectroscopy 
 
The fluorescence properties of 0.2 μg mL-1 SiQDs in various physiological 
solutions were measured using fluorescence spectroscopy Spex 
FluoroMax/GRAMS 32 with 365-nm excitation. Fluorescence spectra were 
recorded between 400 and 850 nm.    SiQDs in PBS and Krebs showed 
emission spectra in the range of 560-700 nm. Physiological solution containing 
SiQDs with phenol red dye or phenol red and protein showed broad emission 
spectra in the range of 400-700 nm. The fluorescence spectra of 0.2 μg mL-1 
SiQDs in various physiological solutions collected between 400 and 850 nm 
with 365-nm excitation wavelength are showed in Figure 3.12. Again, there is 
some overlap between phenol red and the SiQDs in the emission spectra which 
is the reason phenol red-free media were used in the experiments reported in 
later chapters wherever appropriate. In particular, experiments in which 
quantitative measurements of the emission of SiQDs were required used such 
dye-free media.  
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Figure 3. 12 Emission spectra of alkyl-capped silicon quantum dots (SiQDs) 
measured using emission spectroscopy, Spex FluoroMax/GRAMS 32 with 
excitation wavelength 365 nm. The 0.2 µg SiQDs in 1% volume: volume (v: v) 
cremophor was dispersed in various physiological solutions. The fluorescence 
of SiQDs at 620 nm is masked in the case of the RPMI and DMEM because 
these media contain phenol red; the PBS and Krebs do not and the SiQD 
fluorescence is more clearly distinguished.  
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3.3.6 Luminescent Morphology, Particles Distribution, and Aggregation 
Studies of SiQDs in Physiological Solutions  
3.3.6.1 Scanning Confocal Microscope 
 
Fluorescence images of 1 mg mL-1 SiQDs in 0.7% (v/v) cremophor solution and 
drying on the top of a clean glass slide are shown in figure 3.11. The images 
were collected by confocal microscope (Leica TCS SP2, UK) with the 488 nm 
line of an Argon/Krypton ion laser as the excitation light. SiQDs showed strong 
luminescence and the particles tended to aggregate on the top of coverslip 
(Figure 3.13). The objects observed by fluorescence microscopy are large 
aggregates of SiQDs, unlike the higher resolution AFM images in which 
individual SiQDs can be seen.  
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Figure 3. 13 Luminescent image (x1000 magnifications) of SiQDs captured 
using Confocal Laser Scanning Microscope, Leica TCS SP2, Spectral Confocal 
and Multiphoton Microscope. The SiQDs suspension solution 50 μL of 100 µg 
ML-1 in 50 µL organic solvent diethyl ether was dispersed in phenol red free 
medium and dried on the top of slide. 
 
47.62 µm 
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3.3.6.2 Epi-fluorescene Microscopy 
 
Fluorescence images of 100 μg mL-1 and 1 mg mL-1 SiQDs in 50 μL organic 
solvents diethyl ether were dispersed in complete medium without phenol red 
detection and observed using an epifluorescence microscope. 50 μL of SiQDs 
suspension solution on the top of slide and covered with coverslip showed 
strong luminescence and exhibited less particle aggregation. The image of 
strongly luminescence SiQDs dispersed in culture medium captured using 
fluorescent microscope is shown in Figure 3.14-15.  
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Figure 3. 14 Luminescence image (100 x magnifications) (A) and luminescence 
image (400 x magnifications) (B) of SiQDs captured using Luminescence 
microscopy (Leica Laborlux). SiQDs 100 µg ML-1 in 50 µL organic solvent 
diethyl ether was dispersed in phenol red free medium.  
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Figure 3. 15 Luminescence image (100 x magnifications) and luminescence 
image (400 x magnifications) of SiQDs captured using Luminescence 
microscopy (Leica Laborlux). SiQDs 1 mg ML-1 in 50 µL organic solvent diethyl 
ether was dispersed in phenol red free medium.  
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3.3.6.3 Confocal Raman Microscope 
 
Fluorescence images of SiQDs inside treated IGE cells with 0.2 μg mL-1 SiQDs 
dispersed in complete medium for 1 hour (preliminary studied) were measured 
with a confocal Raman microscope using an argon ion laser (488 nm) as 
excitation source (WiTec model CRM 200, Ulm, Germany). SiQDs accumulate 
inside the cell and SiQDs showed strong luminescence after internalisation by 
the cell. The image of strong luminescence of SiQDs inside the cell is shown in 
Figure 3.16-19.  
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Figure 3. 16 The original image of SiQDs inside the IGE cells captured using 
confocal microscope. The starving cells had been incubated with 0.2 µg mL -1 
SiQDs for 1 hour. 
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Figure 3. 17 The luminescence image of SiQDs inside the IGE cells captured 
using confocal microscope. The starving cells had been incubated with 0.2 µg 
mL -1 SiQDs for 1 hour. 
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Figure 3. 18 The three dimensional luminescence image of SiQDs inside the 
IGE cells captured using confocal microscope. The starving cells had been 
incubated with 0.2 µg mL -1 SiQDs for 1 hour. 
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Figure 3. 19 The Raman & luminescence spectrum of SiQDs inside the IGE 
cells measured using confocal microscope. The starving cells had been 
incubated with 0.2 µg mL -1 SiQDs for 1 hour. The left-hand spectrum is the 
Raman spectrum of a clean Si wafer, the right hand spectrum shows the broad 
fluorescence of the SiQDs, the reflected laser light at 0 cm-1, the Si Raman 
peaks at 520 and 950 cm-1 and O-H Raman stretching modes near 3500 cm-1. 
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3.4 Discussion 
 
Luminescent probes are the major tool applied in many studies of cell 
organelles and cell function. Consequently various organic dyes have been 
introduced and widely used in cell biology and biomedical science. However the 
organic dyes still have some limitations. Typically organic dyes have low 
stability in physiological conditions and are highly photo sensitive (O'Farrell et 
al., 2006). The intensity and colour of luminescence of  both organic dyes and 
quantum dots (QDs) both depend on their electronic structure (O'Farrell et al., 
2006), however QDs have controllable properties which are determined largely 
by their radius and may be tuned more easily. QDs show the potential to 
overcome the difficulties of organic dyes under physiological condition and 
imaging with high intensity excitation light as in confocal experiments (Michalet 
et al., 2005). However the toxicity aspect is still a concern for QDs application in 
life science as the typical QDs are composed of elements in groups II-VI, III-V of 
periodic table and many of them contain heavy metals, especially Cd. Therefore 
silicon QDs are one type of QD that is particularly attractive because Si is 
known to be metabolised to relatively harmless silicate species (Park et al., 
2009). 
 
To control the size of semiconductor (silicon) particles and exploit the quantum 
confinement effects is challenging because as well as the particles’ stability, 
one must also control the polydispersity of the size distributions. Lars H. Lie and 
colleagues, 2002 successfully prepared alkyl-capped silicon quantum dots 
(SiQDs). They prepared strong luminescent SiQDs from silicon wafer with high 
current densities in hydrofluoric (HF)-ethyl alcohol solution followed by a reflux 
in anhydrous toluene with undecene  (Lie et al., 2002).   Consequently SiQDs 
revealed narrow size distribution and were stable in aqueous solutions as well 
as water insoluble, their stability is a consequence of the strong Si-C bond 
between the particle surface and the undecyl (C11) capping reagent. However 
SiQDs were easy to prepare as a clear colloidal solution in organic solvents and 
dispersed in aqueous media to make monodidperse distribution colloidal. SiQDs 
in organic solvents for instance dimethyl sulfoxide (DMSO), diethyl ether, and 
tetrahydrofuran can make clear colloidal solution in aqueous media (Dickinson 
et al., 2008). The aqueous dispersion SiQDs showed linear correlation between 
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luminescent intensities and concentration. They also tolerate media pH 
changing (Dickinson et al., 2008). SiQDs showed strong luminescent inside 
tumour derived cell lines as well as low cytotoxicity (Alsharif et al., 2009). 
 
In this study, SiQDs were prepared by a minor modification of the methods of 
Lars H. Lie and colleagues, 2002. The method used is described in detail by 
Chao et al  and was successful in producing narrow size distributions of SiQDs 
with mean diameters in the range of 5 to 7.5nm (diameter of particle + cap, the 
diameter of the Si core is about 2.5 nm). The sizes of the SiQDs are smaller 
than the Bohr radius of the bulk materials and therefore they show strong 
quantum confinement effects with unique optical properties (Shirahata, 2011). 
They were confirmed by the onset of absorption of light at wavelengths below 
400 nm and the emission of orange photoluminescence in the range 600-650 
nm typically. Additionally SiQDs in aqueous media showed narrow size 
distribution, and low flocculation with strong intensities luminescent 
characterised by using fluorescent and confocal microscopy.  In addition, SiQDs 
which had been incubated with epithelium cell were internalised and revealed 
strong luminescent detected using confocal microscope inside the cell.  
 
In summary, the mean SiQDs diameter was obtained from AFM height 
measurements and was in the range of 5 to 7.5 nm. This is similar to previous 
work (Chao et al., 2007, Alsharif et al., 2009). Also the image of SiQDs which 
had been capped by AFM revealed a roughly spherical shape. SiQDs which had 
been dispersed in DCM showed a yellowish, clear solution with high 
luminescence. Dispersion of the SiQDs in ether or DCM was found to be the 
simplest accurate method to divide a given sample into equal portions for 
biological studies. These solvents have a high vapour pressure and evaporate 
quickly to leave dry SiQD samples and therefore do not contaminate the 
biological systems (see toxicity data in later chapters). The low concentration of 
SiQDs in organic solvent such as diethyl ether and dispersed in physiological 
solutions without foetal Bovine serum (FBS) exhibited high luminescent 
intensities compared with the complete solution with FBS. Alkyl-capped SiQDs 
revealed strong emission with a maximum wavelength of around 650 nm and it 
was found that a 1 cm -2 of 20 silicon chips can produce up to 10 mg of SiQDs. 
A uniform and successful size distribution of SiQDs in physiological solution was 
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also measured using confocal microscopy and fluorescence microscopy. The 
SiQDs which had been internalisation by the cell showed strong luminescent 
intensities measured using confocal Raman microscopy. It revealed that 
photochemical properties of SiQDs were durable to cell metabolism (preliminary 
studied 1 hour).    
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Chapter 4. Cellular Internalisation Studies: Imaging and Cellular 
Localisation of Alkyl-Capped Silicon Quantum Dots (SiQDs) 
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4.1 Introduction 
 
Fluorescent organic dyes have several limitations which are revealed in 
experiments associated with high energy and long exposure time; in particular 
they are susceptible to photo-oxidation and fading (O'Farrell et al., 2006). In 
addition, the fluorescent properties of organic dyes may not be stable in 
different physiological solutions because of protonation or other chemical 
interactions (Invitrogen, 2005, O'Farrell et al., 2006). Quantum dots or 
fluorescent semiconductor nanoparticles have drawn the attention of many 
researchers because of their stability and brightness. Furthermore quantum 
dots also have unique photophysical properties; the colour of the fluorescence 
can be changed by tuning the particle size and Q-dots of different fluorescent 
colours can be excited by the same wavelength.  These properties are 
advantageous for multicolour detection using only one excitation wavelength 
(Jaiswal and Simon, 2004).  
Despite this, the standard cadmium selenide particles do show some 
cytotoxicity in long duration experiments and therefore other materials, 
particularly silicon quantum dots, are being investigated as an additional, safer 
choice for the fluorescent probe (O'Farrell et al., 2006, Martin, 2013). Silicon 
quantum dots are promising fluorescent probes with small overall diameter, low 
cytotoxicity effects, strong fluorescence, and, appropriately capped, are stable 
under aqueous conditions.  
In addition to being a safer alternative QD with properties resulting from 
quantum confinement, Si QDs also have a much simpler structure than other 
quantum dots because an organic monolayer can be used to both cap and 
stabilise the inorganic core as well as facilitating conjugation to biomolecules via 
standard organic chemistry (Sailor and Lee, 1997). Changing the layer capping 
on the silicon core can turn on and off the photoluminescence, allowing for 
tuning of chemical and physical characteristics (Sailor and Lee, 1997); 
(Bateman et al., 1998).  SiQDs have been used for cell specific target labelling, 
while other applications, including use in drug discovery, diagnostics and 
genetic disease have also been proposed but require further study. Wang and 
colleagues (2004) developed a multiple layer capping of SiQDs with alkyl-linker 
and oligonucleotides. These systems produce a SiQD probe with sequence-
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specific binding to target DNA (Wang et al., 2004).   Cellular interactions of 
SiQDs were studied by Shiohara and colleagues (2011); the group showed that 
allylamine capped silicon nanocrystals can be used as a biocompatible 
biological markers. The fluorescent amine terminated silicon nanocrystal was 
internalised by a human-derived tumour breast cell line and accumulated in 
lysosomes as confirmed by confocal fluorescence (Shiohara et al., 2011).   
A new application of SiQDs was developed by Erogbogbo and colleagues 
(2010) to produce a multifunctional probe. Micelles were used to encapsulate a 
mixture of SiQDs and Iron oxide QDs. The composite object allows both  
fluorescence imaging and exploitation of magnetic effects  (Erogbogbo et al., 
2010). In a similar fabrication as that of Erogbogbo et al, SiQDs were combined 
with a fluorescent enhancer and encapsulated within micelles.  In this case, 
SiQDs were combined with an anthracene-based dye followed by micelle-
encapsulation. Fluorescence of the SiQDs was excited via energy transfer from 
the attached dye (Erogbogbo et al., 2012).   
In an effort to improve stability and increase applications of SiQDs for 
commercial products and biological applications, SiQDs have been coated with 
polymer, styrene and 4-vinylbenzaldehyde using miniemulsion polymerisation 
techniques. The polymer encapsulated SiQDs tolerated alkaline conditions and 
emitted strong luminescence (Harun et al., 2011). SiQDs have also been 
encapsulated with the polymer Pluronic F127 (containing the block copolymer 
P85 (PPO)). The F127 encapsulated SiQDs were internalised via caveolae-
mediated endocytosis and targeted at the endoplasmic reticulum; they were 
successfully used to image the ER in live cells in long duration studies  (Shen et 
al., 2011). 
Dextran-coated silicon quantum dots have been used in positron emission 
tomography (PET). PET is a powerful nuclear imaging technique for 
investigating nanomaterial probe distribution deeply inside animal and human 
bodies. The radioactive copper (64Cu2+)-labelled and dextran-coated SiQDs 
show exceptional fluorescent stability and quantitative PET images (Tu et al., 
2011). Due to lack of toxicity and the absence of heavy metals, SiQDs have 
been increasing used in in vivo studies. Micelle-encapsulated SiQDs with 
various end terminal groups: methoxy, amine, folate, and transferrin groups 
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have been used by Erogbogbo and colleagues, 2011 to image different kinds of 
tumours, their spreading stage and localisation (Erogbogbo et al., 2011b).  One 
dimensional (1D) silicon nanostructures were studied by Zhang and colleagues 
(2012). The internalisation of folate-functionalised silicon nanotubes was 
observed to be accelerated, and on accumulation in immortalised Chinese 
hamster ovary cells (CHO) these nanostructures showed strong fluorescence 
(Zhang et al., 2012). In order to improve aqueous dispersibility, SiQDs have 
been coated with allylamine. The amine-terminated SiQDs were stable and 
resistant against aging in alkaline conditions; however, they  produced adverse 
effects on a human liver derived cell line (HepG2) (evaluated cytotoxicity using 
the MTT assay (Ahire et al., 2012)).  
In a recent study by Hajjaji and colleagues, 2014, SiQDs were used as a 
thermal probe. These new applications of the alkyl-capped silicon quantum dots 
show that novel  ways of employing silicon nanoparticles may yield valuable 
and increasing applications in the future (Hajjaji et al., 2014).         
In spite of much progress in silicon quantum dot (QDs) applications studies, 
there are not many studies that focus on basic information concerning how cells 
interact and internalise SiQDs. There are a few, but not many studies 
concerning the basic safety information of silicon nanoparticles. The expected 
low cytotoxicity of SiQDs (which has been confirmed in a few studies (Alsharif et 
al., 2009), is based on the absence of heavy metals and the known metabolism 
of bulk silicon which is degraded and eliminated from organism in the form of 
silicic acid (Park et al., 2009). However, to increase the applications of silicon 
particles in life sciences, it remains essential to obtain direct cytotoxic profile 
and to study the mechanism of internalisation of SiQDs. 
Alkyl-Capped Silicon Quantum Dots (SiQDs) are a type of semiconductor 
nanoparticle. SiQDs comprise nanocrystalline silicon that is surrounded by C11 
alkyl monolayer. The alkyl monolayer protects the silicon core from oxidation 
and stabilises the particle in an aqueous environment (Alsharif et al., 2009). 
This is necessary because Si has a tendency to react with water and oxygen to 
form, eventually, SiO2 or silicates. The hydrophobic character of the alkyl 
monolayer makes the SiQDs  water-insoluble, but they can be dispersed in 
organic solvents such as dichloromethane (DCM) and diethyl ether (ether) to 
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make homogeneous solutions (Dickinson et al., 2008). SiQDs in DCM and ether 
produce a yellowish, clear suspension. The serial dilutions of SiQDs show a 
linear correlation of emitting intensity against concentration. This is useful for 
quantitation and another advantage over molecular dyes which show strongly 
nonlinear intensity concentration calibrations because of intermolecular 
interactions. SiQDs in DCM showed a strong orange fluorescence maximum at 
620 - 670 nanometres (nm) for excitation energies below about 500 nm.  
The SiQDs synthesised in this study have a mean diameter in the range 5-7.5 
nanometre (nm); this figure includes the stabilising capping monolayer of 
hydrophobic undecyl-chains. A homogenous suspension of SiQDs with narrow 
size distribution can nevertheless be prepared in aqueous solutions by first 
suspending SiQDs in organic solvents. A small amount of solution is then 
rapidly mixed with aqueous solutions or even physiological media. Ether or 
Cremophor were preferred vehicles to achieve the dispersal of SiQDs in 
aqueous media, the former because it’s high volatility means that after 
dispersal, the ether rapidly evaporates and therefore no toxic effects are 
observed from the organic solvent.  The latter was chosen because it is widely 
used in pharmacology for administration of hydrophobic drugs.  SiQDs in 
physiological solution such as phosphate buffered saline (PBS), Krebs solution, 
and cell culture medium without phenol red and foetal Bovine serum (FBS) also 
emit fluorescence at 620 – 670 nm, but it is generally preferable to work in 
phenol-red free media to avoid interference from the absorption of that dye (see 
Chapter 3). Although SiQDs in physiological solutions showed similar 
fluorescence spectra to those for dispersions in organic solvents, the 
fluorescence signal was generally lower simply because of the dilution required 
to achieve dispersal in aqueous media.  
The work reported in this chapter is concerned with the fluorescent properties of 
SiQDs in physiological solutions, their use as fluorescent stains in experiments 
with cultured cells and confirmation of their internalisation by human cells 
(CACO-2). Optical images of CACO-2, which had been treated with 
physiological solution containing SiQDs, were captured using epifluorescence 
and confocal microscopy. Moreover, the SiQDs fluorescence spectra were 
analysed using a confocal Raman microscope with spectrograph to confirm 
SiQDs localisation inside the cell.   In this study CACO-2 was used as a model 
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in which to explore the uptake and interaction of SiQDs with cells using 
fluorescence imaging. CACO-2 cells were derived from tumour colon cells and 
commonly used by other workers in studies of nanoparticle cytotoxicity 
(Ruizendaal et al., 2009). The CACO-2 cell line was chosen as a model for the 
interaction of nanoparticles with the gastrointestinal tract, a major route for the 
exposure of humans to nanoparticles (oral route). 
4.2 Methods 
4.2.1 Cellular Internalisation Studies Using SiQDs and Observation with an 
Epi-Fluorescence Microscope 
 
To quantify internalisation and demonstrate visualisation of alkyl-capped silicon 
quantum dots (SiQDs) inside human cells, the human-derived colon tumour 
cells (CACO-2) were treated with SiQDs for 1 and 4 hours. In addition some 
experiments with longer term exposure of 14 days to look for chronic effects 
were made. The CACO-2 were cultured as described in Section 2.3 but in 
Dulbecco’s modified Eagle’s medium (DMEM) complete medium without phenol 
red in 75 cm2 culture flasks (filter cap) (T75). For visualisation of the cellular 
fluorescence, (short time studies) 5x103 cells mL-1 of CACO-2 were cultured 
overnight on cleaned coverslips using 70% (v/v) ethyl alcohol. After 24 hours, 
the cells were treated with freshly prepared 0.2 μg mL-1 SiQDs from a stock 
solution of 1 mg mL-1 SiQDs in 0.7% (v/v) cremophor solution in phenol red-free 
medium for 1 and 4 hours. The treated cells were washed 3 times with 
phosphate-buffered saline (PBS). To visualise SiQDs inside the living cells, the 
coverslip was taken out from the plate and placed on the top of the slide with 
the cells on the top side. Then the coverslip was sealed with 50 μL Mowiol 
mounting medium and another cleaned coverslip. The mounted slides were 
visualised using an epi-fluorescence microscope (Leica Laborlux) with 
excitation provided by a mercury arc lamp and a 300-400 nm bandpass filter 
which selects mainly the 365 nm line of the mercury lamp.   
To visualise the optical images of cells after 14 days ‘chronic’ exposure, 5% 
(v/v) of 70-80 % confluence of CACO-2 (103 cells mL-1) were cultured in culture 
flasks (filter cap), treated surface area 25 cm2 (T25) overnight. After 24 hours, 
the cells were treated with various concentrations of freshly preparation SiQDs 
at 0.5, 5, and 50 μg mL-1 from a stock solution of 1 mg mL-1 SiQDs in 10 μL 
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diethyl ether (ether) in phenol red-free medium.  The cells were treated with 
SiQDs for 14 days and the medium were replaced with a fresh preparation of 
SiQDs suspension every two days. After 14 days the cells were washed with 
PBS 3 times. Then the cells were removed from the flasks using trypsin 
solution. The cell pellets were then collected and suspended in 500 μL PBS. To 
visualise SiQDs inside the cells, 50 μL of the cell suspension was mixed with 50 
μL Mowiol mounting medium and 50 μL of the mixture dropped on the top of a 
clean slide. The slide then was covered with clean coverslips. The cell slides 
were visualised using an epifluorescence microscope (Leica Laborlux) with 
excitation provided by a mercury arc lamp and a 300-400 nm bandpass filter 
which selects mainly the 365 nm line of the mercury lamp.    
4.2.2 Cellular Internalisation Studies Using SiQDs and Detection with High 
Resolution Scanning Confocal Microscope  
 
To quantify internalisation and visualisation of alkyl-capped silicon quantum 
dots (SiQDs) inside human cells, CACO-2 cells were treated with SiQDs for 
0.5,1, 2 and 4 hours. The CACO-2 were cultured as described in Section 4.2.1. 
For optical images of short time studies 5x103 cells mL-1 of CACO-2 were 
cultured on cleaned coverslips overnight. After 24 hours the cells were treated 
with freshly prepared 0.2 μg mL-1 SiQDs from stock solution 1 mg mL-1 SiQDs in 
0.7% (v/v) cremophor solution in phenol red free medium for 0.5, 1, 2 and 4 
hours. The treated cells were washed 3 times with phosphate-buffered saline 
(PBS). To visualise SiQDs inside the living cells, the coverslip was taken out 
from the plate and placed on the top of a glass slide with cells on the top side. 
Then the coverslip was sealed with 50 μL Mowiol mounting medium and 
covered with another cleaned coverslip. The mounted slides were imaged using 
a confocal microscope (Leica TCS SP2,UK) with the 488 nm line of an 
Argon/Krypton ion laser as the excitation light. 
4.2.3 Spectral Analyses of SiQD Internalisation Using Confocal Raman 
Microscope 
 
To quantify internalisation and visualisation of alkyl-capped silicon quantum 
dots (SiQDs) inside human cells, CACO-2 cells were treated with SiQDs for 1 
hour. The CACO-2 were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) as described in Section 4.2.1. For optical images of short time studies 
5x103 cells mL-1 of CACO-2 were cultured on cleaned silicon wafers overnight. 
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After 24 hours the cells were treated with freshly prepared 0.2 μg mL-1 SiQDs 
from stock solution 1 mg mL-1 SiQDs in 0.7% (v/v) cremophor solution in phenol 
red free medium for 1 hour. The treated cells were washed 3 times with 
phosphate buffered saline (PBS). To visualise SiQDs inside the living cells, the 
wafer was taken out from the plate and placed on the top of the slide. The slides 
were visualised and images captured using a confocal microscope (CRM200, 
Witec, Ulm, Germany) with the 488 nm line of an argon ion laser (35 mW output 
power) as the excitation light as well as detected luminescence/Raman 
spectrum. 
4.3 Results 
4.3.1 Cellular Internalisation Studies Using SiQDs and Observation with 
Epi-Fluorescent Microscope 
 
To characterise cellular internalisation of SiQDs inside human derived tumour 
cells over short and long exposure times, CACO-2 were treated with SiQDs for 
periods of 1, 4 hours and up to 14 days. Internalisation of SiQDs by CACO-2 
was confirmed using an epi-fluorescence microscope (excitation ~365 nm from 
Hg Lamp). Fluorescent images were overlaid on the bright field optical images 
using ImageJ software; this facilitates localisation of the fluorescence and, with 
control experiments, allows the SiQD fluorescence to be distinguished from 
background. The SiQD fluorescence signal dominates the background and is 
shown as a red false colour representing the intensity of fluorescence (the CCD 
camera in the microscope is monochrome) (Figure 4.1).  The overlaid 
fluorescence images of CACO-2 treated with SiQDs for 4 hours showed 
stronger luminescent of SiQDs when compared with 1 hour treated cells and 
control cells. CACO-2 treated with SiQDs for 4 hours showed strong 
luminescence (red spots in Figure 4.1 E&F) while 1 hour-treated cells showed 
some fluorescence, but not strongly localised (weak, blurry red colours in 
Figure 4.1 C&D). The CACO-2 treated with SiQDs for 14 days showed the 
brightest luminescence indicating that the cells continue to internalise the 
SiQDs for long periods with no apparent harmful effect on the cell morphology.  
The SiQDs internalised by CACO-2 appear to  localise around membranes, but 
there is some fluorescence dispersed in the cytoplasm. This is perhaps 
expected because of the highly lipophilic nature of the alkyl capping on the 
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SiQDs. Bright fluorescence from SiQDs internalised by CACO-2 and overlaid 
optical images are shown in Figure 4.1 and Figure 4.2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 1 The CACO-2 cell images were captured using an Epi-fluorescent 
microscope with excitation light of wavelength 300-400 nm and x400 
magnification.   The bright field and fluorescent field of the same image were 
overlaid using ImageJ software (//IMAGEJ.NIH.GOV/IJ/). A, and B are the 
overlaid images of CACO-2 without exposure to SiQDs. C and D are the 
overlaid images of 1 hour-treated (0.2 μg mL-1) CACO-2 internalised SiQDs. E 
and F are the overlaid images of 4 hours-treated (0.2 μg mL-1) CACO-2. The 
red colour and red dots represent fluorescence from SiQDs.  
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Figure 4. 2 The CACO-2 cell images captured using an Epi-fluorescent 
microscope with excitation wavelength 300-400 nm and x400 magnification.   
The bright field and fluorescent field of the same image were overlaid using 
ImageJ software (//IMAGEJ.NIH.GOV/IJ/). G and H are the overlaid images of 
CACO-2 without SiQDs. I and J are the overlaid images of 14 days 
treated    (50 μg mL-1) CACO-2 internalised SiQDs. The red colour and red dots 
represent the fluorescence of SiQDs.  
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4.3.2 Cellular Internalisation Studies Using SiQDs and Detection with High 
Resolution Scanning Confocal Microscope  
 
Additional fluorescence imaging studies of CACO-2 internalised SiQDs were 
performed with a high resolution confocal microscope. CACO-2 which had been 
treated with SiQDs for 0.5, 1, 2, and 4 hours showed strong luminescent 
compared to the cellular autofluorescence background (Figures 4.3-4.6). Again, 
the images of SiQDs fluorescence inside CACO-2 were consistent with 
localisation mainly at cell membranes and the cell cytoplasm.  Although the 
small amount of SiQDs was used to incubate the CACO-2 with very short time 
0.5 hour the SiQDs internalised CACO-2 showed strong luminescent with red 
spots detection with high resolution microscope, confocal. The fluorescent 
images of SiQDs internalised CACO-2 at 0.5, 1, 2, and 4 hours captured using 
confocal microscope are showed in Figure 4.3-4.6.  
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Figure 4. 3 The CACO-2 cells bright field and fluorescent field images were 
captured using a confocal microscope with an excitation wavelength 488 nm 
and x1000 magnification.   K is the bright field image of CACO-2 treated with 
0.2 μg mL-1 of SiQDs for 0.5 hour. L is the fluorescent field image of K.   M, M is 
the overlaid images of K and L, CACO-2 internalised SiQDs. The red dots 
represent fluorescence from SiQDs. 
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Figure 4. 4 The CACO-2 cells bright field and fluorescent field images were 
captured using a confocal microscope with excitation wavelength 488 nm (1000 
(oil) X magnification).   N is the bright field image of CACO-2 treated with 0.2 μg 
mL-1 of SiQDs for 1 hour. O is the fluorescent field image of N.   P, P is the 
overlaid images of N and O, CACO-2 internalised SiQDs. The red dots 
represent fluorescence from SiQDs. 
 
  
 
 
98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 5 The CACO-2 cells bright field and fluorescent field images were 
captured using scanning microscope with excitation wavelength 488 nm (1000 
(oil) X magnification).   Q is the bright field image of CACO-2 treated with 
0.2  μg mL-1 of SiQDs for 2 hours. R is the fluorescent field image of Q.   S, S is 
the overlaid images of Q and R, CACO-2 internalised SiQDs. The red dots 
represent fluorescence from SiQDs. 
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Figure 4. 6 The CACO-2 cells bright field and fluorescent field images were 
captured using scanning microscope with excitation wavelength 488 nm (1000 
(oil) X magnification).   T is the bright field image of CACO-2 treated with 0.2 μg 
mL-1 of SiQDs for 4 hours. U is the fluorescent field image of T.   V, V is the 
overlaid images of T and U, CACO-2 internalised SiQDs. The red dots 
represent fluorescence from SiQDs. 
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4.3.3 Quantitative Analyses of SiQDs Internalisation Using Confocal 
Microspectroscopy  
 
To confirm that the fluorescence images represent SiQDs internalised by 
CACO-2, the confocal microscope was used to capture luminescence spectra of 
the fluorescence reported in Figures 4.3-4.6. CACO-2 cells were starved to 
avoid high background fluorescence. The cells were cultured in 10x dilution of 
foetal Bovine serum (FBS) of regularly complete medium. Likewise, prevent 
precipitation and aggregation of SiQDs in the culture medium when contained 
high concentration of FBS).  The starved CACO-2 showed strong fluorescence, 
dominating the background and revealed luminescence-Raman spectral 
features characteristic of SiQDs (orange-red emission with a large Stokes shift 
– the difference between excitation and emission wavelengths). The 
luminescence/Raman spectra of SiQDs internalised CACO-2 are present in 
Figure 4.7 – 4.8.  
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Figure 4. 7 The confocal fluorescent spectral images at an excitation 
wavelength of 488 nm of SiQDs inside starving CACO-2 which had been 
treated with 0.2 μg mL-1 for 1 hour. A is the original luminescence image of 
CACO-2 internalised SiQDs. B is the one dimensional luminescence image of 
A. C is the three dimensional luminescence image of A. D is the 
luminescence/Raman spectra of SiQDs inside CACO-2. The bright yellow 
colour is a false colour that represents the intensity of emission from SiQDs. In 
image (a) the colour scale represents the total intensity of the whole spectrum, 
including the elastically-scattered (reflected) light at 0 cm-1. The intensity shown 
at each pixel of (b) & (c) is the integral of the spectrum in (d) over the range of 
wavenumbers from 200 to 7000 cm-1 from the excitation line (0 cm-1 in relative 
wavenumbers). 
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Figure 4. 8 The confocal fluorescent spectrum images at excitation wavelength 
488 nm of SiQDs inside starving CACO-2 which had been treated with 
0.2 μg mL-1 for 1 hour. E is the original luminescence image of CACO-2 
internalised SiQDs. F is the one dimensional luminescence image of E.   G is 
the three dimensional luminescence image of E. H is the luminescence/Raman 
spectra of SiQDs inside CACO-2. The bright yellow colour is a false colour that 
represents the intensity of emission from SiQDs. In image (e) the colour scale 
represents the total intensity of the whole spectrum, including the elastically-
scattered (reflected) light at 0 cm-1. The intensity shown at each pixel of (f) & (g) 
is the integral of the spectrum in (d) over the range of wavenumbers from 200 to 
7000 cm-1 from the excitation line (0 cm-1 in relative wavenumbers). 
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4.4 Discussion 
 
Fluorescent semiconductor nanocrystals or quantum dots (QDs) are well known 
in the electronic field for optoelectronic applications such as diodes, lasers, and 
solar cells  (Mastronardi et al., 2012). Typical QDs are composed of elements of 
groups II and VI, IV and VI or III and V of the periodic table (Erogbogbo et al., 
2011a). QDs reveal superior optical properties such as broad excitation spectra, 
size dependent emission, brightness, and high photostability (Erogbogbo et al., 
2011a). Their unique optical properties of QDs have increased applications in 
other fields apart from electronic applications such as biology and medical as 
biological labelling or fluorescent probes. The application of QDs in biology and 
medical fields arise from their suitability for confocal microscopy: their stability 
and bright fluorescence help resolve difficulties related to cell auto-fluorescence 
with high background noise and the fading of luminescent molecular dyes in 
long-time imaging experiments. However, cytotoxicity remains a concern for QD 
applications in biology and medical fields because QDs exhibit unique 
physicochemical properties and behave differently from the bulk materials. The 
methodologies for safety evaluation in bulk materials do not necessarily apply to 
QDs. In particular, some QDs contain heavy metals such as cadmium which 
may leach from the particles and is known to be cytotoxic (Derfus et al., 2004).  
Alternative SiQDs which do not contain heavy metals are being sought,  Lie et 
al, 2002 developed a technique to produce SiQDs without any heavy metals 
(Lie et al., 2002). This study employed alkyl-capped silicon quantum dots 
(SiQDs) which were synthesised by a modified version of the Lie technique. The 
SiQDs are composed of a silicon core and stabilised with an organic n-alkyl 
(C11) monolayer (Alsharif et al., 2009). SiQDs are strongly hydrophobic because 
of this surface termination and are easily suspended in organic solvents. These 
suspensions show intense luminescent under excitation with ex  550 
nanometre (nm). SiQDs suspended in organic solvents can also be used to 
prepare clear (non-turbid) lyophobic colloids in aqueous or physiological media 
(Dickinson et al., 2008). The application of SiQDs as fluorescent labels and their 
potential in the life sciences were investigated by Alsharif et al, 2009. They 
found that SiQDs were internalised by tumour-derived cell lines and non-tumour 
cells using a confocal fluorescence microscope. The internalisation was more 
dominant (faster) in tumour cells particularly in HeLa cells. In addition the SiQDs 
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showed a lack of acute toxicity (Alsharif et al., 2009). The studies reported in 
this thesis have also shown evidence of internalisation of SiQDs in CACO-2 - a 
model of the gastrointestinal tract.  
Stable SiQDs in organic solvents showed strong luminescent under excitation 
ex  550 nm, however when SiQDs were dispersed in aqueous or physiological 
solutions the luminescent intensities were slightly compromised (Erogbogbo et 
al., 2012). Previous work (Dickinson et al., 2008) showed that alkyl-capped 
SiQDs are very slowly oxidised in aqueous media (over a period of several 
days) with shifts in the emission maxima of their fluorescence spectra. Our 
studies in CACO-2 which had been treated with SiQDs at concentrations as low 
as 0.2 μg mL-1 confirmed the optical properties of SiQDs inside the CACO-2 
cells using epi-fluorescence and confocal microscopy. The SiQDs internalised 
by CACO-2 showed strong luminescence over the background as well as the 
characteristic SiQD fluorescence/Raman spectra inside the cells.  
In summary, concentrations of SiQDs as low as 0.2 μg mL-1 dispersed in 
physiological solution showed detectable internalisation of SiQDs by the human 
colon-derived tumour cell line, CACO-2. Luminescence was detected after 0.5 
hour exposure using confocal microscopy. In addition, work with starved cells 
showed that these internalised SiQDs more vigorously as confirmed by Figure 
4.7- 4.8 images D and H show fluorescence spectral of SiQDs inside CACO-2 
conformation that SiQDs were internalised is available in Chapter 6 in the 
discussion of the flow cytometry data.   
The CACO-2 cells which had been started to grow from the frozen stock in 
phenol red free culture medium and continued to culture in that medium as well 
as collected cells using phenol red-free trypsin showed a minimum 
autofluorescent background and revealed strong fluorescence of SiQDs inside 
the cells.  
Cremophor EL is widely used to improve solubility of water insoluble chemicals, 
in particular for drug solubility and absorption (Kiss et al., 2013).  Cremophor 
can also be used to prepare solution dispersion of SiQDs in physiological 
solutions for studying internalisation of SiQDs. However cremophor does exhibit 
some background fluorescence, although the emission from SiQDs is stronger. 
We did not make extensive use of cremophor in later chapters of this thesis 
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because it produces suspensions that have a slight turbidity and it showed 
some adverse effects on endothelial cells (Kiss et al., 2013).   
For cell slides preparation, it was found that Mowiol mounting medium was 
suitable for cell uptake studies of SiQDs. Mowiol, which contains 2 basic 
chemicals: Mowiol 40-88poly (vinyl alcohol) and Glycerol BioXtra, ≥99% (GC), 
also has a colourless and sticky texture and showed low background 
autofluorescence using confocal microscopy with 488 nm excitation.  
The CACO-2 internalised SiQDs showed bright fluorescent images and 
luminescence/Raman spectra of SiQDs inside the cells detected by a confocal 
Raman/luminescence microscope. The SiQDs internalised by CACO-2 were 
found to be localised near membranes but with some fluorescence dispersed in 
the cell cytoplasm.  
SiQDs can therefore be used as a fluorescent stain to study cell organelles and 
cell functions by epi-fluorescence and confocal microscopy.  
Internalisation studies of CACO-2 using SiQDs as a fluorescence probe showed 
evidence of uptake and accumulation of SiQDs inside the cells using both 
epifluorescence and confocal fluorescence microscopy. Hence it was good 
evidence for further study to understand the mechanism of internalisation and 
the potential adverse effects of SiQDs to the cells. 
Figures 4.7 and 4.8 show confocal spectral images of a single CACO-2 cell. It 
is located at the bottom right hand corner of the images (a)-(c) and (e)-(g). Each 
pixel of these images contains a fluorescence spectrum such as Figure 4.7(d) 
and Figure 4.8(h). The false colour scale represents the intensity of detected 
light across a defined range of wavenumbers in the spectrum. In (a) and (e) the 
raw data are shown, which include a contribution from reflected laser light a 0 
cm-1 relative wavenumbers, i.e. light scattered from the cell or slide without 
change in wavelength (488nm). The colour scales in (b)-(c) and (f)-(g) are 
adjusted to integrate over the range 200-7000 cm-1 which removes the 
contribution of reflected light and the cell is now clearer in the image. Finally, 
the sample spectra in (d) and (h) show the characteristic broad fluorescence 
band of SiQDs with a maximum at about 3000 cm-1 or equivalently 570 nm, 
slightly shorter in wavelength than for SiQDs free in solution, but still with the 
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typical large Stokes shift between absorption and emission (Lie et al., 2002), 
(Dickinson et al., 2008). There are also some Raman bands visible in these 
spectra just below 3000 cm-1 and more intense at 3500 cm-1. The latter is simply 
the water Raman band, but the former is due to C-H stretching vibrations and is 
most likely associated with components of the cell membrane. The very sharp 
features which appear in these spectra with no detectable line-width are cosmic 
ray events recorded by the CCD detector and do not represent Raman or 
fluorescence bands. Overall, the spectral images demonstrate the origin of the 
fluorescence as fom SiQDs and confirm their uptake by CACO-2. 
The ability of the CACO-2 to internalise the neutral charge SiQDs could extend 
the application of fluorescent SiQDs more efficiently in cells and also increase 
the potential use of SiQDs to studies involving cell organelles, cell function and 
the treatment of disease.   
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Chapter 5. Potential Cytotoxicity of Alkyl-Capped Silicon 
Quantum Dots (SiQDs) 
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5.1 Introduction 
 
In this study, the possible cytotoxicity of alkyl-capped silicon quantum dots 
(SiQDs) was investigated. The suitability of SiQDs for cell imaging was first 
investigated by Alsharif and colleagues (Alsharif et al., 2009). The group noted 
that SiQDs were internalised by tumour derived cell lines and primary cell lines, 
and also reported cell line dependent internalisation.  The endocytosis inhibitors 
filipin, cytochalasin B, and actinomycin D were used to verify the internalisation 
mechanism of SiQDs and specific endocytotic processes involving SiQDs 
internalisation (Alsharif et al., 2009). Cytotoxicity was investigated by 
undertaking cell viability, cell proliferation and apoptosis studies, ultimately 
leading to the conclusion that SiQDs do not produce any adverse effects on 
HeLa and SW1353 cells (human chondrosarcoma). Moreover, various particle 
sizes and coatings known as mesoporous silicon (Psi) (2-50 μm) or silicon 
quantum dots (QDs) have been used increasingly in applications of life science 
as promising oral drug delivery agents (Santos et al., 2010).  
Although silicon QDs do not contain any heavy metals and have been classified 
as low toxicity (Martin, 2013),  the literature regarding SiQDs toxicity is sparse 
and incomplete. Conventional toxicology of chemicals was originally 
investigated by Paracelsus and shows direct correlation between both 
concentration and exposure time with an adverse effect  (Elsaesser and 
Howard, 2012).   Despite this, SiQDs that show unique photo properties are 
very small in size, typically ranging between 5 to 7.5 nm which make them very 
different from bulk material (Hardman, 2006). SiQDs may possess unique 
adverse effects when the particle size is within this range (Li et al., 2003). 
Particles smaller than 100 μm may also generate free radicals (Li et al., 2003). 
Information regarding toxicity of QDs is also important for the development of 
biological applications using  nanomaterials. Optimised imaging and therapeutic 
potential of nanomaterials require at least four basic characteristics, including  
internalisation by the target cell, specified localisation, well defined interaction 
with the cell, and low toxicity with safe metabolic profile (Santos et al., 2013).    
Previous SiQDs cytotoxicity studies have been based on the cytotoxicity of the 
bulk material as there are currently no standard protocols specified for 
nanomaterial cytotoxicity studies. According to the basic understanding of bulk 
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materials, the concentrations of SiQDs used for cytotoxicity experiments in the 
present study were adapted between 0 to 200 μg mL-1. Furthermore, previous 
studies by Santos and colleagues (2010) evaluated cytotoxicity of microporous 
silicon at concentrations 0.2 – 4 mg mL-1 with the particles size in the range of 
1.2 μm -75 μm. The group highlighted that in CACO-2 cells (a model intestinal 
epithelial cell), the toxic effects of microporous silicon were significantly 
increased when studied with the small particle size after the cells were treated 
for more than 11 hours. Moreover, cell damage, apoptosis, and death in the cell 
line appeared to be influenced in a dose-dependent manner (Santos et al., 
2010).  
The effect of smaller nanoparticles on human cells is still unclear. A number of 
approaches can be used to assess this. Measuring cell viability using 2-(4,5-
dimethyl-2-thiazolyl)-3,5-diphenyl-2H-tetrazolium bromide (MTT assay) has 
been widely conducted and is one of the most popular cytotoxicity studies. The 
MTT assay is sensitive, practical, quantitative, and reproducible. The quantity of 
end product (formazan) is also directly proportional to the number of the viable 
cells (Ferrari et al., 1990, Ciapetti et al., 1993). The yellow MTT is metabolised 
by viable cells using mitochondrial and non-mitochondrial enzymes (Bernas and 
Dobrucki, 2002).  The positive charge of MTT facilitates cellular internalisation 
and metabolism occurs in intracellular and extracellular producing a dark purple 
end product of insoluble formazans (dark purple) (Berridge et al., 2005). MTT is 
metabolised by oxidoreductase dependent reducing agents and happens mainly 
in mitochondria. The reducing agents are the products of cell respiration such 
as NADH, NADPH. The cells which low metabolic or high metabolic activities 
may give false positive or false negative results. Also mitochondrial stress will 
give an apparent reducing in cells viability.  
Additionally, another quantitative measure of cell viability is through 
determination of ATP inside the cell. ATP is the energy source of all living 
organisms. ATP is  used for many biological processes such as membrane 
transport and cell motility and also the intracellular ATP content is directly 
correlated with the number of living cells (Imamura et al., 2009, Kolibab et al., 
2012)  Quantifying cell viability using the adenosine 5´- triphosphate (ATP) 
assay or firefly luciferase assay of ATP is a sensitive technique. The chemical 
reaction behind the assay involves extracting ATP from the cells. In the 
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presence of luciferin the ATP-luciferin complex reacts with luciferase to emit 
light which is proportional to the ATP concentration (Hoffner et al., 1999). The 
ATP assay has been validated by comparing with traditional cell viability count. 
There is high correlation between ATP content and the conventional viable 
count method (Jensen et al., 2008).    
Through use of multiple cytotoxicity evaluation methods which quantify how 
nanoparticles interact with human cells, the balancing of reactive oxygen 
species (ROS) with antioxidant capacity can be determined by measuring ROS 
content using 2´, 7´- dichlorofluorescein diacetate (DCFH-DA) fluorescine.  ROS 
are by-products of cellular metabolism which often originate from mitochondria 
activity (Thannickal and Fanburg, 2000). Collectively, ROS form a group of 
oxidative species: superoxide anion (O2
•-), hydroxyl radical (OH•), hydrogen 
peroxide (H2O2), singlet oxygen (
1O2), and hypochlorous acid (HOCl) (Manke et 
al., 2013). Excess levels of ROS generates oxidative stress (OS) which 
contributes to cellular macromolecule damage (Thannickal and Fanburg, 2000). 
DCFH-DA is a nonfluorescent dye and is nonpolar. DCFH-DA is able to cross 
the cell membrane and is converted to  nonfluorescent DCFH by intracellular 
esterases via  a hydrolysis reaction (Wang and Joseph, 1999). ROS inside the 
cell react with DCFH by an oxidation reaction which produces highly fluorescent 
dichlorofluorescein. The fluorescent product shows linear correlation with ROS 
concentration (Wang and Joseph, 1999). 
In addition, the effect of oxidative stress on DNA can be investigated using the 
Comet assay. DNA damage may occur even with low cytotoxic effects or 
negative results from other safety evaluation methods without cell death. The 
unique properties of nanoparticles could influence their ability to generate 
unpredictable genotoxic effects (Singh et al., 2009). The Comet assay detects 
single cell DNA damage using a gel electrophoresis technique (Singh et al., 
1988, Speit and Hartmann, 2006); thus, an individual cell can be evaluated. A 
cell with DNA damage shows the migration of single strand DNA fragments with 
an appearance similar to  a comet shape (Speit and Hartmann, 2006).                 
 In the present study the effects of SiQDs on CACO-2 cells were evaluated. 
CACO-2 is a human colon derived cell line which is widely used to study 
nanoparticle cytotoxicity via the oral exposure route (Ruizendaal et al., 2009).  
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Toxicity evaluation of SiQDs interaction on CACO-2 was performed with various 
toxicity endpoints: cell morphology evaluation using bright field microscope, 
potential adverse effects on cell viability detected with MTT assay, quantitative 
ATP measurement using FLASC assay, determination of oxidative stress 
condition using DCFH-DA assay, and evaluation of DNA damage potential 
using the Comet assay.  
5.2 Methods 
 
5.2.1 Route of Exposure of SiQDs Internalisation by CACO-2 
 
CACO-2 cells were cultured as described in Section 2.3 but without phenol red 
in the culture medium. Cells with starting density of 1-2 x 105 cells mL-1 were 
treated with SiQDs for 1 and 4 hours in 6, 12, 96 wells-plates, and T25 culture 
flasks. In addition, some experiments were conducted with longer term 
exposure of 14 days in order to look for chronic effects.   
5.2.2 Cell Morphology Studies 
 
Cell morphology studies were used to examine external morphology changes of 
the cells using a light microscope with 400x magnification to capture images of 
CaCO2 cells during the MTT assay. 
5.2.3 Potential Adverse Effects of SiQDs on CACO-2 Cell Viability (MTT 
assay)  
 
To evaluate the cytotoxicity of silicon quantum dots (SiQDs), the 3-(4, 5-
dimethylthaiazol-2-yl)-2,5-diphenyltetrazolium (MTT) reduction assay was used 
to determine any adverse effects on the viability of the cells. CACO-2 cells with 
density 1-2 x 105 cells mL-1 were cultured overnight in 96 well and 12 well 
plates. The cells were then treated with 50 μg mL-1 of freshly preparation 
SiQDs, positive control (15 μg mL-1 H2O2), and controls (untreated and solvent 
treated) for 4 and 24 hours. Thereafter the treated cells were washed and 
incubated with MTT dye (50 μg mL-1) for 2 hours.  After 2 hours the MTT 
solution was removed and the dark purple colour from the cells was dissolved 
using neat isopropanol. The plates were then incubated for a further 10 
minutes. Finally, the solution (0.1 mL) was removed from the 12 well plates and 
transferred to 96 well plates. The absorbance at 570 nm was measured using a 
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spectrophotometer (Thermo Scientific Multiskan microplate reader (96 wells 
plate)).  The percentage cell viability was calculated and compared with the 
control cells.  Results were obtained as the mean ± SD of the triplicate 
independent MTT experiments.  
5.2.4 Effect of SiQDs on Intracellular ATP Content     
 
A bioluminescent method was used to measure intracellular ATP content. An 
adenosine 5-triphosphate (ATP) bioluminescent somatic cell assay kit (Sigma-
Aldrich) was used to measure ATP content inside the cells (Appendix5.1). 
CACO-2 cells were incubated with SiQDs at 100 µg mL-1 in culture media for 4 
and 24 hours and SiQDs 0.5, 5, or 50 µg for 14 days.  As a positive control, 
cells were also treated with 2,4-dinitrophenol (2, 4 DNP)(ATP production 
inhibitor) (7 mg mL-1) for 4 and 24 hours. ATP was extracted from CACO-2 cells 
(50 μL) using somatic cell ATP releasing reagent (FLSAR (100 μL). The extract 
was decanted in to micro UV cuvettes containing luciferin-luciferase solution 
and MgSO4 and luminescence read in a fluorescence spectrometer 
(SpexFluoroMax/GRAMS 32) with the instrument’s excitation beam blocked 
with a piece of black card.  The luminescence was read at 560 nm and the 
luminescence intensities of the samples were compared with positive and 
negative control group. 
5.2.5 Measurement of Oxidative Stress in CACO-2 Cells Treated with 
SiQDs 
 
To determine the level of ROS inside the cells, 2,7-
dichlorodihydrofluoresceindiacetate (H2DCFDA) was used.  To measure ROS 
contents in acute and longer incubation studies, CACO-2 cells which had been 
incubated with SiQDs at 100 µg mL-1 for 4 and 24 hours and SiQDs at 0.5, 5 or 
50 µg mL-1 for 14 days were incubated with 0.5 mg mL-1 H2DCFDA (stock 20 
mM in DMSO) in culture medium for 45 minutes. The H2DCFDA cell solutions 
were transferred to micro UV cuvettes using positive displacement pipetting for 
accurate aspiration and complete dispensing and immediately the fluorescence 
was measured at an excitation wavelength of 485 nm with the emission 
wavelength at 530 nm.  
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5.2.6 DNA Damage Potential Evaluation of SiQDs  in CACO-2 cells 
 
To evaluate the potential for SiQDs to induce DNA damage, CACO-2 cells 
treated with SiQDs (200 μg mL-1), positive control (cells treated with 15 μg mL-1 
H2O2) as well as control (solvent treated cells) for 4 and 24 hours were used to 
evaluate DNA damage using single cell gel electrophoresis (SCG) or Comet 
assay using method of Singh and colleagues (1988). The alkaline Comet assay 
(pH ˃ 13) measures DNA lesions  including single and double DNA beaks 
(SSBs, DSBs) and alkali-labile site (ALS) (Singh et al., 1988, Tice et al., 2000). 
The CACO-2 cells were cultured in a T-25 flask at a cell density 5 x 105 cells cm 
-2 in 4 mL DMEM medium for 24 hours before treatment. After treatment, the 
cells were gently harvested from the flask using trypsin and the cell pellets were 
re-suspended in 1 mL of cool PBS in amber microcentrifuge tubes and stored 
on ice. In the dark room under dim light, a mixture of equal parts cell 
suspension and 1% (w/v) low melting agarose in PBS (37 oC ) was prepared 
(200 μL in total ). The mixed solutions (60 μL) were dropped on the top of pre-
coated 1% (w/v) low melting point agarose on SuperFrost microscope slides 
and covered with coverslips (two areas per slide). The agarose slides were 
allowed to solidify on ice and then the slides without coverslips were gently 
immersed into chilled lysing solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 
Triton X-100 (1% v/v), DMSO (1% v/v)).  The slides were left in the lysing 
solution to liberate DNA. The slides were then  transferred  into chilled alkaline 
buffer (300 mM NaOH, 1 mM EDTA, pH ˃ 13) in an electrophoresis tank and 
left for 30 minutes to allow DNA unwinding. The electrophoresis was performed 
at constant voltage of 22V, 0.5-0.7 mA for another 30 minutes in the same 
alkaline buffer. The slides were then placed into chilled neutralising buffer 
solution (0.5 M Trisma base pH 7.5) to allow the DNA to reconstitute. Finally, 
the DNA slides were dried and stained with SYBR gold solution (1: 10000 (v/v) 
in 1X Tris-EDTA (0.1 M Trisma base, 0.05 M EDTA). The following day, the 
cells were re-hydrated with water and fluorescent cells images, 200x 
magnification (Olympus U-RFLT50/Olympus CX40) with excitation wavelength 
490 nm were counted (50 images for each slide and 2 slides for each 
treatment). As the glowing cells were counted, the counting capture images 
were directly connected to the image analysis programme (Comet IV (IN STEM) 
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and the following parameters recorded: head length, tail length, and head 
intensity of DNA. The independent Comet experiments were performed in 
duplicate.  Results are the mean ± SD of the two whole cells samples (100 
cells) in the two independent experiments.    
5.2.7 Metabolic Activity Measurement and measurement of Oxidative 
Stress  CACO-2 cells Treated for 14 Days  
 
For studies of chronic exposure, CACO-2 (103 cells mL-1) were cultured in T25 
culture flasks overnight. After 24 h, the cells were treated with various 
concentrations of freshly prepared SiQDs at 0.5, 5, or 50 μg mL-1 from a stock 
solution of 1 mg mL-1 SiQDs in 10 μL diethyl ether (ether) in phenol red-free 
medium.  The cells were treated with SiQDs for 14 days and the medium was 
replaced with a fresh preparation of SiQDs suspension every two days. After 14 
days the cells were washed with PBS 3 times and detached using trypsin 
solution. The cell pellets were then suspended in 500 μL PBS. ATP and ROS 
production were measured using the FLASC and DCFH-DA assays.  
5.2.8 Statistical Analysis 
 
All statistical analysis was performed using SPSS software (IBM Statistics 21). 
The level of significance for the effects and interactions of particular parameters 
were calculated using-one-way ANOVA. The results are presented as the 
means and standard deviation (Mean ± SD). Post Hoc tests were used for the 
comparison for the significant parameters. A p value ≤ 0.05 was taken as 
statistically significant.  
5.3 Results 
 
5.3.1 Route of Exposure of SiQDs Internalisation by CACO-2 
 
CACo-2 cells were exposed to suspensions of SiQDs. The cells showed SiQDs 
accumulation with orange fluorescence detected inside the cells using an epi-
fluorescent microscope. A typical fluorescent image is showed in Figure 5.1. 
(B).     
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Figure 5. 1 CACO-2 cell images were captured using an Epi-fluorescent microscope with excitation light of wavelength 300-400 nm and 
400x magnification.   Internalisation studies (B) luminescence image of the dots inside Caco2 cells, (A) image of the control group. Cells 
were incubated with the dots (0.2 μg mL-1) for 60 minutes. Red corresponds to the fluorescence from the SiQDs. 
 
 
A B 
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5.3.2 Cell Morphology Studies 
 
To detect the effects of 0.1-0.5 % v/v of diethyl ether alone and SiQDs 
suspended diethyl ether in culture medium (0.1-0.5 % v/v ether) on CACO-2 cell 
morphology, CACO-2 cells were treated with both solutions for various time 
points, (0.5, 1, 2, 4, 24 hours or 14 days) and at various concentrations of 
SiQDs, (0.2, 0.5, 5, or 50 μg mL-1). The images of the control CACO-2 cells and 
the SiQDs treated CACO-2 cells were captured using a bright field microscope. 
Images of CACO-2 as shown in Figures 5.2 and 5.3, no differences were 
detected between treated cells and control cells. An image of 50 μg mL-1 SiQDs 
treated CACO-2 for 4 hours is shown in Figure 5.2 (B), and images of cells 
treated with 0.5, 5, and 50 μg mL-1 SiQDs for 14 days are shown in Figure 5.3 
(B-D) and images of the control cells are shown in Figure 5.2, 5.3 (A).  
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Figure 5. 2 CACO-2 cell images were captured using an Epi-fluorescent microscope with 400x magnification.   The bright field image A 
represents the morphology of CACO-2 in the control group (0.1% v/v ether), and image B shows the morphology of 4 hours-treated (50 
μg mL-1) CACO-2 with SiQDs. The red luminesce of the SiQDs is overlaid on the optical image on the right. 
 
A B 
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Figure 5. 3 CACO-2 cell images were captured using an Epi-fluorescent microscope with 400x magnification.   The bright field image A 
represents the morphology of CACO-2 in the control group (0.1% v/v ether), and image B, C, and D show the morphology of 14 Days-
treated (0.5, 5, or 50 μg mL-1) CACO-2 with SiQDs, respectively. The red luminesce of the SiQDs is overlaid on the optical images. 
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5.3.3 Effects of SiQDs on CACO-2 Cell Viability  
 
SiQDs at concentration 50 μg mL-1 treated CACO-2 for 4 and 24 hours did not 
cause any adverse effects on cell viability. The MTT results of the treated 
CACO-2 showed no difference compared to CACO-2 cells in the control group 
(Figure 5.4).  On the contrary, the positive control group (CACO-2 treated with 
15 μg mL-1 H2O2) showed markedly reduced viability when compared with the 
control CACO-2 cells and SiQDs treated CACO-2 cells (Figure 5.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 4 Cytotoxicity studied in CACO-2 after exposed to SiQDs for 4 and 24 
hours using MTT assay. Cell viability (% of control) is plotted as means ± SD for 
n=3 experiments. 
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5.3.4 Effects of SiQD treatment on cellular ATP concentrations in CACO-2 
cells    
 
Measurement of intracellular ATP showed that ATP levels were not significantly 
different between CACO-2 cells treated with SiQD at 100 μg mL-1 and control 
CACO-2 cells. This was the case for cells treated for 4 -or 24 hours, suggesting 
that SiQDs had no effect on CACO-2 - ATP production. In contrast, as a 
positive control (ATP production inhibitor), the ATP content of 2,4-DNP treated 
CACO-2 was significantly decreased at both 4 and 24 h incubation times 
(Figure 5.5).    
 
 
 
 
 
 
 
 
Figure 5. 5 Cellular ATP content measured in CACO-2 cells after exposed to 
SiQDs for 4 and 24 hours using FLASC (Sigma-Aldrich). The ATP content (% of 
control) represent with means ± SD for n=3 experiments. 
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5.3.5 Measurement of reactive oxygen species in CACO-2 cells treated 
with SiQDs 
 
Using the DCFH-DA fluorescent dye, treatment of CACO2 cells with SiQDs at 
100 ug mL-1 for up to 24 hours did not result in a significant increase in 
production of intracellular ROS. On the other hand, H2O2 treated CACO-2 cells 
exhibited much higher ROS concentrations compared to both control and SiQD 
treated cells. Cellular ROS content inside SiQDs treated CACO-2, control, and 
H2O2 treated CACO-2 is shown in Figure 5.6. The vehicle control showed 
slightly higher ROS production compared to medium after 24 hours.   
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Figure 5. 6 Cellular ROS content measured in CACO-2 cells after exposure to 
SiQDs for 4 and 24 hours using H2DCFDA (Sigma-Aldrich). The ROS contents 
(% of control) are indicated as means ± SD for n=3 experiments. 
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5.3.6 DNA Damage Potential Evaluation of  SiQDs in CACO-2 
 
 Single cell electrophoresis (Comet Assay) showed that CACO-2 cells treated 
with 200 μg mL-1 SiQDs for 4 or 24 hours did not show any significant change in 
any Comet parameters when compared to vehicle control. There was a 
significant decrease in head length at 4 hours compared to vehicle control, but 
this effect was not present at 24 hours; the SiQD treated cells appear to recover 
and no significant difference was observed compared to the control. CACO-2 
cells treated with the positive control (15 μg mL-1 H2O2) showed nucleus 
elongation (Figure 5.7 A, B) and marked increases in tail intensity (Figure 5.8-
5.9) compared to controls.  
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Figure 5. 7 (A, B) Comet images of CACO-2 cells after exposed to H2O2 (15 µg mL-1) and (C, D) Images of CACO-2 cells after exposed 
to SiQDs (200 µg mL-1) for 24 hours using Comet IV (Perceptive, UK).  
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Figure 5. 8 DNA damage in CACO-2 cells after exposed to SiQDs (200 µg mL-1) 
for 4 hours determined by Comet IV (Perceptive, UK). Head length, tail length 
and head intensity represent with means ± SD, whole cells experiments (n=2). 
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Figure 5. 9 DNA damage in CACO-2 cells after exposed to SiQDs (200 µg mL-1) 
for 24 hours determined by Comet IV (Perceptive, UK). Head length, tail length 
and head intensity are indicated as means and SD. 
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5.3.7 Metabolic Activity Measurement and Validation of Oxidative Stress of 
Treated CACO-2 for Long Term 14 Days  
 
To evaluate the effects on ATP levels and oxidative stress of long time 
exposure to SiQDs, CACO-2 cells were treated with 0.5, 5, and 50 μg mL-1 
SiQDs for 14 days. The FLASC ATP assay and DCFH-DA assay were 
performed to detect intracellular ATP and ROS content. After 14 days there are 
no significant differences in the intracellular ATP or ROS concentrations 
between SiQDs treated CACO-2 cells and control CACO-2 cells (Figure 5.10-
5.11).       
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Figure 5. 10 Cellular ATP content measured in CACO-2 cells after exposed to SiQDs for 14 days using FLASC (Sigma-Aldrich). The ATP 
contents (% of control) are indicated as means ± SD for n=3 experiments. 
** 
0
20
40
60
80
100
120
140
160
Medium Diethyl ether(0.1%v/v) Diethyl ether(1%v/v) Diethyl ether(10%v/v) SiQDs(0.5μg mL-1) SiQDs(5μg mL-1) SiQDs(50μg mL-1) 
CACO-2(14days)
C
e
ll
u
la
r 
A
T
P
 c
o
n
te
n
t 
(%
 o
f 
c
o
n
tr
o
l)
 
129 
 
 
 
Figure 5. 11 Cellular ROS content measured in CACO-2 cells after exposed to SiQDs for 14 days using H2DCFDA (Sigma-Aldrich). The 
ROS content (% of control) is indicated as means ± SD for n=3 experiments. 
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5.4 Discussion 
 
If QDs are to be used as luminescent probes (especially for medical imaging) 
the safety of these materials is a major concern. Although SiQDs do not contain 
any heavy metals, safety assessment is still crucial, particularly for nanomaterial 
applications in life sciences.   Despite this, at present there are no standard 
procedures for nanomaterial safety evaluations.  Furthermore, nanomaterials 
have unique characteristics and properties which differ from bulk material 
(Singh et al., 2009), (Doak et al., 2012).  Particles smaller than Bohr radius 
might  elicit different cellular responses compared to the bulk material (Nel et 
al., 2006).  
The utility of SiQDs as fluorescent probes for cell imaging was demonstrated by 
Alsharif and colleagues in 2009. They reported that SiQDs could be internalised 
by both primary and human tumour derived cell lines as shown using confocal 
microscopy (Alsharif et al., 2009). Accumulations of SiQDs inside CACO-2 cells 
were also shown using epi-fluorescence and confocal Raman microscopy.  
Previously, cytotoxicity evaluations of low concentration of SiQDs have been 
carried out in HeLa (immortalised epithelial cervical carcinoma) and SW1353 
cell lines (chondrosarcoma).  At this concentration, SiQDs did not produce 
adverse effects on HeLa and SW1353 in terms of cell morphological features 
(membrane sinking or blebbing), cell viability assay (CellTiter-Blue, Promega), 
cell proliferation assay (MTT), or cell apoptosis assay (DeadEnd Colorimetric 
TUNEL, Promega). Exposure to SiQDs did not result in membrane damage, 
decreased cellular metabolism or proliferation or increased cell death (Alsharif 
et al., 2009).   
In the current study, safety of SiQDs was evaluated using cytotoxicity effects 
models. In particular, CACO-2 cells were used as a model cell system as they 
are intestinal cells and might be more relevant to human exposure than the 
HeLa cells and other cells used previously by Alsharif et al. (2009). The MTT 
assay was first used to investigate cell viability of CACO-2 cells after exposure 
to SiQDs. According to the results, the concentration of SiQDs leading to cell 
death is likely to be very high.  The cell viability information from the MTT assay 
alone cannot classify the level of cytotoxicity and assess safety of SiQDs. In 
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addition another cell viability assay which measures the effect of SiQDs on 
cellular ability to produce ATP was used. Adverse effects of SiQDs are revealed 
by the concentration of ATP produced by the cells. High densities and healthy 
cells generate high concentration of ATP (Jensen et al., 2008, Xia et al., 
2008a). In addition, the intracellular effect of SiQDs was investigated using a 
reactive oxygen species (ROS) assay. Possible DNA damage was assessed 
using the Comet assay. None of these assays showed toxic effects of SiQDs, 
either acutely or chronically at the concentrations used (up to 200 μg mL-1). The 
only evidence of acute effects was found to be that of ether – the vehicle used 
to disperse the SiQDs – in the cellular ATP content assay. In the presence of 
ether, the cells generate more ATP for reasons that are not clear. 
The unique physicochemical properties of nanoparticles including size, shape, 
surface, and free radical are all factors attributable to the generation of unique 
adverse effects in living organisms. Nanoparticles are hypothesised to generate 
cytotoxicity, oxidative stress, and inflammatory responses (Sayes et al., 2007, 
Xia et al., 2006, Nel et al., 2006). However, in this study neither cytotoxicity nor 
increased oxidative stress was detected in CACO-2 cells treated with SiQDs. 
However, more studies need to be designed for specific safety evaluations 
relevant to applications of nanoparticles.  In order to establish the safety of 
nanoparticles more information on various aspects such as the interaction of 
nanoparticles with additional cell lines to mimic the route of administration are 
needed. The systemic toxicity (in vivo) also needs to be explored.  
The phagocytic and non-phagocytic cells, macrophage (RAW 264.7), lung 
epithelium (BEAS-2B) cells have been used for studying potential cytotoxicity 
effects of pollutants (particle sizes). Pollutants with ultrafine particles (UFPs) 
show adverse effects when three well-known oxidative stress markers, heme 
oxygenase-1 (HO-1) expression, glutathione, and reactive oxygen species 
(ROS), are investigated. The UFPs have been confirmed to be internalised by 
those cells by detection with electron microscopy (Li et al., 2003). It is indicated 
that the size of nanoparticles less than 0.1 μm together with inherent 
compounds (pollutants: organic carbon and polycyclic aromatic hydrocarbon 
(PAH) cause oxidative stress in macrophage and lung epithelium cells. The 
positively charged silicon (Si NP-NH2) shows more cytotoxic effects and 
induces high oxidative stress compared with the neutral silicon (Si NP-N3) while 
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negatively charge silicon (Si NP-COOH) shows very low cytotoxicity effects in 
macrophage NR8383 cells (Bhattacharjee et al., 2010). In addition, liver cell 
lines (HHL-5, HepG2) and embryonic cells (3T3-L1) treated with silicon coated 
with poly-acrylic acid (PAAc) reveal no adverse effects when cell morphology, 
cell proliferation, viability, and DNA damage assays are performed (Wang et al., 
2012).   
Another significant toxic effect of nanoparticles may be on the inflammatory 
cellular response.  This can be studied by looking at potential cytotoxicity effects 
of nanoparticles in phagocytic cells (Singh et al., 2009).  One study investigated 
macrophage cells (RAW 264.7) treated with two types of silicons with diameter 
3 nm (nanodots) and 100-300 nm (microdots) and found some effects on the 
cellular inflammatory responses. The cells showed internalisation of silicon 
nanoparticles (3nm) by fluorescence microscopy. However, in that study the 
nanoparticles were associated with increased cytotoxicity at concentrations 
above 20 ug mL-1 unlike in the current study where SiQDs showed no toxicity at 
this concentration for CACO-2 cells. Concentrations above 20 ug mL-1 were 
also associated with decreased synthesis of tumour necrosis factors-alpha 
(TNF-) and interleukin 6 (IL-6). Microdots with a larger diameter than silicon 
dots were less toxic to the macrophage cells but induced increased production 
of IL-6 and TNF-alpha at relatively low concentrations (Choi et al., 2009). 
Production of cytokines by CACO-2 cells in response to SiQDs was not studied 
in the current investigation as endogenous levels of these are likely to be very 
low in these non-immune cells. However, further studies involving investigation 
of SiQD effects on macrophage cytotoxicity and cytokine production should be 
performed. 
In addition, a pharmacokinetic assessment using an in vivo model is also 
important to determine the toxicity effects on distribution, clearance and specific 
organ (Fischer and Chan, 2007, Santos et al., 2013). The first in vivo study of Si 
nanoparticles coated with dextran has shown that porous Si or Si nanoparticles 
show low toxicity. The biodegradation product of porous Si is orthosilisic acid 
(Si(OH)4  and this is removed from the body through renal clearance (Park et al., 
2009).  
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In conclusion, no evidence for toxicity of SiQDs at a concentration of up to 200 
ug mL-1 in CACO-2 cells was obtained using a range of toxicity tests. These 
confirm the findings of Alsharif et al. (2009) but using a more physiologically 
relevant cell line and some additional tests such as assessment of DNA 
damage and oxidative stress.  
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Chapter 6. Mechanism of Internalisation of Alkyl-Capped Silicon 
Quantum Dots (SiQDs) 
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6.1 Introduction 
 
There is a strong relationship between the lipid content in the cell membrane 
(plasma membrane), proteins and the internalisation of molecules into the cell.  
The membrane of eukaryotic cells plays a vital role to separate the cytoplasm 
from environment as well as forming internal compartments of organelles 
(Phillips et al., 2009). The plasma membrane also functions as a part of 
sensory, signalling pathways, controls transport into and out of the cytoplasm, 
intracellular trafficking and energy metabolism in organelles (Phillips et al., 
2009). 
Endocytosis is one of the molecular transportation systems (Marsh and 
McMahon, 1999). The endocytosis processes may be divided into broad 
categories: phagocytosis and pinocytosis. The pinocytosis process or 
internalisation from the extracellular medium is the dominant process in all cell 
types (Seto et al., 2002, Conner and Schmid, 2003). Pinocytosis includes 4 
basic mechanisms, macropinocytosis, clathrin-mediated endocytosis (CME), 
caveolae-mediated endocytosis and clathrin-and caveolae-independent 
endocytosis (Conner and Schmid, 2003). The main function of endocytosis is 
vital for cell survival by controlling homeostasis of the cell. The cell uses 
endocytosis to regulate the lipid and protein composition of the cell membrane 
(Doherty and McMahon, 2009).  In addition, endocytosis is not just vesicular as 
transport also has a role in regulation of many intracellular signalling cascades 
as well as mitosis, antigen presenting, and cell migration (Doherty and 
McMahon, 2009). The cell controls lipid and protein to internalise membrane 
vesicles constantly. Among vesicular membranes, CME and caveolae-mediated 
endocytosis are the most extensive characterised because they are sensitive to 
endocytosis pharmacological/chemical inhibitors for examples chlorpromazine 
(CP), filipin, and methyl-β-cyclodextrin (MβCD) (Ivanov, 2008). CP is a cationic 
amphipathic drug which inhibits CME. The CP dose required to inhibit clathrin-
mediated endocytosis is in the range of 50-100 μM. However, the concentration 
of CP for cell studies needs to be used with care as CP also shows multiple 
interactions on intracellular lipids to increase membrane fluidity. It has some 
adverse effects on the cytoskeleton including effects on actin dynamics and 
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micropinocytosis (Ivanov, 2008). The exact mechanism by which CP inhibits 
CME is still unclear. It was thought to affect the interaction of the clathrin protein 
and AP2 adaptor complex in formation of the vesicle but recent data suggests 
the effect of this drug is downstream of clathrin-coated vesicle formation (Daniel 
et al., 2015). Other endocytosis inhibitors have effects on endocytosis involving 
caveolins.  Filipin and MβCD both affect cholesterol (Ivanov, 2008).  Cholesterol 
and sphingolipids interact with caveolins to form caveolae (Ivanov, 2008). The 
mechanisms for the inhibitory effects of filipin and MβCD are different. Filipin is 
a polyene antibiotic and binds directly to cholesterol in the cell membrane. It 
also binds to 3β-hydroxysterol, a major component of glycolipid microdomains 
and caveolae of the plasma membrane (Nagasawa et al., 2014). At the low 
concentration (1 μM), filipin treatment results in flattened caveolae probably due 
to lack of cholesterol to interact with caveolin. Filipin also has effects on the 
linkage between cortical F-actin and the plasma membrane but the relevance of 
this to endocytosis is still not clear (Ivanov, 2008). MβCD is a cyclic 
heptosaccharide that at 5-10 mM forms soluble inclusion complexes with 
cholesterol and therefore depletes cholesterol from the cell membrane (Ivanov, 
2008). Similar to filipin, this affects the formation of caveolae which are flatter 
than normal, with caveolin 1 also shown to locate in the wrong area of fibroblast 
membranes. Comparison between the endocytosis inhibitors CP, filipin, and 
MβCD reveals that MβCD has broader inhibition effects including effects on 
CME and fluid-phase endocytosis as well as caveolae-mediated endocytosis 
(Ivanov, 2008).   
The internalisation mechanism of alkyl-capped silicon quantum dots (SiQDs) in 
human cells was characterised because these materials have potential use as 
luminescent labels in biology as well as being of fundamental interest for the 
study of the interaction of nanomaterials with biological systems. SiQDs have 
unique physico-chemical properties with low toxicity (Alsharif et al., 2009). 
SiQDs have been proposed as a safe probe for cell imaging (Alsharif et al., 
2009, Ahire et al., 2012). SiQDs revealed no evidence of in vitro cytotoxicity 
with different toxicity end points, cell morphology, apoptosis, and cell viability. 
They also showed a high rate of internalisation including effects on cancer cells 
(HeLa, A172 and MCF7) compared with various non-cancer cells (HSF1, HSF2, 
HM, and A5UG) (Alsharif et al., 2009). Atomic force microscopy (AFM) images 
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showed that the SiQDs are small approximately spherical particles with 
diameters in the range of 5 to 7.5 nanometre (nm). They also have a bright 
orange luminescence, max ~ 650nm. Previous studies by Alsharif and 
colleagues showed that SiQDs are a promising alternative to cadmium selenite 
(CdSe)-based quantum dots for cell imaging. SiQDs were observed using 
confocal microscopy to be rapidly internalised after incubation with many cell 
lines, malignant and non-malignant, though at a slower rate in the primary cells 
(Alsharif et al., 2009).  
Alsharif and colleagues proposed that caveolin-mediated endocytosis might be 
involved in internalisation of SiQDs into HeLa cells as caveolin and cholesterol 
are major components of the caveolae (flask-shaped features on the cell 
membrane). It was found that treatment with filipin significantly decreased the 
accumulation of SiQDs into HeLa cells (Alsharif et al., 2009).   Filipin is a well-
known endocytosis inhibitor which operates by binding to cholesterol on the cell 
membrane (Nagasawa et al., 2014). Recent studies on the genes encoding 
caveolins have revealed 3 gene families, cav-1, cav-2, and cav-3. The cav-1 
and cav-2 genes are co-expressed in many cell types. The last, cav-3, is 
thought to be only expressed in skeletal muscle (Cohen et al., 2004). The 
studies described in this chapter are concerned with the uptake of SiQDs by 
several different cell lines as stated, CACO-2, HepG2, Huh7, and HeLa.  They 
are tumour derived cells from the intestine, the liver and cervical epithelium. The 
relevance of caveolin to this process is also investigated.  
Objectives  
1.   To measure internalisation of SiQDs using fluorescence method (flow   
cytometry)  
2.   To measure the influence of inhibitors of endocytosis process-filipin, 
chlorpromazine, MβCD 
3.        To quantify caveolin gene expression in the cell lines  
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6.2 Methods 
6.2.1 Cellular Internalisation Potential of SiQDs in Different Cell Lines 
 
Four different cells, CACO-2, Huh7, HeLa, and HepG2 were seeded in T-25 
flasks at a density of 1.5 x 105 cells mL-1 in the appropriate medium and 
incubated at 37 oC with 5% CO2. CACO-2 cells were cultured as described in 
Section 2.4. HeLa, HepG2, and Huh7 cells were cultured in complete RPMI-
1640 medium (R7509) with 10% (v/v) FBS instead of Dulbecco’s modified 
Eagle’s medium.  However, all other cell culture procedures were performed 
exactly as described for the CACO-2 cells. 
After 24 hours the cell medium was replaced with complete medium containing 
0.1% (v/v) foetal bovine serum (FBS) and freshly prepared 100 µg mL-1 SiQDs 
in 0.5% (v/v) diethyl ether and incubated at 37 oC with 5% CO2
 for 1 hour or 24 
hours. In a separate flask, the cells were incubated in the complete medium 
containing 0.1% (v/v) FBS with no SiQDs but the equivalent volume of diethyl 
ether. These were used as the control flasks. After 24 hours the culture medium 
was replaced with PBS and washed 3 times to eliminate the treated samples. 
Then the PBS was replaced with trypsin and left for 3 minutes. The trypsin 
reaction was stopped by added complete medium containing 10% (v/v) FBS. To 
remove FBS the cells suspension was washed using cell washer (BD FACSTM 
Lyse/Wash Assistant), compatible machine in PBS with precipitation G Force 
461G, precipitation time 10 second, wash force 350 g, and wash volume 
6400 μL. The precipitation cells suspensions were used for measuring 
luminescent intensities inside the cell. To compare luminescence intensity of 
SiQDs inside the cell among various cell types, the luminescence intensities 
were recorded in each individual cell. In each sample 3,000 events were 
collected using the BD LSR II flow cytometer. In the BD LSRII system, several 
excitation and detection wavelengths are available; SiQDs show strong orange-
red luminescence and are best detected with low excitation wavelength 
(355 nm) and at a long detection wavelength (675 nm). The data are presented 
as luminescence intensities average values (Mean ± SD).  
6.2.2 Specific Gene Expression of Caveolin-Mediated Endocytosis, 
Caveolin 1 and Caveolin 2 
 
RNA preparation 
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RNA was extracted from the cell lines. Cells at 70-80% confluence were used 
as the source of the RNA extraction. Cells were washed with phosphate 
buffered saline (PBS) 3 times. The PBS solution was replaced with a trypsin 
solution to remove the cells from the plate. To produce a cell pellet, the trypsin 
reaction with the cells suspension was stopped using cell culture medium 
containing 10-20% (v/v) foetal bovine serum (FBS) and centrifuged at 1000 G 
for 5 minutes. The cell pellet was re-suspended in PBS and centrifuged at 1000 
G for 5 minutes to obtain a clean cell pellet for RNA extraction.  Tri-reagent 
(Sigma-Aldrich) (1 mL) was added to the cell pellet and pipetted up and down to 
mix well. The cell suspension was transferred into an RNase-free screw cap 1.5 
mL micro centrifuge tube and incubated at room temperature for 10 minutes to 
allow the reagent to dissociate the nucleoprotein complexes. After 10 minutes 
100 µL of 1-bromo-3-chloropropane was added and mixed well by hand till the 
suspension solution became a milky pink colour; it was then incubated at room 
temperature for another 10 minutes. Then the suspension was centrifuged at 
12000 G and 4 oC for 10 minutes. After centrifugation, the cell suspension 
revealed 3 different layers. The first layer on the top was a clear RNA-   
containing solution, the middle, opaque layer contained the DNA and the third 
layer in the bottom was the dark pink solution comprising mainly protein.  The 
first layer (500 μL) was collected and placed into a new RNase-free micro 
centrifuge tube. To precipitate the RNA, 500 µl of isopropanol was added to the 
tube and mixed well using vortex. Then the solution was incubated at room 
temperature for 10 minutes. After 10 minutes the RNA was separated from the 
solution by centrifugation at 12000 G and 4 oC for 10 minutes. The isopropanol 
was carefully decanted and the white RNA pellet was collected. To clean the 
pellet and get rid of the remaining isopropanol, the pellet was re-suspended in 
75% (v/v) ethanol in RNase-free water and vortexed till the pellet moved out 
from the bottom of the tube. To collect the RNA, the suspension was 
centrifuged at 7500 G, 4oC for 5 minutes. After centrifugation the 75% (v/v) 
ethanol was carefully decanted and left the RNA pellet dried at room 
temperature for 10 minutes. After 10 minutes the RNA pellet was re-suspended 
in 50 µL RNase-free water and mixed well using vortex. The RNA solution was 
stored at -80 oC and checked for purity using a Nanodrop spectrophotometer 
ND-1000 (Thermo Scientific) before performing cDNA synthesis. The RNA 
solution absorbance at the unit of 1 at 260 nanometre (nm) is equivalent to 40 
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µg mL-1 RNA. The purity of the RNA is indicated by using the ratio of RNA 
solution absorbance at 260 nm to 280 nm. Acceptably pure RNA has an 
absorbance ratio in the range of 1.8 to 2.0; an increase in the absorbance at 
280 typically indicates the presence of proteins in the sample. 
 
cDNA synthesis      
 
The cDNA strand was synthesised using M-MuLV Reverse Transcriptase 
(200,000 U mL-1) (New England Biolabs) with random oligonucleotide 
sequences (primers) (Random Hexamers (0.4 µg µL-1)), deoxynucleotide 
(dNTPs) solution mix (40 mM, 10 mM in each dNTP (dATP, dCTP, dGTP, and 
dTTP)), RNase-free water, 10X Reverse transcriptase Reaction Buffer (1X : 75 
mM KCl, 50 mM Tris-HCl, 3 mM MgCl2, 10 mM dithiothreitol, pH 8.3) (reagents 
supplied with M-MuLV Reverse Transcriptase) and RNase Inhibitor (40,000 U 
mL-1). The procedure to synthesize the first cDNA strand was started by 
preparing the first mixing solution (1) by adding 1 µL of random hexamers, 1 µL 
of dNTPs and 6 µL of RNase-free water into an RNase-free micro centrifuge 
tube. The tube (1) was then placed on ice. In another RNase-free micro 
centrifuge tube the second solution (2) was prepared by adding 2 µL 10X 
Buffer, 0.1 µL RNase inhibitor, 0.25 µL Reverse Transcriptase Enzyme, and 
7.65 µL RNase-free water and placed on ice. Then 2 µL of the RNA solution 
was added into the first mixing tube (1) and mixed well. The RNA mixing 
solution was incubated at 65 oC for 10 minutes to denature the RNA. After 10 
minutes the denatured RNA solution was cooled on the ice for 2 minutes to 
allow the primers to recombine with the RNA. Then solution (2) was added into 
the first tube and mixed well. The combination solution tube was incubated at 
37 oC for 50 minutes to allow the reverse transcription reaction to reverse 
transcribe RNA to cDNA. To inactivate any remaining enzyme, the cDNA 
solution tube was incubated at 70 oC for 15 minutes.  After 15 minutes the 
cDNA solution was stored at -20 0C prior to qPCR analysis.  
 
Quantitative reverse transcriptase real time PCR analysis 
 
Quantitative reverse transcriptase real time PCR analysis using an ABI 
StepOne PCR System was used to determine expression of caveolin1 and 
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caveolin2. TaqMan caveolin 1 and caveolin 2 assays were employed to verify 
the specific gene expression in various cells types compared with the control 
gene. Caveolin 1 and caveolin 2 genes, predominate in almost cell types were 
characterised by qPCR using TaqMan Gene Expression Assays (Life 
Technologies). The amplified caveolin 1 or 2 gene with included   FAMTM 
reporter dyes and control gene, glyceraldehyde-3-phosphatedehydrogenase 
(GAPDH) with VICTM reporter dye were recorded by qPCR using MicroAmp 
Fast Optical 48-well PCR plate (Applied Biosystems) on an Applied Biosystems 
StepOneTM Real-Time PCR system. Quantifying caveolin gene expression was 
detected by recording the fluorescent signal of the reporter dye; the PCR cycle 
at which the fluorescence signal of the reporter dyes crosses the threshold of 
the baseline background (control gene) in the exponential phase of 
amplification. This cycle is named the threshold cycle (CT). The CT value is 
inversely correlated with the amount of small DNA or gene expression. A low CT 
value represents a greater amount of small DNA or gene expression 
(Schmittgen and Livak, 2008). The comparative CT method was employed to 
analyse the qPCR data and the data are presented as the amount of the gene 
of interest relative to the control gene glyceraldehyde-3-
phosphatedehydrogenase (GAPDH). 
6.2.3 Endocytosis Inhibitor Optimal Concentration 
 
Optimal dosages of common endocytosis inhibitors dosages, 2, 4, 6, 8, 10, 12, 
and 14 µg mL-1 of chlorpromazine, Methyl-β-cyclodextrin (MβCD) 2, 4, 6, 8, 10 
mmole L-1 were determined for the internalisation inhibition studies of SiQDs 
(Vercauteren et al., 2010). The maximum concentrations that did not produce 
deleterious changes in cell morphology were measured Filipin at 5 µg mL-1 and 
MβCD at concentration 10, 7.5, 5, and 2.5 mM were used to treat HeLa and 
Huh7 cells for 1 hour and 24 hours. Chlorpromazine at concentrations 2, 10, 20, 
and 30 µM was used to treat HeLa and Huh7 to discover the optimal 
concentrations for clathrin-mediated endocytosis inhibition. After 1 and 24 hours 
the cells were observed for morphological changes compared with the control 
groups. The cell morphology were observed under phase contrast microscope 
(OPTIKA) (200 x magnification) with cell images captured with Scopelmage 
DynamicPro (BUC2-500C).   
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6.2.4 Endocytosis Inhibition Studies of SiQDs on HeLa and Huh7 
 
Cellular internalisation of macromolecules, the dominant process in many cells 
is known as pinocytosis (Conner and Schmid, 2003).  In this study the 
pinocytosis pathways involved in the cellular internalisation of alkyl-capped 
silicon quantum dots (SiQDs) into the human cell lines were investigated using 
well-known endocytosis inhibitors, chlorpromazine (CP), methyl-β-cyclodextrin 
(MβCD), and filipin III. The cells were cultured with phenol red free medium (to 
avoid interference from the dye in the flow cytometry measurements) in culture 
treated T-75 flask and incubated at 37 oC with 5% CO2. 70-80% cells confluence 
was seeded in a culture treated T-25 flask at a density of 1.5 x 105 cells mL-1. 
The cells were cultured overnight in incubator, 37 oC with 5% CO2.    After 24 
hours incubation cells were treated with the appropriate chemical inhibitor 
(chlorpromazine, MβCD or filipin) in phenol red free complete medium 
containing 0.1% foetal bovine serum (FBS) for 1 hour. Then the medium was 
replaced with 100 µg mL-1 of SiQDs with constant concentration of the inhibitor 
in complete medium containing 0.1% FBS for 24 hours. HeLa and Huh7 were 
pre-treated with 1 mM MβCD, or 30 µM chlorpromazine, or 0.8 µM, 3 µM filipin 
and continued treatment with SiQDs for another 24 hours. The filipin treatment 
was performed slightly differently with the filipin was washed out before 
continued incubation with SiQDs. Quantitation of SiQDs which had been 
internalised by the cells treated with inhibitor was carried out using flow 
cytometry system to measure the amount of SiQDs inside the cells by recording 
the SiQDs fluorescent intensity and comparing with untreated cells. The 
luminescence intensities were recorded in each individual cell and in each 
sample using flow cytometry at wavelength 355 and 675 nm. 
6.2.5 Statistical Analysis 
 
All statistical analysis was performed using SPSS software (IBM Statistics 21). 
The level of significance for the effects and interactions of particular parameters 
were calculated using two-way anova. Where a statistically significant main 
effect was found, differences between treatment levels were evaluated using 
Tukey’s post hoc test. For the studies on inhibition of dot accumulation, 
significance was assessed by using independent sample T tests. A p value ≤ 
0.05 was taken as statistically significant.  
143 
 
6.3 Results 
6.3.1 Cellular Internalisation Potential of SiQDs in Different Cell Lines  
 
Four different human cell lines HepG2, CACO-2, HeLa, and Huh7 were treated 
with freshly prepared SiQDs (50 and 100 µg mL -1) in complete medium 
containing 0.1% foetal Bovine serum (FBS) and diethyl ether for 1 hour and 24 
hours before analysis accumulation of SiQDs inside the cell by flow cytometry. 
To qualify the internalisation potential of SiQDs by the accumulation of SiQDs 
inside the cells were measured by detecting luminescent intensities using flow 
cytometry. The cells luminescent intensities measured using flow cytometry 
(excitation at 355 nm and emission at 675 nm) is shown in Figure 6.1.  
There was a significant effect of concentration (P<0.001) and cell type on 
luminescence intensity (P<0.001) for data obtained at 1 hour and 24 hours 
when data were analysed by two-way ANOVA; however, there was also a 
significant interaction (P<0.001) term at both time points, suggesting that the 
response of cells to concentration was dependent on the cell line.  There was 
also a strong dependence on exposure time. With an exposure time of 1 hour, 
luminescence intensity did not differ significantly with SiQD concentration for 
CACO2 cells, whilst there was a small, but statistically significant, increase in 
luminescence intensity compared to controls with HeLa, HepG2 and Huh7 cells 
(Figure 6.1). After 24 hours, there was a more marked response of HepG2 and 
Huh7 cells to increasing concentrations of SiQDs, with a statistically significant 
effect of increasing SiQD concentration on luminescence intensity. The same 
was true for CACO2 cells, but to a lesser extent. The response of HeLa cells to 
increasing SiQD concentration was also statistically significant but the 
magnitude of increase was not greatly different from that with the shorter 
exposure time. The highest levels of luminescence intensity at both 
concentrations and time points were seen for HepG2 cells with a level of 143.96 
arbitrary fluoresence units seen after 24 hours when a concentration of 100 μg 
mL-1 was used.  
This study suggested that the internalisation of SiQDs into the cells (as 
evidenced by luminescence intensity measured by flow cytometry was 
significantly influenced by both SiQD concentration and cell type. Each cell 
types responded differently in terms of internalisation when SiQDs 
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concentrations were increased. After 24 hours exposure, the HepG2 and Huh7 
showed high internalisation of SiQDs inside the cells in response to increase 
the concentrations of SiQDs while the CACO-2 and HeLa showed slightly 
increased internalisation of SiQDs. 
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Figure 6. 1 Luminescent intensities measured using flow cytometry (excitation 355 nm and recorded emission at 675 nm) for control cells 
(no SiQDs) and cells treated with 50 or 100 μg ml-1 SiQD for 1hour or 24 hours. Bars are means ± SD for n=3 experiments.  Within each 
cell type and exposure time, bars with different superscript letters are significantly different (in response to SiQD concentration) at the 
P<0.05 or less. Data were analysed using ANOVA, with Tukey’s post hoc test where appropriate to distinguish the effects of different 
SiQD concentrations. 
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6.3.2 Specific Gene Expression of Caveolin-Mediated Endocytosis, 
Caveolin 1 and Caveolin 2 
 
The previous studies (section 6.3.1) using flow cytometry to quantify cellular 
internalisation of SiQDs showed that HepG2 and Huh7 had relatively high 
potential to internalise SiQDs with more limited transport into HeLa and CACO-
2. To find out whether the differences could be explained by the specific gene 
expression of caveolin-mediated endocytosis pathway, caveolin1 and caveolin2 
gene expression were determined in CACO-2, HeLa, HepG2, and Huh7 by 
qPCR using TaqMan assays. The control gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used to normalise the data. The tri-reagent 
extraction procedure produced a high yield and good quality of RNA based on 
absorbance. A summary RNA concentration and purity is showed in Table 6.1. 
The control GAPDH gene required 17 to 18 PCR cycles to reach the detection 
threshold in all 4 cell lines as shown in Figure 6.2. &Table 6.2., but the number 
of cycles needed for the other genes to be detected was higher for the cDNA 
from all cell lines. The gene expression levels for caveolin 1 and 2 relative to 
control (GAPDH) are shown in Table 6.3. The highest expression of both 
caveolin1 and caveolin2 was detected in HeLa cells. Levels of both transcripts 
were extremely low ( 0.1% of that in HeLa) in HepG2. For Huh7 and CACO-2, 
levels of caveolin2 were higher than caveolin1 and only slightly lower than the 
level of caveolin 2 in HeLa. A summary of all the data concerning caveolins is 
shown in Table 6.4. 
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Table 6. 1 RNA yields (ng mL-1) extracted with Tri-reagent and RNA purity measured using Nanodrop (n=3 experiments). 
 
RNA samples Nanodrop 
RNA concentration (ng mL-1) RNA purity (Ration A260:A280) (1.8 to 2) 
CACO-2  1022.5 - 3843.5 1.95 - 2 
HeLa  1078.7 - 1555.5 1.95 - 1.98 
HepG2  1247.1 - 2075.7 1.98 - 2 
Huh7  1491.0 - 2024.0 1.99 - 2 
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Figure 6. 2 The lines graphs show the PCR cycles of the reporter dyes. The point when the PCR cycles crossed the threshold is the 
threshold cycle (CT). The CT point in this graph is 25.05. 
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Table 6. 2 PCR cycles, the fluorescent signal crossed the threshold (amount of fluorescence emitting) of GAPDH, caveolin1, and 
caveolin2 in CACO-2 and HeLa (n=3 experiments).  
 
Cell lines Caveolin1 
CT(CAV1) 
GAPDH CT(G1) ∆CT (CAV-1) 
(AvgCAV-1-G1) 
CAV-1 relative to 
G1 (2
-∆CT
) 
Caveolin2 
CT(CAV-2) 
GAPDH CT(G2) ∆CT (CAV-2) 
(AvgCAV-2-G2) 
CAV-2 relative to 
G2 (2
-∆CT
) 
CACO-2(Mean) 27.03±0.06 17.51±0.02 9.52±0.05 0.001366 23.99±0.07 17.55±0.03 6.44±0.04 0.011536 
HeLa(Mean) 21.15±0.08 17.24±0.04 3.91±0.04 0.066771 22.32±0.06 17.33±0.02 4.99±0.05 0.031535 
HepG2(Mean) 35.69±0.31 17.65±0.02 18.04±0.29 0.0000037 34.89±0.43 17.66±0.03 17.23±0.40 0.0000065 
Huh7(Mean) 25.92±0.05 17.77±0.02 8.15±0.03 0.003521 24.33±0.17 17.81±0.02 6.52±0.14 0.010867 
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Table 6. 3 Caveolin1 and caveolin2 expression values compared with the control gene (GAPDH) in CACO-2, HeLa, HepG2, and Huh7 
(n=3 experiments). 
 
Cell Lines Gene expression relative to control (GAPDH)(2-∆CT x1000) 
Caveolin1 Caveolin2 
CACO-2 1.37 11.54 
HeLa 66.77 31.54 
HepG2 0.004 0.007 
Huh7 3.52 10.87 
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Table 6. 4 Summary of caveolin1 and caveolin2 expression in the four different 
cell lines. 
 
Cell lines Caveolin1 Caveolin2 Dots uptake 
HeLa High High Low/Medium 
Huh7 Medium Medium Medium 
HepG2 Very low Very low High 
CACO-2 Low Medium Low 
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6.3.3   Endocytosis Inhibitors Optimal Concentration 
 
The effect of various concentrations of well-known endocytosis inhibitors was 
characterised in selected cells to find out the optimal concentration for further 
studies. The chosen compounds were filipin, methyl-β-cyclodextrin (MβCD), 
and chlorpromazine. Filipin and MβCD are expected to affect caveolin-mediated 
endocytosis. Chlorpromazine is believed to affect clathrin-mediated endocytosis 
(Ivanov, 2008). The optimal concentration to be used is the maximum 
concentration of the chemical at which the cell still shows normal cell 
morphology and survives throughout the incubation time or periods of interest. 
As HeLa and Huh7 both showed relatively high levels of caveolin expression, 
they were chosen for these studies. MβCD and chlorpromazine are potent 
inhibitors of the endocytosis process but Vercauteren and colleagues 
(Vercauteren et al., 2010) found that relatively low concentrations of these 
inhibitors can also cause cytotoxic effects (Vercauteren et al., 2010). HeLa and 
Huh7 were therefore treated with chlorpromazine at doses of 2, 10, 20 and 30 
µM and MβCD doses of 2, 4, 6, 8, and 10 mM with the cells continuously 
exposed to these concentrations for 24 hours.  
After 24 hours, MβCD has no detectable adverse effects on HeLa and Huh7 
morphology when the concentration was lower than 2 mM. However, at higher 
concentrations (2 mM and above), MβCD caused HeLa and Huh7 to detach 
from the flask and few of the cells survived. Images of HeLa and Huh7 treated 
with MβCD at a high concentration (10 mM) are shown in Appendix 6.1-6.2.  
Chlorpromazine did not cause HeLa and Huh7 to detach from the flask but it 
changed cellular morphology with cells no longer elongating. Instead they 
showed circular cell morphology. Nevertheless, the chlorpromazine-treated cells 
still reached high confluence and attached to the flask throughout the studied 
period, albeit with the morphology changed compared with the control cells. The 
cells which had been treated with low or high concentrations of chlorpromazine 
showed the same morphology. All treated cells showed similar morphological 
changes as shown in Appendix 6.3-6.4.  
Additionally HeLa and Huh7 were treated with filipin (8 µM) for 1 hour.  The 
protocol of filipin treatment was slightly different from chlorpromazine & MβCD 
because filipin is a cholesterol binder. The cells were washed with PBS for 3 
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times to eliminate residual filipin before started to treat the cells with SiQDs. 
This concentration also caused all HeLa and Huh7 cells to detach from the flask 
(no images). However, this effect was not seen at filipin concentrations lower 
than 8 μM (no images).    
6.3.4 Endocytosis Inhibition Studies of SiQDs internalisation into HeLa 
and Huh7 
 
Investigations on the clathrin-mediated endocytosis mechanism of SiQDs in 
HeLa and Huh7 were carried out by pre-treatment with chlorpromazine at a 
concentration of 30 µM, MβCD at 1 mM and filipin at 0.8 and 3 µM. After pre-
treatment of the cells with endocytosis inhibitors for 1 hour, the cells were 
treated with SiQDs for 24 hours with constant amount of the endocytosis 
inhibitors chlorpromazine and MβCD. The protocol was slightly different in 
filipin-treated cells. The 1 hour filipin-treated cells were washed to eliminate the 
excess filipin outside the cells before incubation of the cells with SiQDs for 
another 24 hours. The effects of endocytosis inhibitors on the internalisation of 
SiQDs were measured as luminescent intensities using flow cytometry to 
quantify the accumulation of SiQDs inside the cells.  The internalisation of 
SiQDs by the cells was evaluated by comparison with the control groups. The 
cell luminescent intensities data (mean ± SD) is shown in Table 6.5. With 
values corrected for baseline fluorescence summarised in Table 6.6.  
Filipin treatment at two different concentrations (0.8 uM and 3 uM) did not affect 
accumulation of SiQDs in either cell line. MβCD at concentration 1 mM showed 
a statistically significant internalisation inhibition effect on Huh7 but not on 
HeLa. Due to the effects of chlorpromazine on cell morphology even at low 
concentrations, it was not possible to obtain reliable data but it appeared that for 
HuH7 cells, chlorpromazine treatment resulted in an apparently increased 
accumulation of SiQDs though this was not statistically significant. It is possible 
that the increased accumulation of SiQDs could be non-specific due to the 
chlorpromazine damaging membranes making the cell "leaky". There was no 
apparent effect of this treatment in HeLa cells. 
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Table 6. 5 Fluorecent intensities inside HeLa and Huh7 measured using flow cytometry with excitation wavelength 355 nm and recorded 
emission at wavelength 675 nm (means ± SD for n=3 experiments). 
  
Treatment/Cells HeLa Huh7 
Control (Ether) 75.50±1.73 111.50±2089 
SiQDs 100 µg mL-1 93.75±2.75 206.25±3.10 
Filipin 0.8 µM (Ether) 75.75±2.63 118.50±3.79 
SiQDs 100 µg mL-1 & Filipin 0.8 µM 96.00±5.48 207.50±9.75 
   
Control (Ether) 52.00±3.46 115.50±2.89 
SiQDs 100 µg mL-1 112.75±4.65 196.00±13.24 
Filipin 3 µM (Ether) 76.25±6.85 122.25±2.22 
SiQDs 100 µg mL-1 & Filipin 3 µM 131.50±2.38 197.25±2.06 
   
Control (Ether) 77.25±3.30 108.00±3.37 
SiQDs 100 µg mL-1 94.00±5.03 137.25±1.71 
Chlorpromazine(CP) 30 µM (Ether) 105.75±2.22 153.25±14.38 
SiQDs 100 µg mL-1 & CP 30 µM 121.50±2.52 201.75±26.61 
   
Control (Ether) 72.75±5.74 105.00±1.83 
SiQDs 100 µg mL-1 89.75±2.22 140.75±3.95 
Methyl-β-cyclodextrin (MβCD) 1.0 mM 
(Ether) 
71.00±2.16 146.50±7.50 
SiQDs 100 µg mL-1 & MβCD 1.0 mM 102.75±20.66 130.75±6.18 
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Table 6. 6 Fluorescent intensities accumulations inside HeLa, and Huh7 which had been treated with endocytosis inhibitors followed by 
SiQDs and the control cells (no inhibitors) (means ± SD for n=3 experiments). 
 
Fluorescent intensities HeLa Huh7 
SiQDs 100 µg mL-1 18.25±3.69 94.75±4.79 
SiQDs 100 µg mL-1 & Filipin 0.8 µM 20.25±4.57 89.00±11.92 
   
SiQDs 100 µg mL-1 60.75±4.86 80.50±14.62 
SiQDs 100 µg mL-1 & Filipin 3 µM 55.25±7.81 75.00±3.46 
   
SiQDs 100 µg mL-1 17.00±7.48 35.75±3.30 
SiQDs 100 µg mL-1 & MβCD 1.0 mM 31.75±20.43 15.75*±11.09 
   
SiQDs 100 µg mL-1 16.75±5.62 29.25±2.06 
SiQDs 100 µg mL-1 & CP 30 µM 15.75±3.95 48.50±25.68 
 
*significant P≤0.05 
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6.4 Discussion 
 
Previous studies by Alsharif and colleagues (2009) showed that alkyl-capped 
silicon quantum dots (SiQDs) are internalised rapidly into human tumour 
delivered cells, show low cytotoxicity, and have bright luminescence. They are 
therefore promising alternative probes to the standard cadmium selenide 
quantum dots for studying cellular processing to observe and monitor changes 
in living specimens. They also found that characterisation of internalisation to 
specify pathways with establishing endocytosis inhibitor filipin (a cholesterol 
binging dye),   cytoclalasin B (microfilament disturbing), and actinomycin D 
(motility effected) had effects on accumulation of SiQDs in HeLa (high evident 
SiQDs internalisations) by decreasing the evidence of internalisation of SiQDs 
into the cells detected by laser confocal microscope (Alsharif et al., 2009). 
The current experiments have confirmed that HeLa cells can accumulate 
SiQDs. Slightly unexpectedly, two other tumour cell lines HepG2 and HuH7 
showed significantly higher levels of accumulation compared with HeLa but a 
fourth cell line CACO-2 showed levels similar to HeLa. HepG2 and HuH7 were 
both derived originally from liver tumours but why these cells should accumulate 
SiQDs more than HeLa (cervical tumour) or CACO-2 (colon tumour) is not clear. 
As the four cell lines are not structurally very different and the experiments were 
performed at similar cell densities, the differences in accumulation seen 
consistently suggest the update of SiQDs is specific. To assess whether the 
differences might be due to levels of expression of genes relevant to 
endocytosis, expression of caveolins was studied in the four cell lines. Studying 
caveolin expression using qPCR revealed that HeLa expressed caveolin1 at a 
high level and caveolin2 at a moderate level. Caveolin expression in the other 
cell lines was lower overall. In particular and in line with reports from others 
(Palozza et al., 2008, Gai et al., 2014), there was very low expression of both 
isoforms in HepG2 cells (Truong et al., 2010) . Huh7 and CACO-2 both showed 
much lower expression of caveolin1 than in HeLa though caveolin2 was higher 
than caveolin1 and almost as high as that seen in HeLa cells. These results are 
difficult to interpret in relation to the SiQDs data but in view of the very low 
caveolin levels in HepG2, it seems unlikely that expression of this protein is 
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making an important contribution to the high level of SiQD accumulation seen 
for this cell line.  
Since caveolin, especially caveolin 2, was expressed in the other cell lines, it 
was decided to perform some inhibition experiments to assess the relevance of 
this protein to SiQD uptake in these cells. Two different caveolin inhibitors filipin 
and MβCD were used for these studies. Due to the similar levels of caveolin 
expression seen in HuH7 and CACO-2, it was decided to focus only on HuH7 
and HeLa cells in the caveolin inhibition studies. Contrary to previous studies 
(Alsharif et al., 2009), filipin did not inhibit SiQDs accumulation in HeLa cells 
and there was no effect seen either for HuH7. The reason for the discrepancy 
between this work and the previous study is not clear but it could be due to use 
of flow cytometry and lower concentrations of inhibitors in the current study and 
confocal microscopy by Alsharif et al. (2009). SiQDs accumulation in HuH7 cells 
was inhibited specifically by MβCD (1 mM) but there was no effect in HeLa 
cells. This inhibitor works differently to filipin. Filipin functions via cholesterol 
binding and binds to 3β-hydroxysterol, a major component of glycolipid 
microdomains and caveolae of the plasma membrane (Nagasawa et al., 2014). 
MβCD inhibits caveolin-mediated endocytosis by extraction of cholesterol from 
plasma membrane (Nagasawa et al., 2014). The main difference between the 
two cell lines is the lower caveolin1 expression in HuH7. If endocytosis involving 
caveolin2 was affected more by MBCD than the process involving caveolin1, 
this could explain the current findings but whether this is a correct explanation is 
unclear. 
The clathrin-mediated endocytosis inhibitor,  chlorpromazine, acts on the 
plasma membrane to inhibit coated pit formation  (Nagasawa et al., 2014) 
though as discussed in section 6.1, the precise mechanism for inhibition is still 
unclear. Because of the effect on chlorpromazine on cell morphology, the data 
obtained using this inhibitor needs to be treated with caution but there was no 
evidence for an inhibitory effect in either cell line. The toxic effects of 
chlorpromazine on both HuH7 and HeLa cells are surprising because the 
concentration used (5 uM) is slightly lower than the 5 ug mL-1 (14 uM) used 
recently to inhibit uptake of nanoparticles in both HuH7 and HepG2 cells (Liu et 
al., 2014) without any apparent adverse effects by the drug on cell morphology. 
It was not possible to study the effect of chlorpromazine on SiQD accumulation 
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in HepG2 cells due to time constraints but it is possible that a clear result might 
have been obtained if this had been done, especially since the accumulation of 
SiQDs in this cell line seems more likely to involve clathrin due to apparent 
absence of caveolin. 
In summary the small (5-7.5 nm) strongly luminescent SiQDs were internalised 
by four different human cancer cell lines, CACO-2, HeLa, HepG2, and Huh7 on 
the basis of flow cytometry analysis. The highest levels of accumulation were 
seen with HepG2 and HuH7 cells. Some further evidence for a role for 
caveolin2 in this process in HuH7 was obtained. The reason why HepG2 cells 
showed the highest accumulation of SiQDs remains unclear as caveolin 
expression is very low. Further work on a possible role for clathrin in the 
endocytosis process in these cells including inhibition studies by 
chlorpromazine is needed.  
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Chapter 7 General Discussion 
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A true understanding of the mechanism of how alkyl-capped silicon quantum 
dots (SiQDs) are internalized by human cells could help in understanding more 
about the toxicity of quantum dots (QDs) in general. Moreover, internalization 
and safety evaluation profiles are vital in supporting an urgent need for 
increasing the application of QDs as fluorescent labelling and biological probes 
as well as their use in delivery of drugs and targeted treatments.  
The current studies started with synthesis and quantification of SiQD’s 
physicochemical properties using electrochemical etching technique and 
hydrosilation reaction, and characterization using absorption and emission 
spectroscopy, atomic force microscope, fluorescent microscope, and confocal 
and Raman microscopy (Lie et al., 2002, Dickinson et al., 2008, Alsharif et al., 
2009). Previous studies had shown that these particles could accumulate in 
several cell lines including HeLa cells (Alsharif et al., 2009). The current study 
was particularly concerned with using a more relevant cell type CACO-2 cells to 
model oral exposure to SiQDs and showed that this cell line could also 
accumulate the particles. A more detailed analysis of possible toxicity in these 
cells was then performed. The factors associated with SiQDs physicochemical 
properties such as small size, high surface areas, and neutral surface charge 
may also be responsible for adverse biological effects (Singh et al., 2009).  In 
the current study, SiQDs at concentration 50 μg mL-1 showed no adverse 
effects or any cell death in CACO-2 cells. Previous studies showed that neutral 
charged azide-terminated Si NPs (Si NP-N3) caused more cytotoxicity effects in 
CACO-2 and rat alveolar macrophage (NR8383) than negatively charged Si 
NP-COOH which showed no adverse effects using the MTT assay (Ruizendaal 
et al., 2009, Bhattacharjee et al., 2010, Bhattacharjee et al., 2013). Interference 
with cellular ATP production can lead to two main adverse effects, decreased 
cell viability as well as mitochondrial injury and some previous studies involving 
other types of nanoparticle showed this occurred (Xia et al., 2008b, Jensen et 
al., 2008, Imamura et al., 2009, Kolibab et al., 2012). However, the current 
study shows no harmful effects of SiQDs on ATP production in CACO-2 cells.  
Oxidative stress is a well-documented mechanism for cellular damage induced 
by nanoparticles (Nel et al., 2006, Xia et al., 2006, Sayes et al., 2007). 
Consequently production of intracellular reactive oxygen species (ROS) may 
cause oxidative damage to lipids, proteins, and DNA (Thannickal and Fanburg, 
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2000). Owing to quantum confinement effects, small nanoparticles called QDs 
reveal discrete energy levels and have large energy gap (O'Farrell et al., 2006). 
As a result, QDs have the potential to absorb energy and generate 
fluorescence.  Moreover, QDs and engineered nanoparticles (ENPs) also have 
a capacity to transfer energy to nearby oxygen molecules (the reduction and 
oxidation (redox) cycling) to form reactive singlet oxygen (1O2) species as well 
as generate ROS and oxidative stress. Cytotoxicity and oxidative stress 
induction by nanoparticles or ultrafine nanoparticles has been reported widely 
particularly in pulmonary base cells lines. Brown et al. (2001) reported that low 
toxicity ultrafine particles are able to generate reactive oxygen species (ROS) 
as much as some other environmental particles (ultrafine carbon black ,ufCB) 
(Brown et al., 2001, Wilson et al., 2002). The environmental particles or 
particulate matter (PM10) particles also have ability to cause cytotoxicity and 
oxidative stress which is thought to be relevant to inflammatory effects, DNA 
damage, and pathological changes (cancer) (Donaldson et al., 2003). The 
particles appear to generate oxidative stress in a murine macrophage cell line 
(RAW 264.7) and a human bronchial epithelial cell line (BEAS-2B) by induction 
of cellular heme oxygenase-1 (HO-1) expression and decreasing intracellular 
glutathione  (Li et al., 2003, Xia et al., 2006). Apart from pulmonary cell lines, 
exposing CACO-2 cells to conventional low toxicity nanoparticles also caused 
oxidative stress detected by glutathione depletion (Gerloff et al., 2009). 
Interestingly pulmonary clearance of nanoparticles is an additional excretion 
route for nanoparticles reaching the gastrointestinal tract (Gerloff et al., 2009). 
The present study investigation oxidative stress by SiQDs, measuring ROS 
production and DNA damage using dichlorofluorescein diacetate (DCFH-DA 
assay) and Comet assay. SiQDs treated CACO-2 cells showed no induced 
ROS production even with exposure for 14 days. Also there was no DNA 
damage generated by high concentration of SiQDs up to 200 μg mL-1.  The 
finding that Si NPs show no generation of oxidative stress and DNA damage 
was also confirmed by others using DCFH-DA and Comet assays in non-
phagocytic and phagocytic cells (Wang et al., 2012, Bhattacharjee et al., 2013).   
Once it had been shown that, similar to the previous studies with HeLa cells 
(Alsharif et al., 2009), SiQDs were also nontoxic in CaCO2 cells, it was decided 
to undertake studies using two additional cell lines from human liver as well as 
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further studies on SiQD uptake by CaCO2 and HeLa cells. This study showed 
that even though all four cell lines studied were derived from human tumours, 
their ability to accumulate SiQDs varied. The lowest accumulation was seen in 
HeLa cells with the amount seen in CaCO2 slightly higher. However, both of the 
cell lines from the liver, HepG2 and HuH7, showed more accumulation. For this 
reason, it would have been better if more time had been available to have also 
done the toxicity investigations on one or both of these cell lines. There appear 
to have been no previous studies by others on toxicity of SiQD in either of these 
liver cell lines.  
Alsharif et al (2009) proposed that the SiQD internalization process involves 
pinocytosis and showed cholesterol-dependent effects by endocytosis inhibitors 
but all the studies involved HeLa cells. Profiles and knowledge of cellular NPs 
internalization mechanisms are important for further investigations and are 
fundamental for drug localization (e.g. contrast agents) and treatment 
applications (drug delivery) (Tansil and Gao, 2006, Coti et al., 2009, Elsaesser 
et al., 2010, Fischer et al., 2010, Iversen et al., 2011, Canton and Battaglia, 
2012). The current study aimed to find out more about SiQD accumulation 
inside four different cell lines including HeLa. The results were slightly 
unexpected but showed big differences in expression of caveolin 1 and 2 
between all four cell lines. The role for caveolin 1 in HeLa pinocytosis 
suggested by Alsharif et al. (2009) could not be confirmed and generally the 
inhibition studies were unsuccessful in increasing our understanding of the 
endocytosis process.  
Further studies are needed on endocytosis since the data obtained from 
pharmacological endocytosis inhibitor experiments did not prove to be 
conclusive. It is difficult to obtain specific information on the mechanism of 
endocytosis by the types of experiment using chemical inhibitors that were 
performed. In order to improve the specificity of the experiment, it would be 
necessary to use higher resolution imaging (with for example confocal 
fluorescence) to investigate time-dependent localization of the SiQDs as they 
enter and move within the cells. 
Based on the current findings, SiQDs have been found to show little or no acute 
toxicity in vitro. However, in order to show that SiQDs can have uses in vivo, 
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much more information is required than can be obtained simply by in vitro 
toxicology studies. Very little is known about the possible effect of SiQDs on the 
immune/inflammatory response, including effects on cytokines. More complete 
studies are needed.  
In vivo there is some evidence that SiQDs and porous silicon are cleared from 
mice by renal excretion as silicate eventually (Park et al., 2009).  There is also 
evidence from the same study that SiQDs can cause some histopathological 
changes in the liver soon after administration but after 4 weeks morphology is 
normal. However, overall the extent of information on the toxicity of SiQDs in 
vivo remains very sparse and it is quite likely that the surface chemistry of the 
SiQDs could have a large effect on their eventual fate in the body because the 
chemistry is already well-known to affect their stability to air and water. Further 
studies using additional animal species and longer term follow-up are needed. 
 
Summary of achievements 
•A low cost and practical technique, electrochemical (etching) has been used to 
produce monodisperse small particles of alkyl capped silicon quantum dots 
(SiQDs). 
 
•The SiQDs in the size range 5 -7.5 nm (mean diameter 5 nm, Si core 2.5 nm) 
show strong quantum confinement effects with intense orange fluorescence 
620 nm which corresponds to double the bulk band gap of 1.1 eV. 
 
•A uniform and successful dosing protocol was established in order to visualise 
fluorescence SiQDs and enable cytotoxicity evaluations in various human cell 
lines (CACO-2, HeLa, Huh7, and HepG2). 
 
•The consistent protocol and low background fluorescence enabled visualisation 
of the fluorescence of SiQDs in CACO-2 using epi-fluorescent and confocal 
microscopy. 
 
•Successful protocols for studying the interaction of SiQDs with CACO-2 for 
acute and chronic cytotoxicity studies were achieved using various cytotoxicity 
evaluation endpoints including cell viability, cell metabolism, oxidative stress 
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intermediated measurement, and the effects of oxidative stress and SiQDs on 
human cell DNA (MTT assay, ATP, ROS measurements, and Comet assay).  
 
•SiQDs did not produce any cytotoxicity effects on the human cell line (CACO-2) 
(a model for the main route of exposure of nanoparticles by the oral route) in 
acute and subchronic studies.  
 
•The strong fluorescence of SiQDs in the red regions of the visible spectrum 
(low cell florescent background) facilitates confirmation of SiQD internalisation 
by various human cell lines (CACO-2, HeLa, Huh7, and HepG2) using the 
confocal microscope as well as laser-fluorescence flow cytometry.    
 
•A RT-PCR Taqman-based gene expression assay was employed to study 
caveolin expression including caveolin1 and caveolin2 in several cell lines 
(CACO-2, HeLa, Huh7, and HepG2). The levels detected were in line with 
previous reports in the literature including apparent absence of caveolin in 
HepG2. 
 
•The mechanism of internalisation of SiQDs in selected cells (HeLa and Huh7) 
was probed by observing the effect of inhibitors of known aspects of 
endocytosis.  
 
•Filipin and MβCD inhibited the internalisation of SiQDs in the following cell 
lines (HeLa and Huh7). However, even at low doses both filipin and MβCD 
themselves showed some toxic effects and the conclusion that SiQDs uptake is 
cholesterol-dependent must be regarded as preliminary. Chlorpromazine did not 
inhibit uptake and was also cytotoxic. Of the three inhibitors, filipin showed the 
lowest cytotoxicity.  
 
Future work 
 
•Because the selected endocytosis inhibitors (filipin, CP, and MβCD) showed 
cytotoxic effects, other agents ought to be studied, e.g. 2,4-dinitrophenol (2,4-
DNP) which is an inhibitor of energy (ATP) dependent pathways and inhibits 
ATP production.   
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•It would also be of interest to extend the number of cell lines to further evaluate 
the relationship between caveolin expression and SiQD uptake. True phagocytic 
macrophages would also be interesting to study as their uptake of SiQDs is 
likely rather different. Primary hepatocytes are another cell type of interest in 
view of the findings on the liver tumour cell lines HepG2 and HuH7. 
 
•In vivo studies of the pharmacokinetics and the ultimate fate of SiQDs in the 
whole body will be important before any use of SiQDs in medical applications. 
Some work of this type has been performed by others (Park et al., 2009) and  
indicates SiQDs are metabolised to silicate and excreted.  
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Appendices 
 
Appendix 5. 1 Adenosine 5’-triphosphate (ATP) bioluminescent somatic cell 
assay kit (Catalogue Number FLASC), Sigma-Aldrich. 
 
1. Principles 
 
 
 
 
 
 
 
 
2. Reagents 
2.1 ATP Assay Mix (Catalogue Number FLAAM) 1 vial (lyophilized powder) 
contains luciferase, luciferin, MgSO4, DTT, EDTA, bovine derum albumin (BSA), 
and tricine buffer salts.   The vial must be mixed with 5 mL of ultrapure water 
before use, Sigma-Aldrich. 
2.2 ATP Assay Mix Dilution Buffer (Catalogue Number FLAAB) 1 vial 
(lyophilized powder) contains MgSO4, DTT, EDTA, BSA, and tricine buffer salts. 
The vial must be mixed with 50 mL of ultrapure water before use, Sigma-
Aldrich. 
2.3 Somatic Cell ATP Releasing Reagent (Catalogue Number FLSAR) 1 vial 
(10x concentrate). Cellular ATP is released almost immediately which increase 
membrane permeability to many small molecules, Sigma-Aldrich. The vial must 
be diluted 10-fold with ultrapure water before use, Sigma-Aldrich. 
2.4 ATP Standard (Catalogue Number FLAAS) 1 vial (lyophilized powder) 
contains ATP and disodium salt hydrate (1 mg). The vial must be mixed with 10 
mL of ultrapure water before use (2.0 x 10-6 mole), Sigma-Aldrich. 
 
 
 
Intracellular ATP  Free ATP 
ATP + Luciferin  
Reaction 1  
Reaction 2  Free ATP 
Firefly Luciferase 
Mg
2+
 
Reaction 3  Intracellular ATP + O2  Oxyluciferin + AMP + CO2  
+ Light 
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3. Procedures 
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Appendix 6. 1 Phase contrast microscope (OPTIKA) with ScopeImage DynamicPro (BUC2-500C) captured on HeLa (200 x 
magnification), the cells density at the beginning was 1.5 x 105 cells mL-1. Image A the cells were treated with appropriate medium for 24 
hours as a control cells. Image B the cells were treated with Methyl-β-cyclodextrin (MβCD) at a concentration of 10 mM for 24 hours.  
 
 
 
A 25µm B 25µm 
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Appendix 6. 2 Phase contrast microscope (OPTIKA) with ScopeImage DynamicPro (BUC2-500C) captured on Huh7 (200 x 
magnification), the cells density at the beginning was 1.5 x 105 cells mL-1. Image C the cells were treated with appropriate medium for 24 
hours as a control cells. Image D the cells were treated with Methyl-β-cyclodextrin (MβCD) at a concentration of 10 mM for 24 hours.  
 
 
 
 
C 25µm D 25µm 
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Appendix 6. 3 Phase contrast microscope (OPTIKA) with ScopeImage DynamicPro (BUC2-500C) captured on HeLa (200 x 
magnification), the cells density at the beginning was 1.5 x 105 cells mL-1. Image E the cells were treated with appropriate medium for 24 
hours as a control cells. Image F the cells were treated with chlorpromazine at a concentration of 2 µM for 24 hours. 
 
 
 
E 25µm 25µm F 
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Appendix 6. 4 Phase contrast microscope (OPTIKA) with ScopeImage DynamicPro (BUC2-500C) captured on HeLa (200 x 
magnification), the cells density at the beginning was 1.5 x 105 cells mL-1. Image G the cells were treated with appropriate medium for 24 
hours as a control cells. Image H the cells were treated with chlorpromazine at a concentration of 10 µM for 24 hours. 
 
 
G 25µm 25µm H 
172 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
173 
 
//IMAGEJ.NIH.GOV/IJ/, H. 
AHIRE, J. H., WANG, Q., COXON, P. R., MALHOTRA, G., BRYDSON, R., CHEN, 
R. & CHAO, Y. 2012. Highly Luminescent and Nontoxic Amine-Capped 
Nanoparticles from Porous Silicon: Synthesis and Their Use in Biomedical 
Imaging. Acs Applied Materials & Interfaces, 4, 3285-3292. 
ALIVISATOS, A. P. 1996. Semiconductor clusters, nanocrystals, and quantum dots. 
Science, 271, 933-937. 
ALIVISATOS, A. P., GU, WEIWEI, LARABELL, CAROLYN 2005. Quantum dots as 
cellular probes. Annual Review of Biomedical Engineering, 7, 55-76. 
ALSHARIF, N. H., BERGER, C. E. M., VARANASI, S. S., CHAO, Y., HORROCKS, 
B. R. & DATTA, H. K. 2009. Alkyl-Capped Silicon Nanocrystals Lack 
Cytotoxicity and have Enhanced Intracellular Accumulation in Malignant Cells 
via Cholesterol-Dependent Endocytosis. Small, 5, 221-228. 
BATEMAN, J. E., EAGLING, R. D., WORRALL, D. R., HORROCKS, B. R. & 
HOULTON, A. 1998. Alkylation of porous silicon by direct reaction with 
alkenes and alkynes. Angewandte Chemie-International Edition, 37, 2683-2685. 
BERNAS, T. & DOBRUCKI, J. 2002. Mitochondrial and nonmitochondrial reduction 
of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial 
fluorescent probes. Cytometry, 47, 236-42. 
BERRIDGE, M. V., HERST, P. M. & TAN, A. S. 2005. Tetrazolium dyes as tools in cell 
biology: new insights into their cellular reduction. Biotechnology annual review, 
11, 127-52. 
BHATTACHARJEE, S., DE HAAN, L. H. J., EVERS, N. M., JIANG, X., MARCELIS, 
A. T. M., ZUILHOF, H., RIETJENS, I. M. C. M. & ALINK, G. M. 2010. Role 
of surface charge and oxidative stress in cytotoxicity of organic monolayer-
coated silicon nanoparticles towards macrophage NR8383 cells. Particle and 
Fibre Toxicology, 7, 1-12. 
BHATTACHARJEE, S., RIETJENS, I. M. C. M., SINGH, M. P., ATKINS, T. M., 
PURKAIT, T. K., XU, Z., REGLI, S., SHUKALIAK, A., CLARK, R. J., 
MITCHELL, B. S., ALINK, G. M., MARCELIS, A. T. M., FINK, M. J., 
VEINOT, J. G. C., KAUZLARICH, S. M. & ZUILHOF, H. 2013. Cytotoxicity 
of surface-functionalized silicon and germanium nanoparticles: the dominant 
role of surface charges. Nanoscale, 5, 4870-4883. 
BLEY, R. A., KAUZLARICH, S. M., DAVIS, J. E. & LEE, H. W. H. 1996. 
Characterization of silicon nanoparticles prepared from porous silicon. 
Chemistry of Materials, 8, 1881-1888. 
BORSELLA, E., D'AMATO, R., FALCONIERI, M., TRAVE, E., PANARITI, A. & 
RIVOLTA, I. 2013. An outlook on the potential of Si nanocrystals as 
luminescent probes for bioimaging. Journal of Materials Research, 28, 193-204. 
174 
 
BOTTI, S., TERRANOVA, M. L., SESSA, V., PICCIRILLO, S. & ROSSI, M. 2001. 
Silicon quantum dots in diamond matrix: a new synthesis route. Applied 
Organometallic Chemistry, 15, 388-392. 
BROWN, D. M., WILSON, M. R., MACNEE, W., STONE, V. & DONALDSON, K. 
2001. Size-dependent proinflammatory effects of ultrafine polystyrene particles: 
A role for surface area and oxidative stress in the enhanced activity of ultrafines. 
Toxicology and Applied Pharmacology, 175, 191-199. 
BRUCHEZ, M., MORONNE, M., GIN, P., WEISS, S. & ALIVISATOS, A. P. 1998. 
Semiconductor nanocrystals as fluorescent biological labels. Science, 281, 2013-
2016. 
BURIAK, J. M. 1999. Organometallic chemistry on silicon surfaces: formation of 
functional monolayers bound through Si-C bonds. Chemical Communications, 
1051-1060. 
BURIAK, J. M., STEWART, M. P., GEDERS, T. W., ALLEN, M. J., CHOI, H. C., 
SMITH, J., RAFTERY, D. & CANHAM, L. T. 1999. Lewis acid mediated 
hydrosilylation on porous silicon surfaces. Journal of the American Chemical 
Society, 121, 11491-11502. 
BUZEA, C., PACHECO, I. I. & ROBBIE, K. 2007. Nanomaterials and nanoparticles: 
Sources and toxicity. Biointerphases, 2, MR17-MR71. 
CANHAM, L. 2000. Gaining light from silicon. Nature, 408, 411-412. 
CANHAM, L. T. 1990. SILICON QUANTUM WIRE ARRAY FABRICATION BY 
ELECTROCHEMICAL AND CHEMICAL DISSOLUTION OF WAFERS. 
Applied Physics Letters, 57, 1046-1048. 
CANTON, I. & BATTAGLIA, G. 2012. Endocytosis at the nanoscale. Chemical Society 
Reviews, 41, 2718-2739. 
CHAN, W. C. W., MAXWELL, D. J., GAO, X. H., BAILEY, R. E., HAN, M. Y. & NIE, 
S. M. 2002. Luminescent quantum dots for multiplexed biological detection and 
imaging. Current Opinion in Biotechnology, 13, 40-46. 
CHAN, W. C. W. & NIE, S. M. 1998. Quantum dot bioconjugates for ultrasensitive 
nonisotopic detection. Science, 281, 2016-2018. 
CHAO, Y., SILLER, L., KRISHNAMURTHY, S., COXON, P. R., BANGERT, U., 
GASS, M., KJELDGAARD, L., PATOLEO, S. N., LIE, L. H., O'FARRELL, N., 
ALSOP, T. A., HOULTON, A. & HORROCKS, B. R. 2007. Evaporation and 
deposition of alkyl-capped silicon nanocrystals in ultrahigh vacuum. Nature 
Nanotechnology, 2, 486-489. 
CHOI, B. H., HWANG, S. W., KIM, I. G., SHIN, H. C., KIM, Y. & KIM, E. K. 1998. 
Fabrication and room-temperature characterization of a silicon self-assembled 
quantum-dot transistor. Applied Physics Letters, 73, 3129-3131. 
175 
 
CHOI, J., ZHANG, Q., REIPA, V., WANG, N. S., STRATMEYER, M. E., HITCHINS, 
V. M. & GOERING, P. L. 2009. Comparison of cytotoxic and inflammatory 
responses of photoluminescent silicon nanoparticles with silicon micron-sized 
particles in RAW 264.7 macrophages. Journal of Applied Toxicology, 29, 52-60. 
CIAPETTI, G., CENNI, E., PRATELLI, L. & PIZZOFERRATO, A. 1993. INVITRO 
EVALUATION OF CELL BIOMATERIAL INTERACTION BY MTT ASSAY. 
Biomaterials, 14, 359-364. 
CLIFT, M. J. D., BOYLES, M. S. P., BROWN, D. M. & STONE, V. 2010. An 
investigation into the potential for different surface-coated quantum dots to 
cause oxidative stress and affect macrophage cell signalling in vitro. 
Nanotoxicology, 4, 139-149. 
COHEN, A. W., HNASKO, R., SCHUBERT, W. & LISANTI, M. P. 2004. Role of 
caveolae and caveolins in health and disease. Physiological Reviews, 84, 1341-
1379. 
CONNER, S. D. & SCHMID, S. L. 2003. Regulated portals of entry into the cell. 
Nature, 422, 37-44. 
COTI, K. K., BELOWICH, M. E., LIONG, M., AMBROGIO, M. W., LAU, Y. A., 
KHATIB, H. A., ZINK, J. I., KHASHAB, N. M. & STODDART, J. F. 2009. 
Mechanised nanoparticles for drug delivery. Nanoscale, 1, 16-39. 
DABBOUSI, B. O., RODRIGUEZVIEJO, J., MIKULEC, F. V., HEINE, J. R., 
MATTOUSSI, H., OBER, R., JENSEN, K. F. & BAWENDI, M. G. 1997. 
(CdSe)ZnS core-shell quantum dots: Synthesis and characterization of a size 
series of highly luminescent nanocrystallites. Journal of Physical Chemistry B, 
101, 9463-9475. 
DANIEL, J. A., CHAU, N., ABDEL-HAMID, M. K., HU, L., VON KLEIST, L., 
WHITING, A., KRISHNAN, S., MAAMARY, P., JOSEPH, S. R., SIMPSON, 
F., HAUCKE, V., MCCLUSKEY, A. & ROBINSON, P. J. 2015. Phenothiazine-
derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. 
Traffic, 16, 635-54. 
DERFUS, A. M., CHAN, W. C. W. & BHATIA, S. N. 2004. Probing the cytotoxicity of 
semiconductor quantum dots. Nano Letters, 4, 11-18. 
DICKINSON, F. M., ALSOP, T. A., AL-SHARIF, N., BERGER, C. E. M., DATTA, H. 
K., SILLER, L., CHAO, Y., TUITE, E. M., HOULTON, A. & HORROCKS, B. 
R. 2008. Dispersions of alkyl-capped silicon nanocrystals in aqueous media: 
photoluminescence and ageing. Analyst, 133, 1573-1580. 
DINH, L. N., CHASE, L. L., BALOOCH, M., SIEKHAUS, W. J. & WOOTEN, F. 
1996. Optical properties of passivated Si nanocrystals and SiOx nanostructures. 
Physical Review B, 54, 5029-5037. 
DOAK, S. H., MANSHIAN, B., JENKINS, G. J. S. & SINGH, N. 2012. In vitro 
genotoxicity testing strategy for nanomaterials and the adaptation of current 
176 
 
OECD guidelines. Mutation Research-Genetic Toxicology and Environmental 
Mutagenesis, 745, 104-111. 
DOHERTY, G. J. & MCMAHON, H. T. 2009. Mechanisms of Endocytosis. Annual 
Review of Biochemistry. 
DONALDSON, K., STONE, V., BORM, P. J. A., JIMENEZ, L. A., GILMOUR, P. S., 
SCHINS, R. P. F., KNAAPEN, A. M., RAHMAN, I., FAUX, S. P., BROWN, D. 
M. & MACNEE, W. 2003. Oxidative stress and calcium signaling in the adverse 
effects of environmental particles (PM10). Free Radical Biology and Medicine, 
34, 1369-1382. 
DUBERTRET, B., SKOURIDES, P., NORRIS, D. J., NOIREAUX, V., BRIVANLOU, 
A. H. & LIBCHABER, A. 2002. In vivo imaging of quantum dots encapsulated 
in phospholipid micelles. Science, 298, 1759-1762. 
EASH, S., QUERBES, W. & ATWOOD, W. J. 2004. Infection of Vero cells by BK virus 
is dependent on Caveolae. Journal of Virology, 78, 11583-11590. 
ELSAESSER, A. & HOWARD, C. V. 2012. Toxicology of nanoparticles. Advanced 
Drug Delivery Reviews, 64, 129-137. 
ELSAESSER, A., TAYLOR, A., DE YANES, G. S., MCKERR, G., KIM, E.-M., 
O'HARE, E. & HOWARD, C. V. 2010. Quantification of nanoparticle uptake by 
cells using microscopical and analytical techniques. Nanomedicine, 5, 1447-
1457. 
EROGBOGBO, F., CHANG, C.-W., MAY, J., PRASAD, P. N. & SWIHART, M. T. 
2012. Energy transfer from a dye donor to enhance the luminescence of silicon 
quantum dots. Nanoscale, 4, 5163-5168. 
EROGBOGBO, F., TIEN, C.-A., CHANG, C.-W., YONG, K.-T., LAW, W.-C., DING, 
H., ROY, I., SWIHART, M. T. & PRASAD, P. N. 2011a. Bioconjugation of 
Luminescent Silicon Quantum Dots for Selective Uptake by Cancer Cells. 
Bioconjugate Chemistry, 22, 1081-1088. 
EROGBOGBO, F., YONG, K.-T., HU, R., LAW, W.-C., DING, H., CHANG, C.-W., 
PRASAD, P. N. & SWIHART, M. T. 2010. Biocompatible Magnetofluorescent 
Probes: Luminescent Silicon Quantum Dots Coupled with Superparamagnetic 
Iron(III) Oxide. Acs Nano, 4, 5131-5138. 
EROGBOGBO, F., YONG, K.-T., ROY, I., HU, R., LAW, W.-C., ZHAO, W., DING, H., 
WU, F., KUMAR, R., SWIHART, M. T. & PRASAD, P. N. 2011b. In Vivo 
Targeted Cancer Imaging, Sentinel Lymph Node Mapping and Multi-Channel 
Imaging with Biocompatible Silicon Nanocrystals. Acs Nano, 5, 413-423. 
EROGBOGBO, F., YONG, K.-T., ROY, I., XU, G., PRASAD, P. N. & SWIHART, M. 
T. 2008. Biocompatible luminescent silicon quantum dots for imaging of cancer 
cells. Acs Nano, 2, 873-878. 
177 
 
FERRARI, M., FORNASIERO, M. C. & ISETTA, A. M. 1990. MTT 
COLORIMETRIC ASSAY FOR TESTING MACROPHAGE CYTOTOXIC 
ACTIVITY INVITRO. Journal of Immunological Methods, 131, 165-172. 
FISCHER, H. C. & CHAN, W. C. W. 2007. Nanotoxicity: the growing need for in vivo 
study. Current Opinion in Biotechnology, 18, 565-571. 
FISCHER, H. C., HAUCK, T. S., GOMEZ-ARISTIZABAL, A. & CHAN, W. C. W. 
2010. Exploring Primary Liver Macrophages for Studying Quantum Dot 
Interactions with Biological Systems. Advanced Materials, 22, 2520-2524. 
FOTAKIS, G. & TIMBRELL, J. A. 2006. In vitro cytotoxicity assays: Comparison of 
LDH, neutral red, MTT and protein assay in hepatoma cell lines following 
exposure to cadmium chloride. Toxicology Letters, 160, 171-177. 
FROEHLICH, E. 2012. The role of surface charge in cellular uptake and cytotoxicity of 
medical nanoparticles. International Journal of Nanomedicine, 7, 5577-5591. 
FU, A. H., GU, W. W., LARABELL, C. & ALIVISATOS, A. P. 2005. Semiconductor 
nanocrystals for biological imaging. Current Opinion in Neurobiology, 15, 568-
575. 
FUJIOKA, K., HIRUOKA, M., SATO, K., MANABE, N., MIYASAKA, R., HANADA, 
S., HOSHINO, A., TILLEY, R. D., MANOME, Y., HIRAKURI, K. & 
YAMAMOTO, K. 2008. Luminescent passive-oxidized silicon quantum dots as 
biological staining labels and their cytotoxicity effects at high concentration. 
Nanotechnology, 19, 1-7. 
FURUKAWA, S. & MIYASATO, T. 1988. QUANTUM SIZE EFFECTS ON THE 
OPTICAL BAND-GAP OF MICROCRYSTALLINE SI-H. Physical Review B, 
38, 5726-5729. 
GAI, X., LU, Z., TU, K., LIANG, Z. & ZHENG, X. 2014. Caveolin-1 is up-regulated 
by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma. 
PLoS One, 9, e84551. 
GERLOFF, K., ALBRECHT, C., BOOTS, A. W., FOERSTER, I. & SCHINS, R. P. F. 
2009. Cytotoxicity and oxidative DNA damage by nanoparticles in human 
intestinal Caco-2 cells. Nanotoxicology, 3, 355-364. 
GREEN, M. & HOWMAN, E. 2005. Semiconductor quantum dots and free radical 
induced DNA nicking. Chemical Communications, 121-123. 
HAJJAJI, H., ALEKSEEV, S., GUILLOT, G., BLANCHARD, N. P., MONNIER, V., 
CHEVOLOT, Y., BREMOND, G., QUERRY, M., PHILIPPON, D., VERGNE, 
P. & BLUET, J. M. 2014. Luminescence nanothermometry with alkyl-capped 
silicon nanoparticles dispersed in nonpolar liquids. Nanoscale Research Letters, 
9, 1-6. 
HAN, M., GAO, X., SU, J. Z. & NIE, S. 2001. Quantum-dot-tagged microbeads for 
multiplexed optical coding of biomolecules. Nat Biotechnol, 19, 631-5. 
178 
 
HARDMAN, R. 2006. A toxicologic review of quantum dots: Toxicity depends on 
physicochemical and environmental factors. Environmental Health Perspectives, 
114, 165-172. 
HARUN, N. A., HORROCKS, B. R. & FULTON, D. A. 2011. A miniemulsion 
polymerization technique for encapsulation of silicon quantum dots in polymer 
nanoparticles. Nanoscale, 3, 4733-4741. 
HATA, K., YOSHIDA, S., FUJITA, M., YASUDA, S., MAKIMURA, T., MURAKAMI, 
K. & SHIGEKAWA, H. 2001. Self-assembled monolayer as a template to 
deposit silicon nanoparticles fabricated by laser ablation. Journal of Physical 
Chemistry B, 105, 10842-10846. 
HEINRICH, J. L., CURTIS, C. L., CREDO, G. M., KAVANAGH, K. L. & SAILOR, M. 
J. 1992. LUMINESCENT COLLOIDAL SILICON SUSPENSIONS FROM 
POROUS SILICON. Science, 255, 66-68. 
HINES, M. A. & GUYOT-SIONNEST, P. 1996. Synthesis and characterization of 
strongly luminescing ZnS-Capped CdSe nanocrystals. Journal of Physical 
Chemistry, 100, 468-471. 
HOFFNER, S., JIMENEZ-MISAS, C. & LUNDIN, A. 1999. Improved extraction and 
assay of mycobacterial ATP for rapid drug susceptibility testing. Luminescence, 
14, 255-261. 
IMAMURA, H., NHAT, K. P. H., TOGAWA, H., SAITO, K., IINO, R., KATO-
YAMADA, Y., NAGAI, T. & NOJI, H. 2009. Visualization of ATP levels inside 
single living cells with fluorescence resonance energy transfer-based genetically 
encoded indicators. Proceedings of the National Academy of Sciences of the 
United States of America, 106, 15651-15656. 
INVITROGEN 2005. The handbook-a guide to fluorescent probes and labeling 
technologies. Invitrogen Corp. 
IPE, B. I., LEHNIG, M. & NIEMEYER, C. M. 2005. On the generation of free radical 
species from quantum dots. Small, 1, 706-709. 
IVANOV, A. I. 2008. Pharmacological inhibition of endocytic pathways: is it specific 
enough to be useful? Methods Mol Biol, 440, 15-33. 
IVERSEN, T.-G., SKOTLAND, T. & SANDVIG, K. 2011. Endocytosis and 
intracellular transport of nanoparticles: Present knowledge and need for future 
studies. Nano Today, 6, 176-185. 
JAISWAL, J. K. & SIMON, S. M. 2004. Potentials and pitfalls of fluorescent quantum 
dots for biological imaging. Trends in Cell Biology, 14, 497-504. 
JENSEN, S. E., HUBRECHTS, P., KLEIN, B. M. & HASLOV, K. R. 2008. 
Development and validation of an ATP method for rapid estimation of viable 
units in lyophilised BCG Danish 1331 vaccine. Biologicals, 36, 308-314. 
179 
 
KANG, Z., LIU, Y. & LEE, S.-T. 2011. Small-sized silicon nanoparticles: new 
nanolights and nanocatalysts. Nanoscale, 3, 777-791. 
KIRCHNER, C., LIEDL, T., KUDERA, S., PELLEGRINO, T., JAVIER, A. M., GAUB, 
H. E., STOLZLE, S., FERTIG, N. & PARAK, W. J. 2005. Cytotoxicity of 
colloidal CdSe and CdSe/ZnS nanoparticles. Nano Letters, 5, 331-338. 
KISS, L., WALTER, F. R., BOCSIK, A., VESZELKA, S., OZSVARI, B., PUSKAS, L. 
G., SZABO-REVESZ, P. & DELI, M. A. 2013. Kinetic analysis of the toxicity 
of pharmaceutical excipients Cremophor EL and RH40 on endothelial and 
epithelial cells. J Pharm Sci, 102, 1173-81. 
KOLIBAB, K., DERRICK, S. C., JACOBS, W. R. & MORRIS, S. L. 2012. 
Characterization of an intracellular ATP assay for evaluating the viability of live 
attenuated mycobacterial vaccine preparations. J Microbiol Methods, 90, 245-9. 
KOVALEV, D., HECKLER, H., BEN-CHORIN, M., POLISSKI, G., 
SCHWARTZKOPFF, M. & KOCH, F. 1998. Breakdown of the k-conservation 
rule in Si nanocrystals. Physical Review Letters, 81, 2803-2806. 
LEARY, J. F. 2010. Nanotechnology: what is it and why is small so big? Canadian 
Journal of Ophthalmology-Journal Canadien D Ophtalmologie, 45, 449-456. 
LI, N., SIOUTAS, C., CHO, A., SCHMITZ, D., MISRA, C., SEMPF, J., WANG, M. Y., 
OBERLEY, T., FROINES, J. & NEL, A. 2003. Ultrafine particulate pollutants 
induce oxidative stress and mitochondrial damage. Environmental Health 
Perspectives, 111, 455-460. 
LIE, L. H., DUERDIN, M., TUITE, E. M., HOULTON, A. & HORROCKS, B. R. 2002. 
Preparation and characterisation of luminescent alkylated-silicon quantum dots. 
Journal of Electroanalytical Chemistry, 538, 183-190. 
LIN, C.-H., YANG, M.-H., CHANG, L. W., YANG, C.-S., CHANG, H., CHANG, W.-
H., TSAI, M.-H., WANG, C.-J. & LIN, P. 2011. Cd/Se/Te-based quantum dot 
705 modulated redox homeostasis with hepatotoxicity in mice. Nanotoxicology, 
5, 650-663. 
LITTAU, K. A., SZAJOWSKI, P. J., MULLER, A. J., KORTAN, A. R. & BRUS, L. E. 
1993. A LUMINESCENT SILICON NANOCRYSTAL COLLOID VIA A 
HIGH-TEMPERATURE AEROSOL REACTION. Journal of Physical 
Chemistry, 97, 1224-1230. 
LIU, P., SUN, Y., WANG, Q., SUN, Y., LI, H. & DUAN, Y. 2014. Intracellular 
trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-
PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas. Biomaterials, 
35, 760-70. 
MANGOLINI, L., JURBERGS, D., ROGOJINA, E. & KORTSHAGEN, U. 2006. 
Plasma synthesis and liquid-phase surface passivation of brightly luminescent Si 
nanocrystals. Journal of Luminescence, 121, 327-334. 
180 
 
MANGOLINI, L., THIMSEN, E. & KORTSHAGEN, U. 2005. High-yield plasma 
synthesis of luminescent silicon nanocrystals. Nano Letters, 5, 655-659. 
MANKE, A., WANG, L. & ROJANASAKUL, Y. 2013. Mechanisms of Nanoparticle-
Induced Oxidative Stress and Toxicity. Biomed Research International. 
MARSH, M. & MCMAHON, H. T. 1999. Cell biology - The structural era of 
endocytosis. Science, 285, 215-220. 
MARTIN, K. R. 2013. Silicon: the health benefits of a metalloid. Metal ions in life 
sciences, 13, 451-73. 
MASTRONARDI, M. L., HENDERSON, E. J., PUZZO, D. P. & OZIN, G. A. 2012. 
Small Silicon, Big Opportunities: The Development and Future of Colloidally-
Stable Monodisperse Silicon Nanocrystals. Advanced Materials, 24, 5890-5898. 
MEDINTZ, I. L., UYEDA, H. T., GOLDMAN, E. R. & MATTOUSSI, H. 2005. 
Quantum dot bioconjugates for imaging, labelling and sensing. Nature 
Materials, 4, 435-446. 
MICHALET, X., PINAUD, F. F., BENTOLILA, L. A., TSAY, J. M., DOOSE, S., LI, J. 
J., SUNDARESAN, G., WU, A. M., GAMBHIR, S. S. & WEISS, S. 2005. 
Quantum dots for live cells, in vivo imaging, and diagnostics. Science, 307, 538-
544. 
MURRAY, C. B., NORRIS, D. J. & BAWENDI, M. G. 1993. SYNTHESIS AND 
CHARACTERIZATION OF NEARLY MONODISPERSE CDE (E = S, SE, TE) 
SEMICONDUCTOR NANOCRYSTALLITES. Journal of the American 
Chemical Society, 115, 8706-8715. 
NAGASAWA, S., OGURA, K., TSUTSUKI, H., SAITOH, H., MOSS, J., IWASE, H., 
NODA, M. & YAHIRO, K. 2014. Uptake of Shiga-toxigenic Escherichia coli 
SubAB by HeLa cells requires an actin- and lipid raft-dependent pathway. Cell 
Microbiol, 16, 1582-1601. 
NEL, A., XIA, T., MADLER, L. & LI, N. 2006. Toxic potential of materials at the 
nanolevel. Science, 311, 622-627. 
O'FARRELL, N., HOULTON, A. & HORROCKS, B. R. 2006. Silicon nanoparticles: 
applications in cell biology and medicine. International Journal of 
Nanomedicine, 1, 451-472. 
OBERDORSTER, G., STONE, V. & DONALDSON, K. 2007. Toxicology of 
nanoparticles: A historical perspective. Nanotoxicology, 1, 2-25. 
OHTA, S., INASAWA, S. & YAMAGUCHI, Y. 2012. Real time observation and kinetic 
modeling of the cellular uptake and removal of silicon quantum dots. 
Biomaterials, 33, 4639-4645. 
PALOZZA, P., SESTITO, R., PICCI, N., LANZA, P., MONEGO, G. & RANELLETTI, 
F. O. 2008. The sensitivity to beta-carotene growth-inhibitory and proapoptotic 
181 
 
effects is regulated by caveolin-1 expression in human colon and prostate cancer 
cells. Carcinogenesis, 29, 2153-61. 
PARAK, W. J., PELLEGRINO, T. & PLANK, C. 2005. Labelling of cells with quantum 
dots. Nanotechnology, 16, R9-R25. 
PARK, J.-H., GU, L., VON MALTZAHN, G., RUOSLAHTI, E., BHATIA, S. N. & 
SAILOR, M. J. 2009. Biodegradable luminescent porous silicon nanoparticles 
for in vivo applications. Nature Materials, 8, 331-336. 
PHILLIPS, R., URSELL, T., WIGGINS, P. & SENS, P. 2009. Emerging roles for lipids 
in shaping membrane-protein function. Nature, 459, 379-385. 
RODUNER, E. 2006. Size matters: why nanomaterials are different. Chemical Society 
Reviews, 35, 583-592. 
RUIZENDAAL, L., BHATTACHARJEE, S., POURNAZARI, K., ROSSO-VASIC, M., 
DE HAAN, L. H. J., ALINK, G. M., MARCELIS, A. T. M. & ZUILHOF, H. 
2009. Synthesis and cytotoxicity of silicon nanoparticles with covalently 
attached organic monolayers. Nanotoxicology, 3, 339-347. 
SAILOR, M. J. & LEE, E. J. 1997. Surface chemistry of luminescent silicon 
nanocrystallites. Advanced Materials, 9, 783-&. 
SANTOS, H. A., BIMBO, L. M., HERRANZ, B., SHAHBAZI, M.-A., HIRVONEN, J. 
& SALONEN, J. 2013. Nanostructured porous silicon in preclinical imaging: 
Moving from bench to bedside. Journal of Materials Research, 28, 152-164. 
SANTOS, H. A., RIIKONEN, J., SALONEN, J., MAKILA, E., HEIKKILA, T., 
LAAKSONEN, T., PELTONEN, L., LEHTO, V.-P. & HIRVONEN, J. 2010. In 
vitro cytotoxicity of porous silicon microparticles: Effect of the particle 
concentration, surface chemistry and size. Acta Biomaterialia, 6, 2721-2731. 
SAYES, C. M., REED, K. L. & WARHEIT, D. B. 2007. Assessing toxicity of fine and 
nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity 
profiles. Toxicological Sciences, 97, 163-180. 
SCHMITTGEN, T. D. & LIVAK, K. J. 2008. Analyzing real-time PCR data by the 
comparative C-T method. Nature Protocols, 3, 1101-1108. 
SCHOENFELD, O., ZHAO, X., CHRISTEN, J., HEMPEL, T., NOMURA, S. & 
AOYAGI, Y. 1996. Formation of Si quantum dots in nanocrystalline silicon. 
Solid-State Electronics, 40, 605-608. 
SETO, E. S., BELLEN, H. J. & LLOYD, T. E. 2002. When cell biology meets 
development: endocytic regulation of signaling pathways. Genes & 
Development, 16, 1314-1336. 
SHEN, P., OHTA, S., INASAWA, S. & YAMAGUCHI, Y. 2011. Selective labeling of 
the endoplasmic reticulum in live cells with silicon quantum dots. Chemical 
Communications, 47, 8409-8411. 
182 
 
SHIOHARA, A., PRABAKAR, S., FARAMUS, A., HSU, C.-Y., LAI, P.-S., 
NORTHCOTE, P. T. & TILLEY, R. D. 2011. Sized controlled synthesis, 
purification, and cell studies with silicon quantum dots. Nanoscale, 3, 3364-
3370. 
SHIRAHATA, N. 2011. Colloidal Si nanocrystals: a controlled organic-inorganic 
interface and its implications of color-tuning and chemical design toward 
sophisticated architectures. Physical Chemistry Chemical Physics, 13, 7284-
7294. 
SILVIUS, J. R. 2003. Role of cholesterol in lipid raft formation: lessons from lipid 
model systems. Biochimica Et Biophysica Acta-Biomembranes, 1610, 174-183. 
SIMKO, M. & MATTSSON, M.-O. 2010. Risks from accidental exposures to 
engineered nanoparticles and neurological health effects: A critical review. 
Particle and Fibre Toxicology, 7, 1-15. 
SINGH, N., MANSHIAN, B., JENKINS, G. J. S., GRIFFITHS, S. M., WILLIAMS, P. 
M., MAFFEIS, T. G. G., WRIGHT, C. J. & DOAK, S. H. 2009. 
NanoGenotoxicology: The DNA damaging potential of engineered 
nanomaterials. Biomaterials, 30, 3891-3914. 
SINGH, N. P., MCCOY, M. T., TICE, R. R. & SCHNEIDER, E. L. 1988. A simple 
technique for quantitation of low levels of DNA damage in individual cells. Exp 
Cell Res, 175, 184-91. 
SMITH, A. M., DUAN, H., MOHS, A. M. & NIE, S. 2008. Bioconjugated quantum 
dots for in vivo molecular and cellular imaging. Advanced Drug Delivery 
Reviews, 60, 1226-1240. 
SOOD, A., SALIH, S., ROH, D., LACHARME-LORA, L., PARRY, M., HARDIMAN, 
B., KEEHAN, R., GRUMMER, R., WINTERHAGER, E., GOKHALE, P. J., 
ANDREWS, P. W., ABBOTT, C., FORBES, K., WESTWOOD, M., APLIN, J. 
D., INGHAM, E., PAPAGEORGIOU, I., BERRY, M., LIU, J., DICK, A. D., 
GARLAND, R. J., WILLIAMS, N., SINGH, R., SIMON, A. K., LEWIS, M., 
HAM, J., ROGER, L., BAIRD, D. M., CROMPTON, L. A., CALDWELL, M. 
A., SWALWELL, H., BIRCH-MACHIN, M., LOPEZ-CASTEJON, G., 
RANDALL, A., LIN, H., SULEIMAN, M. S., EVANS, W. H., NEWSON, R. & 
CASE, C. P. 2011. Signalling of DNA damage and cytokines across cell barriers 
exposed to nanoparticles depends on barrier thickness. Nature Nanotechnology, 
6, 824-833. 
SPEIT, G. & HARTMANN, A. 2006. The comet assay: a sensitive genotoxicity test for 
the detection of DNA damage and repair. Methods in molecular biology (Clifton, 
N.J.), 314, 275-86. 
SWERYDA-KRAWIEC, B., CASSAGNEAU, T. & FENDLER, J. H. 1999. Surface 
modification of silicon nanocrystallites by alcohols. Journal of Physical 
Chemistry B, 103, 9524-9529. 
TANSIL, N. C. & GAO, Z. 2006. Nanoparticles in biomolecular detection. Nano Today, 
1, 28-37. 
183 
 
TEDRICK, K., TRISCHUK, T., LEHNER, R. & EITZEN, G. 2004. Enhanced 
membrane fusion in sterol-enriched vacuoles bypasses the Vrp1p requirement. 
Molecular Biology of the Cell, 15, 4609-4621. 
THANNICKAL, V. J. & FANBURG, B. L. 2000. Reactive oxygen species in cell 
signaling. Am J Physiol Lung Cell Mol Physiol, 279, L1005-28. 
THE ROYAL SOCIETY, T. R. A. O. E. 2004. Nanoscience and nanotechnologies: 
opportunities and uncertainties. . 
TICE, R. R., AGURELL, E., ANDERSON, D., BURLINSON, B., HARTMANN, A., 
KOBAYASHI, H., MIYAMAE, Y., ROJAS, E., RYU, J. C. & SASAKI, Y. F. 
2000. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic 
toxicology testing. Environmental and Molecular Mutagenesis, 35, 206-221. 
TRUONG, T. Q., AUBIN, D., FALSTRAULT, L., BRODEUR, M. R. & BRISSETTE, 
L. 2010. SR-BI, CD36, and caveolin-1 contribute positively to cholesterol efflux 
in hepatic cells. Cell biochemistry and function, 28, 480-9. 
TU, C., MA, X., HOUSE, A., KAUZLARICH, S. M. & LOUIE, A. Y. 2011. PET 
Imaging and Biodistribution of Silicon Quantum Dots in Mice. Acs Medicinal 
Chemistry Letters, 2, 285-288. 
VERCAUTEREN, D., VANDENBROUCKE, R. E., JONES, A. T., REJMAN, J., 
DEMEESTER, J., DE SMEDT, S. C., SANDERS, N. N. & BRAECKMANS, K. 
2010. The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: 
Optimization and Pitfalls. Molecular Therapy, 18, 561-569. 
WANG, H. & JOSEPH, J. A. 1999. Quantifying cellular oxidative stress by 
dichlorofluorescein assay using microplate reader. Free Radic Biol Med, 27, 
612-6. 
WANG, L., REIPA, V. & BLASIC, J. 2004. Silicon nanoparticles as a luminescent label 
to DNA. Bioconjugate Chemistry, 15, 409-412. 
WANG, Q., BAO, Y., ZHANG, X., COXON, P. R., JAYASOORIYA, U. A. & CHAO, 
Y. 2012. Uptake and Toxicity Studies of Poly-Acrylic Acid Functionalized 
Silicon Nanoparticles in Cultured Mammalian Cells. Advanced Healthcare 
Materials, 1, 189-198. 
WANG, X., ZHUANG, J., PENG, Q. & LI, Y. D. 2005. A general strategy for 
nanocrystal synthesis. Nature, 437, 121-124. 
WANG, Z., TIRUPPATHI, C., MINSHALL, R. D. & MALIK, A. B. 2009. Size and 
Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial Cells. 
Acs Nano, 3, 4110-4116. 
WARNER, J. H., HOSHINO, A., YAMAMOTO, K. & TILLEY, R. D. 2005. Water-
soluble photoluminescent silicon quantum dots. Angewandte Chemie-
International Edition, 44, 4550-4554. 
184 
 
WILCOXON, J. P., SAMARA, G. A. & PROVENCIO, P. N. 1999. Optical and 
electronic properties of Si nanoclusters synthesized in inverse micelles. Physical 
Review B, 60, 2704-2714. 
WILSON, M. R., LIGHTBODY, J. H., DONALDSON, K., SALES, J. & STONE, V. 
2002. Interactions between ultrafine particles and transition metals in vivo and 
in vitro. Toxicology and Applied Pharmacology, 184, 172-179. 
WOLKIN, M. V., JORNE, J., FAUCHET, P. M., ALLAN, G. & DELERUE, C. 1999. 
Electronic states and luminescence in porous silicon quantum dots: The role of 
oxygen. Physical Review Letters, 82, 197-200. 
XIA, T., KOVOCHICH, M., BRANT, J., HOTZE, M., SEMPF, J., OBERLEY, T., 
SIOUTAS, C., YEH, J. I., WIESNER, M. R. & NEL, A. E. 2006. Comparison of 
the abilities of ambient and manufactured nanoparticles to induce cellular 
toxicity according to an oxidative stress paradigm. Nano Letters, 6, 1794-1807. 
XIA, T., KOVOCHICH, M., LIONG, M., MAEDLER, L., GILBERT, B., SHI, H., 
YEH, J. I., ZINK, J. I. & NEL, A. E. 2008a. Comparison of the Mechanism of 
Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution 
and Oxidative Stress Properties. Acs Nano, 2, 2121-2134. 
XIA, T., KOVOCHICH, M., LIONG, M., ZINK, J. I. & NEL, A. E. 2008b. Cationic 
polystyrene nanosphere toxicity depends on cell-specific endocytic and 
mitochondrial injury pathways. ACS Nano, 2, 85-96. 
YEH, T.-K., WU, J.-P., CHANG, L. W., TSAI, M.-H., CHANG, W.-H., TSAI, H.-T., 
YANG, C. S. & LIN, P. 2011. Comparative tissue distributions of cadmium 
chloride and cadmium-based quantum dot 705 in mice: Safety implications and 
applications. Nanotoxicology, 5, 91-97. 
YU, W. W. 2008. Semiconductor quantum dots: synthesis and water-solubilization for 
biomedical applications. Expert Opinion on Biological Therapy, 8, 1571-1581. 
ZHANG, L. B., COFFER, J. L. & ZERDA, T. W. 1998. Properties of luminescent Si 
nanoparticles in sol-gel matrices. Journal of Sol-Gel Science and Technology, 
11, 267-272. 
ZHANG, W., TONG, L. & YANG, C. 2012. Cellular Binding and Internalization of 
Functionalized Silicon Nanowires. Nano Letters, 12, 1002-1006. 
ZIMMERBERG, J. & GAWRISCH, K. 2006. The physical chemistry of biological 
membranes. Nature Chemical Biology, 2, 564-567. 
 
 
 
 
 
